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Abstract :-
Methylmalonyl-CoA is a key building block in the biosynthesis of 
propionate derived polyketide metabolites. There are several known 
metabolic sources of methylmalonyl-CoA, e.g. succinyl-CoA (citric acid 
cycle), valine and isoleudne. An objective of this research was to investigate 
the role of the DNA base, thymine, as a source of methylmalonyl-CoA in 
Streptomyces and hence probe the link between primary and secondary 
metabolism. Feeding key intermediates of the thymine and valine cataboHc 
pathways, i.e. [^^C^H^-methyl]-thymine, pC-methyl]- and [l-13C]-p-
aminoisobutyric acid, sodium l3-^^C]-isobutyrate, sodium [^^C-methyl}-
methacrylate and sodium [l-13C]-methacrylate, to the monensin A producer, 
Streptomyces cinnamonensis, provided evidence of the reductive 
cataboUsm of thymine occurring in Streptomyces, analogous to mammals. 
The results also provided evidence which supports the existence of a novel 
deaminase er\zyme mediating the transformation of p-aminoisobutyric acid 
and methacrylyl-CoA. 
Cubensic add, isolated from Xylaria cubensis, is a long chain fungal 
metabolite possessing eight pendant methyl groups. Its biosynthesis from 
acetate and L-methioiune vmits was demonstrated with the aid of feeding 
experiments, proving a classical fungal mode of assembly. Attempts to 
incorporate an advanced methylated precursor into cubensic add were 
unsuccessful. Biological intramolecular Diels-Alder reactions are impUcated 
in the biosynthesis of a wide range of polyketide metabolites, e.g. nargenidn, 
solanapyrones. Attempts to demonstrate, by feeding an isotopically labelled 
precursor, an intramolecular Diels-Alder mechanism for the formation of 
the six membered ring in cytochalasin D, proved inconclusive. In the event, 
the precursor was degraded to acetate. This degradation was suppressed in 
the second attempt by the addition of a p-oxidation inhibitor, but still no 
incorporation of labelled precursor was evident. 
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'The only way is up' 
'We are indeed in much the same position as an observer trying to gain an 
idea of the life of a household by a careful scrutiny of the persons or 
materials arriving at, or leaving the house: We keep an accurate record of 
the foods and commodities left at the door and patiently examine the 
contents of the dustbin and endeavour to deduce from such data the events 
occurring within the closed doors/ 
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Metabolism is the collective word for all the chemical reactions which take 
place i n l i v ing systems. Organic compounds (metabolites) are 
interconverted in living cells to produce both the complex molecules of life 
and the waste products of metabolism. Essentially the same metabolic 
sequences are utilised by a wide range of organisms, e.g. bacteria, plants, 
mammals. 
Metabolic pathways can be dassified into two main categories:-
i) catabolic pathways 
ii) anabolic pathways 
The functioits of the catabolic pathways are to degrade primary carbon 
sources, which are taken i n as food, i n order to produce precursors for 
biosynthesis and also to generate chemical energy i n a form which is 
suitable for powering the energy reqmring operations of the cell or 
organism. A further function is the conversion of waste material to a 
chemical form which is suitable for excretion from the cell or organism. The 
function of the anabolic pathways, on the other hand, is to synthesise the 
complex molecules needed to build, maintain and reproduce the living cells 
f rom smaller precursors. These two types of metabolic pathways are dosely 
integrated, i.e. catabolic pathways service the anabolic pathways by 
providing tiie starting materials and the necessary chemical energy for the 
operation of the biosynfhetic pathways.^ 
IJl Primary and secondary metabolism 
Primary metabolism has a broad distribution amoi\g all living organisms 
and is essential to cellular metabolism. The products of these metabolic 
processes are for example, amino adds, sugars and nucleotides e.tc, and 
they can be contrasted with secondary metabolites, which are generally non-
essential to the survival of individual cells but are important to the 
survival and function of the producing organism as a whole. Secondary 
metabolites are generally produced by the products of primary metabolism. 
They' can have very elaborate and diverse structtires, examples of which are 








1.3 Secondary metabolites 
Generally secondary metaboUtes are not necessary for the growth of the 
producing organism, i.e. elimination of the production of secondary 
metabolites by mutation wi l l not necessarily stop or slow down the growth 
of the organism.2 So what is the function of secondary metabolites in 
nature? 
This is a controversial area and attempts to define an imderlying 
benefit common to the production of all secondary metabolites has not been 
forthcoming. A likely function could clearly be defence. For example, 
secondary metabolites are most abundant in micro-organisms which live in 
crowded habitats where nutrients may be limited, and i t could be of benefit 
to the micro-organism to use chemical defence and attack to aid survival. 
Whatever the biological role, the secondary metabolites must have been 
continuously beneficial to the producing organism for the spread and 
survival of the genes encoding them to be selected and reinforced with each 
generation.3 
A great deal of interest has been stimulated, particularly in the 
pharmaceutical industry after screening programmes revealed that a 
number of secondary metabolites display antibiotic activity. The 
Actinomycetes (sporulating, soil-borne organisms), partictilarly, produce a 
wide range of secondary metabolites some of which have useful 
applications in clinical and veterinary medicine and agriculture. Such 
extensive screening programmes have led to the isolation and structure 
elucidation of many secondary metabolites but there still remains an 
extensive untapped microbial resource potentially available for drug 
screening.* 
2.POLYKETIDES 
2.1 History of discovery 
Polyketides are one of the largest families of secondary metaboUtes. They are 
espedally abundant among Actinomycete bacteria, eucaryotic fungi and 
higher plants, but are also present in many other groups, eg. higher animals, 
marine organisms. 
In 1907, J. N . Collie was the first to acknowledge that many natural 
products contained within them a [CH2-00]n unit.5 He hypothesised that a 
diverse range of aromatics, including some naturally occurring spedes, 
could be generated from condensations of acetic add, acetoacetate and 
higher homologues of acetate, and some experimental evidence was also 
provided in support of this theory.^'7 D. Rittenberg and K. Bloch, 40 years 
later, established the involvement of acetate in fatty add biosynthesis by 
successfully incorporating labelled acetate into fatty acids.8'9 This 
encouraged Sir. R. Robinson to elaborate on Collie's ideas and develop his 
hypothesis in a book in 1955 entitied The structural relationships of natural 
products. In this text, he predicted the origin of tetracycline antibiotics and 
other polyketides.io Independently, A. J. Birch outlined his 'acetate 
hypothesis', i.e. that acetate was the building block of many aromatic plant 
metabolites.11'12 xhe discovery led by F. Lynen, that acetyl coenzyme-A acts 
as 'active acetate' in fatty add and steroid construction^3,l4 encouraged Birch 
to analyse and confirm the structures of many aromatic polyketide 
metabolites by demonstrating that they were compatible with the folding of 
extended acetate derived p-keto chains.15,16 Birch^^ was the first to perform 
biosynthetic experiments on fungal aromatic metabolites and therefore 
proving the biosynthetic role of acetate. Another of his contributions was 
the demonstration that the pendant methyl groups of fimgal polyketides are 
derived f rom the methyl group of L-methionine.l8 The basic origin of the 
polyketides was firmly established which opened the doors to a flood of 
reports of novel polyketide metabolites, their structxjre and biogenesis. 
12 Fatty adds 
Fatty adds are primary metabolites which are common to all living cells 
(with the exception of archaebacteria). They are characterised by a long 
hydrocarbon chain wi th a carboxylic add terminus. As constituents of 
phosphoUpids, fatty adds play a critical structural role in the assembly of cell 
membranes. They are also found in cells as triglycerides where they are 
stored as a food reserve. In Actinomycete batch cultures, generally the fatty 
adds are produced during the first stage of growth {tropophase) and are then 
degraded by p-oxidation to acetate which can be utilised i n secondary 
metabolism, e.g. polyketide synthesis, which takes place during the second 
stage of growth (idiophase) of the cvilture. It is useful to discuss the mode of 
assembly of fatty adds in the first instance as the process by which the 
saturated fatty adds are assembled offers a blueprint for the construction of 
polyketide metabolites.l^ 
2.2.1 Fatty add biosynthesis 
There are variations i n the way different organisms organize their cellular 
machinery to biosjmthesise fatty adds, but a pivotal compoimd is acetyl 
coenzyme-A (acetyl-CoA) (3). 
O \ / 
I H H i II II 
OH 
(3) acetyl coenzyme-A 
O OH 
The biosynthesis of long chain fatty adds occurs essentially in two distind 
steps;-20 
i) generation of malonyl-CoA by the action of acetyl-CoA carboxylase on 
acetyl-CoA 
[biotin] 
CH^COSCoA + CO2 + ATP ^ HO2CCH2COSC0A + ADP + P^  
ii) conversion of acetyl-CoA and malonyl-CoA into the fatty add (palmitate) 
by the fatty add synthase in the presence of NADPH as co-factor 
CH3CC)SCoA + 7HO2CCH2COSC0A + 14NADPH + 14H^ 
CH3CH2(CH2CH2)6CH2G02H + 14NADP^ + 8C0A-SH + 6H2O 
The acyl and malonyl thioesters are processed by the fatty add synthase 
(FAS) and the fatty acid is ful ly assembled without the release of partially 
constructed intermediates.20 There is a wide diversity in the structure of the 
FAS's utilised by different organisms but they can generally be classified as 
Type I or Type I I FAS's.^^ Type I FAS's are found in most of the higher 
organisms, eg. insects, birds and mammals. These are either tightly bound 
complexes of individual enzymes which do not dissodate easily, or one or 
two multifimctional proteins upon which all the necessary activities exist. 
Type I I FAS's consist of discrete monofunctional enzymes and an acyl 
carrier protein, all of which are separable and express their individual 
activities in isolation from each other. Examples of organisms possessing a 
Type n FAS are most bacteria, plants and photosynthetic eukaryotes. Yeast 
and fungal FAS's seem to have characteristics of both Type I and Type n 
complexes.21 A few representatives of the Actinomycetes, have FAS's which 
appear to be clusters of multiftmctional proteins with similar characteristics 
to yeast and fungal systems and so are classified as Type I (discussed in 
chapter 4, part B).!^ 
H H i II ^ 




(4) acyl carrier protein 
NH 
The acyl carrier protein (ACP) (4) has the role of co-ordinating fatty add 
biosynthesis, by chaperorung the intermediate acyl groups as thioesters 
around the catalytic sites of the FAS. In Type n FAS's, the ACP is a single 
defined protein but in T3rpe I FAS's, the acyl carrier protein is a domain 
consisting of a serine residue which covalently links the 4'-
phosphopantetheine group to the synthase.l^ 
A summary of the mode of assembly of fatty adds is outlined in scheme 
1.15 Acetyl-CoA becomes activated to malonyl-CoA by the action of the 
biotin requiring enzyme acetyl-CoA carboxylase. Malonyl-CoA is then 
transacylated wi th the 4'-phosphopantetheine moiety of ACP and the 
resultant malonyl-ACP (5) is located at the appropriate site of the 
condensing enzyme, p-ketoacyl-ACP synthase. A decarboxylative 
condensation takes place with a molecule of acetyl-CoA and the resultant p-
ketoacyl-ACP (6) is then transported to the next enzyme, p-ketoacyl-ACP 
reductase, which mediates reduction to the D-alcohol in the presence of 
NAD(P)H to afford D-p-hydroxyacyl-ACP (7). The acyl carrier protein then 
guides the intermediates through the ftirther stages of the cycle, i.e. 
dehydration to yield (8) mediated by p-hydroxyacyl-ACP dehydratase and 
then reduction to give a fuUy saturated Q-ACP unit (9) mediated by enoyl-
ACP reductase in the presence of NAD(P)H. In order to begin the next cyde, 
the Q unit is transesterified onto a free thiol residue at the active site of the 
condensing enzyme such that the thiol of ACP is now released and available 
to transesterify wi th another malonyl-CoA, and the second cyde can begin. 
These cydes repeat themselves imti l the fatty add of optimimi length is 
generated and is released f rom the fatty add synthase to give a free 
carboxylic add. 
Until recently it had been generally accepted that acetyl-CoA tmderwent 
a transacylation wi th a free thiol residue on the condensing enzyme prior to 
the first condensation wi th malonyl-ACP. However a specific p-ketoacyl 
synthase (condensing enzyme DI) has been isolated f rom £. coli, which 
mediates the first condensation between acetyl-CoA and malonyl-ACP.22 
The resultant p-ketoacyl-ACP (6) is then processed as outlined in scheme 1. 
, This is emerging as a general feature of the dissodated Type n FAS's of 
baderia and plants^S and may explain the occurrence of imusual starter 
units, eg. isobutyrate, cydohexylcarboxylate and others, in certain fatty adds. 
This condensing enzyme could be less selective in the condensation of CoA-
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In Type n FAS's, the condensing enzyme I is involved in the assembly of 
the fatty add up to chain length and condensing enzyme n takes the 
fatty add from Ci6 to Cig and beyond.^ ^ 
23 Polyketide biosynthesis 
2.3.1 Fungal polyketides 
The majority of polyketide secondary metabolites identified from fungal 
and plant sources are aromatic, the non-aromatic compounds are more rare. 
The process of polyketide chain assembly is analogous to fatty add 
biosynthesis, i.e. acetyl-CoA is activated to malonyl-CoA. Malonyl-CoA then 
becomes transesterified onto the acyl carrier protein of the polyketide 
synthase (PKS) and a series of decarboxylative condensatioiv reductions etc 
occur. The polyketide synthase has the full complement of reducing 
enzyme that the FAS possesses, but a difference lies in the ability of the PKS 
to stop the reduction / elimination procedure at any stage prior to the next 
condensation. In fatty add biosynthesis a fully saturated chain is formed, eg. 
palmitate (10). In polyketide biosynthesis, however, the polyketide 
backbones often consist of partially reduced ketones or double bonds, 
leading to more complex structures, eg. cubensic add (11). 
(10) palmitate 
OO2H 
(11) cubensic add 
The process by which the oxidation level of the developing 
polyketide chain is adjusted to its fiiwl status, prior to the next condensation 
has been termed processive assembly .24 The alternative is a non-processive 
assembly where a 'polyketo' chain is formed in its entirety, for example (12) 
in the case of cubensic add, and then a series of enzyme activities perform 
all the relevant modifications to yield the polyketide metabolite. 
(12) 
(11) cubensic add 
Experimental evidence supporting a processive assembly of fungal and 
bacterial polyketide metabolites has been provided in the form of 
incorporations of partially reduced di-, tri- and tetra- ketides into several 
polyketide metabolites. Dehydrocurvularin (13), a fxingal metabolite 
produced by wild t3^e Alternaria cinerariae ATCCC 11784 25 is an example. 
The isotopically labelled substrates (14) and (15) have been shown to be 
regiospedfically incorporated into dehydrocurvularin.25 
AcHN 
NHAC 
OH O O 
(14) (13) dehydrocurvularin (15) 
Fxirther examples are the incorporations of partially assembled fragments 
into the Actinomycete metabolites, nargenicin from Nocardia 
argentinensis^^ (discussed in chapter 5) and tylosin (16) produced by mutant 
strains of Streptomyces fradiaeP The isotopically labelled substrates (17) and 
(18) were shown24 to be regiospedfically incorporated into the tylosin 












O' ^ 'OH 
(19) tylactone (18) 
NHAc 
Often polyketides possess branched chain methyl groups, e.g. cubensic 
add (11), and these pendant methyl groups, in fimgal polyketides, are 
generally derived from the methyl group of L-methionine activated as S-
adenosyl-L-methionine (SAM) (20). However in Actinomycete polyketides, 
the branched chain methyl groups are derived from the condensation of 
propionate units, e.g. tylosin (16), discussed in section 2.3.2. 
/NH3 
OH OH 
(20) S-adenosyl-L-methionine (SAM) 
11 
The exact timing of these C-methylations in fungal polyketides is unknown. 
There could exist a methyl transferase enzyme present on the PKS which 
mediates the aiikyla\ion of the methyl group from SAM to the polyketide 
during a processive assembly process, i.e. before the next condensation with 
a C2 unit takes place (discussed in chapter 4). Alternatively the C-
methylations could be post polyketide assembly modifications, like the O-
and N- methylations. From a mechanistic perspective it seems reasonable to 
suggest that the methyl group of SAM will be attacked by either a double 
bond or an activated methylene prior to ketone reduction. This is more 
probable than nucleophilic attack by a saturated polyketide backbone. 
Remarkably experimental evidence to support a processive methylation 
mechanism is lacking, as no advanced methylated precursors have been 
incorporated into fungal polyketides. 
232. Bacterial polyketides 
The polyketide synthases of bacterial polyketides utilise not only acetyl-CoA 
but also, propionyl-CoA and butjnyl-CoA during polyketide assembly. These 
intermediates become activated by carboxylase enzymes to methylmalonyl-
CoA (21) and ethylmalonyl-CoA (22) respectively, Propionyl-CoA 
carboxylase has been isolated and purified from the erythromydn A 
producer Saccharopolyspora erythraea and it mediates the conversion of 
propionyl-GoA to (2S)-methylmalonyl-CoA.28 (2S)-Methylmalonyl-CoA is 
then processed29 by the PBCS after transesterification onto an ACP, scheme 2. 
The PKS possesses all the reducing enzymes utilised in fatty add 
biosynthesis and so the cyde of condensations and reductions can begiiu The 
cyde can stop at any point and the next condensation with a C2 - C4 unit 
takes place (see section 2.3.1). The polyketide chain can therefore become 
very complex, comprising of pendant methyl and ethyl groups which can 
have either D or L configurations with resped to the direction of chain 
assembly, and also ketone, alcohol and double bond functionality or fully 
saturated methylene xmits. 
12 
A C P - S H 
CoA-SH 
OH O 
STEP 2 SACP S T E P l 
STEPS 
STEPS 
S T E P S , ^ 
STEPS 
SACP 
methylnjalonyl- n a C P - S H CoA -SH 11 







3. BIOSYNTHESIS TECHNIQUES 
3.1 Radioactive isotopes 
The radioactive isotopes, and ^ H (both p-emitters), were commonly used 
in bios3nithetic studies between the 1950 - 1970's. They are used to assess 
accurately the level of incorporation of a substrate into a metabolite, by the 
sensitive detection technique of scintillation cotmting. Unfortimately in 
order to determine the regiospecific sites of incorporation, the metabolite 
has to be chemically degraded, which can be a long and laborious task. Also 
to ensure an accurate result the sample requires recrystallisation to constant 
radioactivity which can be difficult with small amoimts of sample. With the 
advances in n.m.r. and analysis techniques of stable isotopes, in recent years 
radioactive isotopes are usually employed in exploration experiments prior 
to the deployment of stable isotopes. 
3.2 Stable isotopes 
The experimental study of biosynthesis has developed largely due to the use 
of radioactive isotopes such as ^HZ and ^H and also the infroduction of 
Foiuier transform nuclear magnetic resonance (n.m.r.)30 which provides 
the ability to detect regiospedfically, the location of stable isotopes in a 
molecule quickly, and without recourse to degradation of the molecule 
under study. The most common stable isotopes used include 1 ^ (nudear 
spin = 0.5), 2 h (nudear spin = 1) and l^N (nudear spin = 0.5). The use of 
isotopes is a popular tool. Enrichment of the l^C signals in a l^C n.m.r. 
spectrum of a metabolite gives information on where the label is located. 
However it is often difficult to accurately calculate the percentage 
incorporation because there are several influencing factors, eg. sample 
concenfration and relaxation effects. A lower practical limit for the accurate 
estimation of enrichment, is a signal enriched to the extent of 20% of the 
natural abtmdance signal.3l 
Deployment of dual labels offers a powerful technique in 
biosynthesis. If two enriched carbons (l^C) are adjacent to each other, 
coupling satellites are apparent as a doublet, flanking the natural abundance 
signal. Incorporations can be measured at very low eiuichments since the 
natural abvmdance of coupled signals is low (0.0123%). This 
approach is useful as it highlights the incorporation of intact C-C bonds into 
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the metabolite from labelled precursors. Extension of this strategy involves 
the use of ISC-^H (23) and ISC-C-^H (24) labelling in a precursor. 
; ' C . D C - D 
(23) (24) 
In the first case, the deuterium in a 13G-2H labelled precursor shifts the 
carbon-13 resonance of the carbon to which it is attached, to a lower 
frequency by 0.3 - 0.6ppm (a-shift). Hence the maximum shift for three 
deuteriums attached to a ^^C, i.e. l^C-^Ha, would be l.Sppm. Also the 
nudear spin on (= 1) increases the multiplidty of the carbon-13 signal in 
the n.m.r. spectrum. In the second case, the deuteritun in a ^SC-C-^H 
labelled precursor induces a lower frequency shift in the l^C n.m.r. spectrum 
of the p-carbonby 0.01 - 0.1 ppm per (p-shift). This labelling combination 
can also cause a higher frequency or zero shift particularly, if the carbon-13 is 
a carbonyl group.32 
The potential of ^ n.m.r. was first demonstrated^S in 1964 and 
deuterium is now widely used as a tracer isotope for biosynthetic studies,^ * 
There are several advantages of using deuterium. The chemical shift values 
obtained in n.m.r. spectra are similar to those in the corresponding 
n.m.r. spectra and hence assigimients are straight forward. It is a less 
expensive isotope and the low natural abimdance of deuterium (0.016%) 
compared with carbon-^ 13 (1.1%), renders it more sensitive, and hence very 
low incorporations into a metabolite are detectable above natural 
abundance. A dear disadvantage, however, is that there is extensive line 
broadening in the n.m.r. and poor resolution. 
Oxygen-18 does not give an n.m.r. signal but its presence can be 
detededby l3Cn.m.r.,35 as 1 3 C - 1 ^ causes a shift of the carbon-13 resonance 
to lower frequency compared with ttiat of The shift range extends 
firom 0.01 - 0.035ppm for singly bonded oxygens to 0.03 - 0.55ppm for doubly 
bonded oxygens.31 Oxygen-17 can be deteded by rLm.r., it has a lower natural 
abundance than oxygen-18, but imfortimately there is line broadening in the 
n.m.r. and it is an expei\sive isotope.^l 
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4. Freds 
This thesis has been divided into parts 1 and 2 in order to highlight the two 
distinct categories of Actinomycete polyketides (part 1) and fungal 
polyketides (part 2). Each polyketide metabolite is discussed in an individual 
chapter, as there are unique aims and experimental targets. 
Monensin A produced by Streptomyces cinnamonensis is an 
Actinomycete metabolite and is outlined in chapter 2. Bacterial polyketide 
metabolites which incorporate propionate reqtiire a metabolic source of 
methylmalonyl-CoA and this chapter discusses the possible sources of this 
key building block, from L-valine, the dtric add cyde and from the DNA 
base thymine. The link between primary and secondary metabolism is 
probed with the aid of appropriate feeding experiments. Chapter 3 discusses 
how the stereochemistry of leptomydn B, an Actinomycete metabolite from 
Streptomyces sp. ATS 1287, may have been established by feeding sodium [2-
13c;2H2]-propionate. 
Part 2 and chapter 4 enters the arena of fungal polyketides and in 
particular cubensic add, a sfraight chain ftingal metabolite isolated from 
Xylaria cubensis. This chapter is split into parts A and B. The biosynthesis 
and biogenesis of cubensic add are discussed in parts A and B respectively. A 
h5T>othctical modular polyketide assembly is proposed based upon the 
established gene sequence and assembly process involved in erythromycin 
A biosynthesis. The mode of assembly of the six membered ring in 
cytodialasin D isolated from Xylaria cubensis is discussed in chapter 5 and 
attempts to prove a biological inframolecular Diels-Alder reaction are 
outlined. 
Chapter 6 includes full experimental details of the experiments 








The polyethers are a large dass of naturally occurring ionophores which 
have attraded a great deal of Interest due to their chemical and biochemical 
properties.36 The first polyether to be isolated was nigeridn (1)37 from 
Sireptomyces hygroscopicus over 30 years ago. 
HOgC 
(1) nigeridn 
The polyethers as a dass have a characteristic structural framework 
consisiting of tetrahydofuranyl and tetrahydropyranyl rings, and branched 
methyl and ethyl xmits. These metabolites are arranged in a conformation 
such that the oxygen atoms are able to complex alkali metal ions, analogous 
to crown ethers. The macrolide antibiotics, also products of Streptomycetes, 
are a second major class of poly oxygenated metabolites which bear a 
resemblance to the polyethers.38 An example is erythromydn A (2) 
produced by Saccharopolyspora erythraea, a key clinical antibiotic of this 
dass. 
There are39 structiiral similarities between these two important 
groups of natural products, both of which have a common biosynthetic 
origin from acetate, propionate and butyrate precursors. Celmer realised in 
1965, that there exists stereochemical homologies within the macrolides and 
he proposed a single stereochemical model which summarised the entire 
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dass.^ This empirical model has served as a guide to the structtiral and 
stereochemical assignment of new macrolide antibiotics and only a few 
exceptions to this model have been found.^l 
NHMea 
O' 
(2) erythromycin A 
A^ P, P, A, 
(3a) APPA polyene prototype 
12 ^11 ^10 
(3b) PAPA polyene prototype 
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A similar study of the polyether group of antibiotics has been 
reported.39 Putative42 partially reduced polyene intermediates in the 
biosynthesis of polyethers are microbiaUy epoxidised to their corresponding 
polyepoxides. These polyepoxides may then undergo enzymatically 
controlled cascade cyclisations generating the polyether frameworks 
(discussed in section 1.2). Cane, Celmer and Westley^ derived, from 
empirical observations, the two polyene prototypes APPA (3a) and PAPA 
(3b) which summarise the stereochemical patterns of more than 30 different 
polyether antibiotics, a And p highlight the recurring stereochemical \mits 
in each of the polyene prototypes indicating structural homologies. Such 
prototypes raise intriguing questions about the biogenetic origin of these 
structurally and stereochemically similar metaboUtes. 
1.2 Monensin A 
The polyether antibiotic monensin A (4)43 is an important agent in the 
control of cocddiosis in poultry .44 Both monensin A (4) and monensin B (5) 
are isolated as crystalline soditun salts from Streptomyces cinnamonensis. 
Monensin A differs from monensin B at C16 (R = Me or Et) with the 
incorporation of a butyrate over a propionate tmit diuing biosynthesis.45 
The structure of monensin A was determined in 19674^  and its 13c n.m.r. 
spectrum was fuUy assigned by two groups in 1982.47 
^Na-OzC 
(4) R = CH2CH3 
(5) R = CH3 
Monensin A was one of the first polyether antibiotics to be subjeded to 
biosynthetic investigations,4S and feeding experiments revealed that the 
carbon skeleton originates from 5. acetate, 7 propionate and 1 butyrate imit 




= acetate = propionate = butyrate 











Extensive isotopic labelling experiments on monensin A, utilising 
sodium [l-i80,l-l3C]-acetate and -propionate,i2(b)/49 and molecular ^K>i^ 
have established the origin of all the oxygen atoms in monensin A (7). The 
oxygen's at C I , C3, C5 were shown to derive from propionate, and those at 
C7, C9, C25 from acetate. The oxygen's at C13, C17, C21, C26 originate from 
molecular oxygen. These results led Cane et fl/.47(b) to speculate that 
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monensin A is biosynthesised from an all (E)-triene intermediate (8) which 
could undergo microbial epoxidation to the triepoxide (9). Such a triepoxide 
(9) could then be subjected to an enzymatically controlled cascade 
cyclisation, to generate the heterocyclic ring systems of monensin A with 
the correct stereochemistry. 




This hypothesis is compelling as it is also consistent with the origin of the 
oxygen's at C13, C17, C21 from molecular oxygen (scheme 1). 
An earlier speculation by Westley42 that lasalocid A (10) and 
isolasalocid A (11) may arise by differential cyclisation of a common 
diepoxide intermediate also reinforces this general view for polyether 
assembly. Westley's speculation was experimentally^^ supported by the 








(11) isolasalocid A 
Related investigations on narasin,52 lenoremycin,53 ICI13960354 and 
maduramicin^^ further strengthen this concept and therefore it is widely 
held that the polyene - polyepoxide hypothesis provides a rational 
explanation for the origin of these antibiotics. However there has been no 
definitive experimental evidence to support the hypothesis. Attempts^ ^ 
have been made to isolate biosynthetic intermediates in the monensin 
pathway, particularly the putative triene intermediate (8), but without 
success. 3-O-Demethylmonensins A and B (12)^7 (differing from the 
monensins by the presence of -OH over -OMe at C3) have been recovered as 
minor components from S. cinnamonensis fermentation broths. 
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^Na-OzC 
(12) 3-O-demethylmonensin A R = CHjCHg 
3-O-demethylmonensin B R = CH3 
Also from a mutant strain of S. cinnamonensis, blocked in monensin 
productioiv 26-deoxymonensins A and B (13) have been isolated.58 These 
intermediates were prepared in labelled form and fed to the cultures of S. 
cinnamonensis, but xmfortunately tiiere was no evidence of incorporation 
into the monensins.58 
+Na-02C 
(13) 26-deoxymonensin A R = CH2CH3 
26-deoxymonensin B R = CH3 
Robinson et al.^ have pursued the synthesis of the partially 
assembled putative diene (14) and triene (15) intermediates in the 
biosynthesis of the monensins, utilising 3H as the isotopic label and 
activated as a thioester (discussed in chapter 4), but upon feeding to 5. 
cinnamonensis there was no evidence of an intad incorporation into the 
monensins. Their interpretation was that the triene (15) was probably 
imable to cross the cell membrane, however the diene (14) could cross the 
cell membrane but was effidentiy degraded, presiunably by p-oxidation 





X = -CH2CH2NHCOC7H15 
Another possibility for the lack of incorporation of (14) and (15) could 
be due to the presentation of the incorrect structure to the system. It has 
been assmned that all of the double bonds involved in the cyclisation 
process have (E)- geometry, as this would lead to the correct stereochemistry 
for the monensins via the triepoxide hypothesis. Townsend^^ has however 
speculated that the triene intermediate (8) could have all (Z)- and not (E)-
double bond geometry. This hypothesis extends from the oxidative 
cyclisation processes involving a heteroatom - ferryl complex and 
particularly that mediated by clavaminate synthase (X = O) and 
isopenicillin-N synthase (X = S). If this system is applied to poly ether 
biosyntiiesis (scheme 2), then a pathway involving [2 + 2] cydoaddition of 
the ferryl species (16), with an olefin, would yield an oxametallocydobutane 
derivative (17) which would break down with retention of configtiration to 
give an oxygen ether (18), i.e. the C-X bond has replaced the C-Fe bond. The 
alternative pathway involving the epoxide ring opening wotild proceed 
with inversion of configuration. Hence, if the [2 + 2} cydoaddition pathway 
is operating, then the double bond geometry of the putative polyene 
intermediate would have to be (Z)- and not (E)-. This suggestion remains to 
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be tested, but adds a new perspective to the study of the biosynthesis of these 
polyethers. 
(16) 









Success has been obtained by Robinson el al.^ recently in the 
incorporation into monensin A of substrate (19), labelled with P^C^Hs]- and 
activated as an N-acetylcysteamine thioester. This incorporation was 
assisted by the addition of a p-oxidation inhibitor (to prevent substrate 
degradation) and 2,6-O-dimethyl-p-cyclodextrin (20) which improves the 
production of monensin A^l and helps to stimulate the uptake and 
incorporation of the substrate (19). The intact incorporation of this partially 
assembled intermediate (19) provides the first evidence of a processive 






2. SOURCES OF METHYLMALONYL-CoA 
2.1 Introduction 
SCoA 
Methylmalonyl-CoA (21) is the key building block in the biosynthesis of 
propionate derived polyketide metabolites. There are several well 
established metabolic routes to this intermediate. 
i) The carboxylation of propionyl-CoA. Propionyl-CoA carboxylase from 
Saccharopolyspora erythraea generates (2S)-methylmalonyl-CoA from 
propionyl-CoA.28 (2S)-Methylmalonyl-CoA then participates in polyketide 
biosynthesis by undergoing a decarboxylative condensation with inversion 
of configuration onto the developing polyketide chain.^ ^ 
ii) The citric acid cycle. Succinyl-CoA can undergo a rearrangement, 
mediated by methybnalonyl-CoA mutase, to (2R)-methylmalonyl-CoA63-65 
iii) Amino acid catabolism. CataboUc pathways particularly that of valine 
and isoleudne (discussed in section 2.3.3) afford methylmalonyl-CoA as a 
metabolic product. 
iv) Degradation of long chain fatty acids. This affords Q fatty adds (i.e. 
butyryl-CoA) which can be converted to isobutryl-CoA mediated by 
isobutyiyl-CoA mutase^^ and then processed via the series of en2ymes 
utilised in tiie catabolism of valine.62 
It is well established67,68 jn mammalian systems, that the catabolism 
of thymine (22) affords (2R)-p-aminoisobutyric acid (25) via the 
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intermediates (5R)-dihydrothymine (23) and p-ureidoisobutyric add (24) 
(scheme 3). So the possibility of thymine (a DNA base) degrading via a 
similar pathway in Streptomyces to afford methylmalonyl-CoA units is 
investigated. This probes further the links between primary and secondary 
metabolism and the possibility of nucleic adds providing a source of 











There are a small number of micro-organisms which are known to 
degrade pyrimidines via this reductive pathway,69 e.g. various yeasts,70 
Pseudomonas facilis^^'"^^ Clostridium sporogenes/^ Clostridium 
sticklandif^ and Nocardia ruhraJ^ However, C. sporogenes and C 
sticklandii are tmable to completely metabolise thymine. Dihydrothymine 
and p-ureidoisobutjrrate were observed as intermediates but there was no 
evidence of further degradation to p-aminoisobutyrate. Also the evidence 
for the reductive pathway in Nocardia rubra is based only on indirect 
evidence.69 Pseudomonas facilis^ and Candida utilis^^ are the only micro-
organisms known to utilise the carbon atoms of the pyrimidines, and this is 
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attributed to their ability to degrade p-alanine, an end product of the 
catabolism of uracil. 
A key objective of this research is to investigate the role of thjmiine as 
a source of methylmalonyl-CoA in Streptomyces. The investigation takes 
the form of feeding the key intermediates of the thymine and valine 
catabolic pathways, i.e. thymine, p-aminoisobutjoic add, sodium isobutyrate 
and sodium methacrylate, to the monensin A producer Streptomyces 
cinnamonensis followed by analyses of the relative incorporations. 
2.2 Synthesis 
2JZ.1 Synthesis of P^C-metfeyfl-thymine and pSC^Hs-meffeyZl-thymine 
49% 






Scheme 4. Reagents and conditions: i) POQ3, reflux 6d, 
ii) Na, MeOH, rt 0.5h, iii) "Buli, THF, -78°C 0.25h, iv) ^*CH3l 
and CH3I, -78 to -50°C 1.5h, v) C02f^ -50°C, vi) 15%Ha, reflux 
24h, vii) H"" Dowex. 
P^C-mcthy/j-Thymine (29) was synthesised as outlined in scheme 4.^/78 
Treatment of 5-bromouracil (26) with phosphorus oxychloride yielded 2,4-
dichloro-5-bromopyrimidine (27). Reaction of (27) with sodium methoxide 
afforded a white predpitate of 2,4-dimethoxy-5-bromopyrimidine (28) which 
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was then treated with »BuLi. The reaction mixture was cooled to -198oC and 
l^CHsI (ImQ) was transferred by vacuimi into the reaction flask. Unlabelled 
CH3I was added to a final specific activity of ^^CHsI of 0.475mCi/mmol and 
the reaction quenched by the addition of CO2. Add hydrolysis and 
purification by ion exchange (H+ form) chromatography afforded [l^C-
me^/zy/]-thymine (29) (926fiCi) with a radiochemical purity of 91.2% 
(determined by radiochemical tl.c. analysis [^uOH : H2O, (86:14) on silica]). 
Autoradio-ography also verified that the site of radioactivity on the t.l.c. 








I < I • I 
8 12 
Fig. 1, thin layer chromatography radioactivity scan with the 
autoradioography result superimposed. 
The IH n.m.r. of the prepared \}^^-methyl]-th.yadne indicated a small 
amotmt of uradl present (thymine : uracil, 9 : 1). The uracil is non-
radioactive and therefore should have no significant effect on the results. 
p3c2H3-methy/]-Thymine (30) was prepared in a similar manner by 
replacing the l^CHgi with 13C2H3L [^X?Hs-methyl]-Thymme was purified by 
sublimation. It sublimed as a white solid at 157oC and 0.023mmHg in a yield 
of 45% based upon 13C2H3L 
30 






H 3 « C . ^ J - OEt 
OEt 
(35) (34) 
Scheme 5. Reagents and conditions: i) NaH, THF, 0°C, ii) ^^CHji, 
reflux 2h, iii) N-{bromomethyI)phtlialimide, 0°C to r.L 1.5h, iv) 
H2NNH2, MeOH, r.t 12h, v) 10% HQ, reflux 12h, vi) H* Dowex. 
The synthesis of (DL)-[13C-metliyZ}-p-aminoisobutyric add was executed by a 
modification of tiie method of Bohme et al7^ as outlined in scheme 5. The 
route starts with sodium hydride treatment of diethyl malonate (31) 
followed by quenching of the resultant anion with 13CH3I. Further 
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alkylation of diethyl [l3G-methyi]-methylmalonate (32) under the same 
conditions, but quenching with N-(bromomethyl)-phthalimide yielded (33). 
Generation of the primary amine was achieved after treatment of (33) with a 
methanolic solution of anhydrous hydrazine to create (34), which was 
hydrolysed imder addic conditions and decarboxylated to yield [l^C-mefhy/J-
P-aminoisobutyric add hydrochloride in an overall yield of 37% from 
^^CHal. This material was used directly for feeding experiments, however, a 
small amoimt was purified, for characterisation purposes, by ion exchange 
(H+ form) chromatography, to afford (DL)-[13(;>methy/l-p-aminoisobutyric 
add (35) as a white solid. 










Scheme 6. Reagents and conditions: i) Na2CD3, 
CH3CN, r.t 2h, ii) NaCN, NaOH, H20,65 - 80°C 
2.5h, HQ^aq), iii) H^, PtOj in ElOH - CHa^ (10:1), 
2.5atm, r.t. 18h, iv) H'^ Dowex. 
The synthetic route to (DL)-[l-13Q.p.aminoisobut)nic add (39) is outlined in 
scheme 6. The synthesis of [l-l3C}<x-cyanopropionic add (37) followed a 
previous preparation by Redwine and Whaley.^ O [l-l^Q-a-Bromopropionic 
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acid (36) was converted into its sodium salt and then treated with sodium 
cyanide and sodium hydroxide, to yield (37) as a colourless oil. This proved 
to be problematic and a poor yielding reaction in our hands. It was 
reported^O that the reaction be heated to SO^C for 2.5 hours, but in the event 
the reaction proved temperamental and heat dependent, and was only 
successful if the temperature reached 80°C. Successive experiments also 
gave inconsistent results. [l-13C]-a-Cyanopropionic acid (37) was taken 
through to the next step without complete characterisation due to its 
volatility. Hydrogenation using Pt02 as a catalyst, in ethanol : chloroform 
(10 : 1), generated the amine hydrochloride (38) in situ.^^ Purification of (38) 
was executed by ion exchange (H"*" form) chromatography to afford (DL)-[1-
13C]-p-aminoisobutyric acid (39) in an overall yield of 8% from [l-13C}-a-
bromopropionic add. 
(DL)-[3-^H2l-p-Aminoisobutyric acid (40) was prepared in a similar 
manner but starting with unlabelled a-bromopropionic acid and 
performing a deuteration with D2-Pt02 in EtOH: CHCI3. This generated (40) 
in an overall yield of 10% from a-bromopropionic acid. These materials 
were used directly for feeding experiments. 
2.2.4 Synthesis of sodium [B-^^Q-isobutyrate 
Sodium [3-13C]-isobutyrate (44) was synthesised as outlined in scheme 7. The 
first step afforded (42) efficiently in 90% yield. A base mediated hydrolysis 
then gave [^^C-methyl]-dimethy\malomc acid (43) which after addification 
and decarboxylation at ISO^C generated [3-^^C]-isohutyric acid. This was 
neutralised to pH 7 to afford the sodium salt (44) in an overall yield of 69% 
from 13CH3I. 
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Scheme 7. Reagents and conditions: i) NaH, THF, 0°C, 
ii) '^CHgl, reflux 2h, iii) 5M KOH, reflux 24h, HCl, 
iv) H p , ISO'^ C 3h, HCI(^ q), v) pH 7 with NaOH^^ q^  
2.2.5 Synthesis of sodium [l^C-wetfiyn-methacrylate 
Sodium [13C-mefhy/]-methacrylate (48) was synthesised as outlined in 
scheme 8. Alkylation of diethyl malonate (45) with ^^CHsI proceeded as 
before (see section 2.2.2) to generate (46). This material was treated with an 
aqueous solution of formaldehyde and potassium bicarbonate to introduce 
the hydroxy methyl group. Acid hydrolysis of (47) followed by purification 
over silica gel afforded methacrylic acid. Neutralisation with dilute NaOH 
yielded the labelled compound (48) in a yield of 33% from (47). Care had to 
be exercised on handling methacrylic acid due to its volatility and ease of 












Scheme 8. Reagents and conditions: i) NaH, THF, 0°Q 
ii) ^^CH3l, reflux 2h, iii) CH20(aq), KHCO3,70°C 2h, r.L 12h, 
iv) 7% HCL^^^y reflux 3d, v) pH 7 with NaOH(3q). 
2.2.6 Synthesis of sodium [l-^Cl-methacrylate 
CH2 
(49) 







Scheme 9. Reagents and conditions: i) Mg, ether, r.L Ih, reflux Ih, 
ii) ^ iii) pH 3 with n^SO^^^y iv) pH 7 with NaOH^^q, 
The synthesis of sodium [l-l^]-methacrylate (51) (sdieme 9) was executed 
using a Grignard reaction.82 The Grignard reagent was generated by the 
cautious addition of 2-bromopropene (49) to activated magnesium turnings 
in ether followed by cannular transfer into a dean flask. Isotopically 
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enriched ^^ OOz (99%), generated in situ by the careful addition of Ba^^CDs 
onto H2SO4, was vacuum transferred into the Grignard reagent. After work 
up, the methacrylic add was purified over silica gel and neutralised to pH 7 
to afford sodium [l-l3c]-methacrylate (51) in a 22.5% yield based upon the 
amoimt of Ba^^COs used. 
2J1.7 Sjmthesis of sodium P^C-met/iyn-methylmalonate 
0 0 0 
Ha^C^ J L - O E t i, ii H g ^ C ^ J L Q H iii Hg^^C^ J — © " N a 
+ 
C v ^ J L - t i a ^ g j - O H 3 « C ^ J — 
^ ^ V - O E t 53% ^ H - ' ^ v OH ^ " IF^ 
o o o 
(47) (52) (53) 
Scheme 10. Reagents and conditions: i) lOM KOH, reflux 24h, 
ii) 0°C, HQ a^qy iii) pH 7 with NaOH(3qj. 
p3C-metfcyZ]-Methylmalonic add (52) was synthesised by the utilisation of 
diethyl [^3c-mfffcy/]-(hydroxymethyl)methylmalonate (47) (see section 2J2.5). 
This, route was chosen over the more conventional methylation of diethyl 
malonate because this procedure obviates any dialkylated product, a 
common problem when trying to monoalkylate diethyl malonate. The 
presence of any [l3C2-mcfhy/]-dimethylmalomc add is problematic and 
would potentially affed the feeding experiment results, because it would be 
decarboxylated in vivo to generate [l3C2-metfeyZ]-isobut5nric add. In this 
chosen route the hydroxymethyl group is acting as a blocking group, to 
prevent dimethylation, which can easily be removed again. The resultant 
(47) was purified over silica gel and hydrolysis under basic conditions 
followed by addification, neatly generates p3C-mgfhy/]-methylmalonic add 
(52) (free from any [l3C2-»ief//y/]-dimethylmalonic add) in a yield of 53%. 
p3C-mef/iyZ]-Methylmalonic add (52) was neutralised to generate the 




The labelled compotmds prepared above were administered to Streptomyces 
cinnamonensis and the details of incorporation into monensin A are 
outlined in section 2.3.2, A to H. These labelled substrates were generally 
administered batchwise, i.e day 3, 3.5 and 4 of a 7.5 day growth cyde, as 
solutions via a sterilised micropore filter, in order to increase the effidency 
of incorporation into monensin A. It is advantageous to supplement the 
cultures at the stage of maximum secondary metabolite production. There 
are two phases of growth in batch cultures of baderia.83 The first is the 
trophophase during which primary metabolism is predominant and the 
second is the idiophase during which period secondary metabolism occurs. 
The distinction between the two phases is not always dear and there may be 
an overlap, therefore timing of feeding experimients is an important factor. 
If the substrate is fed too early in the growth cyde then it may be utilised in 
primary metabolism and become incorporated into the secondary 
metabolite via an indired route resulting in excessive scrambling and low 
incorporation of the isotopic label. Similarly feeding the substrate too late to 
the cultures, when secondary metabolism has slowed down, will also give 
low incorporation results. 
The n.m.r. of monensin A has previously been imambiguously 
assigned.l2 Table A l (Appendix 1, pg. i) details the chemical shifts of the 
carbon atoms of monensin A isolated from S. cinnamonensis, recorded as 
solutions in CDCI3, compared with the literature values.47 The 
Incorporations of the following substrates P^G-wief/iy/J-p-aminoisobutyric 
acid, [l-l^Q-p-aminoisobutyric acid, sodium [13C-mefliyZ]-methacrylate, 
sodium [l-l3C]-methacrylate and sodiimi [3-l3C]-isobutyrate into monensin 
A are tabulated in Fig. 10, in order to aid dired comparison of these 
experiments. The values were calculated by normalising the peak heights in 
the n.m.r. spectrum relative to an tmenriched carbon and then further 
normalised relative to a standard natural abundance spectrum. These 
unenriched carbons were either CIO (CH2) or C28 (OCH3). In Fig. 10 there 
also indudes figures labelled with an asterisk (*) (i.e. C6 (CH), C9 (C), C17 
(CH-O), C19 (CH2)). These signals are internal references which have 
undergone the same calculations as the enriched carbons in order to give a 
further comparison of the Incorporation values of enriched to unenriched 
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carbons. Detailed discussion of all of these results are induded in section 3, 
however they can be stunmarised as follows. 
2.3.2 Feeding experiments 
A 
[l4C-mefhyn-Thymine (29) (32.5(iCi) and 14mg of unlabeUed thymine (as 
carrier) were administered to cultures (6 x lOOcm )^ of S. cinnamonensis 
before sterilisation. The solubility of th5miine preduded batchwise addition 
by a sterilised micropore filter in the normal manner. After 7.5 days 
incubation, the monensins were isolated (monensin A : B, 7 : 3) with a 
radiochemical Incorporation (I) of 2%. 
1= xl00 = 2% 
32.5fxa 
This experiment demonstrates that some l^ c isotope from \^Kl-methyl}-
thymine has been incorporated into the monensins, but it gave no 
information concerning the specific sites of enrichment. However the 
Incorporation was suffident to proceed with a stable isotope study using 
p3C2H3-mef/iyZ]-thymine (30) and n.m.r. analysis. 
B 
p4C-methyZ]-Thymine was added prior to sterilisation of the medium. This 
was judged to be a limitation as substrates should be fed ideally to the 
cultures at the point of maximum secondary metabolite production (see 
section 2.3.1). This limitation was also encountered with P^C^Hs-methy/}-
thymine. It was overcome by keeping aside about 20cm3 of production 
medium when the culture flasks were prepared. (^^c^Hs-mei/iyZl-Thymine 
was added to this media and the whole was sterilised and then administered 
on day 3 to cultures (5 x lOOcm )^ via a sterilised glass pipette such that the 
final concentration was 4.2mM. Such a strategy ensured that the {^"KPiiy-
mefhy/]-thymine was integral with the medium and that there was 
minimum loss of substrate during the feeding procedure. Monensin A was 
isolated on day 7.5. A preliminary n.m.r. (lOOMHz) confirmed the 
presence of monensin A but for full broad - band proton and deuterium 
decoupling (13C{1H, 2H}-n.m,r. (150MHz)) analysis, the sample was sent to 
Edinbui^h University. The resulting spectra are shown in Fig. 2 and Fig. 3. 
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Fig. 2, "C{^H,^H}-n.m.r. of monensin A isolated from 
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Fig. 3, ^^C{^H,^ H}-n.m.r. of monensin A (pvirified by C^ g preparative t.lc) 
isolated from 5. cinnamonensis fed with [^ ^C^H3-me%/]-thymine. 
y 
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The sample giving rise to the spectnmi in Fig. 2 is rather impure and 
contains a labelled impurity showing at 11.4ppm. This sample was 
subsequentiy purified by Cis reverse phase preparative chromatography, 
and the 13Q1H, 2H}-n.m.r. spectrum of the purified sample is shown in Fig. 
3. The Incorporation value of [^^C^Hs-methyll-thyimne into monensin A is 
based upon Fig. 2, as this is a more concentrated sample and the spectrum is 
clearer. In the l3QlH}-spectnam (b), a 13CD3- signal appears as a septet, 
shifted from the natural abimdance signal to a lower frequency. In the 
13C{lH, 2H}-spectrum (c), this broad septet collapses to a singlet, but remains 
shifted to a lower frequency by the same magnitude. Subtraction of these 
two spectra [(b) - (c)] generates the difference spectrum (a). 
From the analysis of the spectra it is deduced that P^C^Hs-methy/]-
thymine has been incorporated into carbon-3 of the seven propionate units 
of monensin A (54), i.e. C27, C29, C30, C31, C34, C35 and C36, at a level of 1 -
2 fold enrichment. For each of these carbons there exists three components, 
l^ CDs, 13CD2H and 13CDH2, indicating that at some point there has been 
partial loss of deuterium on the methyl group. This can probably be 
accoxmted for by the interconversion of the methylmalonyl-CoA pool with 
sucdnyl-CoA, mediated by methyhnalonyl-CoA mutase. 
^Na-OzCi 
(54) 
An Incorporation (0.2 fold) into carbon-4 of the butyrate unit (C33) is 
also evident in the 13C{1H, 2H}-n.m.r. spectrum (Fig.2 (c)) in the form of a 
small signal shifted to a lower frequency, by a magnitude of 0.84ppm from 
the natural abundance signal. The magnitude of one deuterium induced a-
shift (13C-D) is 0.28ppm, i.e. this shifted signal corresponds to a three 
deuterium induced shift, a ^^ CDg component. Interestingly there is no 
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apparent l^CDjH or 13CDH2 component indicating limited exchange of 
deuterium at this site (discussed further in section 3.3). 
p3C-met/iy/]-p-Aminoisobutyric add hydrochloride (35) was neutralised to 
p H 7 wi th dilute sodium hydroxide solution and administered i n three 
batches (day 3,3.5 and 4) to cultures (6 x lOOcm )^ of S. cinnamonensis, such 
that the final concentration of [l3C-meffey/}-p-aminoisobutyric add was 
5.9mM. Monensin A was isolated on day 7.5 and the resultant n.m.r. 
spectrtun is shown in Fig. 4. A high level of enrichment ( 6 - 7 fold) at the 
sites corresponding to carbon-3 of the seven propionate units of monensin 
A (54), Le. C27, C29, C30, C31, C34, C35 and C36, is dearly evident There is a 
small but noticable enrichment (1.5 fold) at C33, carbon-4 of the butjrrate 
unit. Therefore the ratio of Incorporation of [13C-mefliy/}-p-aminoisobutyric 
add into the propionate and butyrate derived units of monensin A is 
approximately 4 : 1 (propionate : butyrate). 
D 
[l-l^Cj-P-Aminoisobutyric add (39) was administered to cultures (2 x 
100cm3) of S. cinnamonensis, such that the final concentration of (39) was 
2.6mM. Monensin A was isolated on day 7.5 and the resultant n.m.r. 
spectnmi is shown in Fig. 5. From this spectrum i t is dearly evident that 
C15, derived from carbon-1 of the butyrate unit of monensin A (55), is 
enriched 2.3 fold, compared wi th natural abvmdance. 
+Na-02Ci 
The sites corresponding to carbon-1 of the propionate units are not 
observably enriched. This experiment contrasts directly w i t h the 
Fig. 4, '•'C n.m.r. (125MHz) of monensin A isolated from S. 
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{^^C-methyiyfi-ammoisobvLtyric acid feeding experiment, in that the same 
precursor is studied but the label is i n a different position. In that 
experiment the sites corresponding to carbon-3 of the propionate imits were 
enriched 6 - 7 fold. The implications of this are discussed in context with the 
other feeding experiments in section 3.2. 
E 
Sodium p3c-methy/]-methacrylate (48) was administered to cultures (6 x 
100cm3) of S. cinnamonensis, such that the final concentration of (48) was 
5.3mM. Monensin A was isolated on day 7.5 and the l^C n.m.r. spectnmi is 
shown in Fig. 6. Carbon-4 of the butyrate unit, C33, is enriched by 4.3 fold. 
Evidence of Incorporations into those carbons derived from carbon-3 of the 
propionate units, however, is not so clear. The values calculated for these 
carbons, i.e. C27, C29, C30, C31, C34, C35 and C36, are only sUghtly higher 
than the unenriched carbons and at best the calculated enrichment averages 
1.5 fold. Accepting this value, the ratio of Incorporation of sodiiun [^^C-
mef/zy/]-methacrylate into the propionate and butyrate derived units of 
monensin A is approximately 1: 3 (propionate : butyrate). 
F 
Soditim [l-l3C]-methacrylate (51) was administered to cultures (6 x lOOcm^) 
of S. cinnamonensis, such that the final concentration was 5.2mM. 
Monensin A was isolated on day 7.5 and the resultant 1 ^ n.m.r. spectrum is 
shown in Fig. 7. The site derived from carbon-l of the butyrate unit, C15, is 
clearly enriched by a magnitude of 4.3 fold. This enrichment is identical to 
that at C33 (carbon-4 of the butyrate tmit) after the sodium [^^-methyl]-
methacrylate feeding experiment. Similarly, carbons corresponding to 
carbon-l of the propionate uiuts of monensin A (55), i.e. C I , C3, C5, C l l , C17, 
C21 and C23, seem to be very slightly enriched. Again the ratio (1:3) of 
Incorporation into the propionate and butyrate derived units of monensin 
A is the same as for the sodium [l3C-metiiy/]-methacrylate feeding 
experiment. 
G 
Sodium [3-l3C]-isobutyrate (44) was administered to culttires (6 x lOOcm^) of 
S. cinnamonensis to a final concentration of 5.6mM. Monensin A was 
isolated on day 7.5 and the i^c n.m.r. spectrum is shown in Fig. 8. 
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Fig. 6, '-^ C n.m.r. (125MHz) of monensin A isolated from S. 
cinnamonensis fed with sodium ["C-/ne%/)-methaaylate 
• 
C33 
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Fig. 7, '^C n.m.r. (125MHz) of monensin A isolated from S. 
cinnamonensis fed with sodium Cl-"C]-methacrvlate 
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A n enzyme activity has been identified f rom S. cinnamonensis 
which mediates the stereospecific interconversion of isobutyryl-CoA and 
butyryl-CoA. This activity has been termed isobutyryl-CoA mutase.66 The 
rearrangement involves migration of the carboxyl carbon of isobutyiyl-CoA 
to the pro-S methyl group. The resultant butyryl-CoA then becomes 
incorporated into the butyrate unit of monensin A , presumably via 
activation to ethylmalonyl-CoA. Sodium [3-l^l-isobut5rrate was prepared in 
racemic form, i.e. half of the molecules had the pro-S methyl group labelled 
wi th 13c (56) and half had the pro-R methyl group labeUed (57), such that 
each is processed to butyrate labelling the C2 and C4 positions, respectively. 
O 





As expected the carbons derived from carbon-2 (C16) and carbon-4 (C33) of 
the butyrate unit are enriched by a magnitude of 9 fold, by l^c n.m.r. 
analysis of monensin A (Fig. 8). Also the carbons derived from carbon-3 of 
the propionate imits of monensin A (54) are enriched 2.5 fold. Therefore the 
ratio of propionate to butyrate Incorporation of sodium [3-l3c]-isobutyrate 
into monensin A is 1 : 3.5 (propionate : butyrate) which mirrors the ratio of 
Incorporation of the isotopically labelled methacrylate substrates into 
monensin A. 
H 
Sodium [i3c-met/iy/]-methylmalonate (53) was administered to cultures (4 x 
100cm3) of S. cinnamonensis to a final concentration of 4.6mM. Monensin 
A was isolated on day 7.5 and the resultant l^C n.m.r. spectnmi is shown in 
Fig. 9. Very little information can be obtained from this experiment as the 
labelled methyhnalonate (53) has been highly metabolised, presumably, via 
4 5 
Fig. 8, '-^ C n.m.r. {125MHz) of monensin A isolated from S. 




Fig. 9, '"'c n.m.r. (125MHz) of monensin A isolated &om 5. 
cinmmonensis ted with sodium ['"'C-mcf/iy/J-maionate 
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sucdnyl-CoA and the citric add cycle causing scrambling of the isotopic label 
and incorporation into monensin A in an indiscriminate manner. Also the 
signals i n the iLm.r. spectrtim are tinlike a 'normal' natural abxmdance 
spectrum. Some are distinctively smaller than expected and broader and 
this makes it harder to assess accurately, if and where ^^C label has been 
incorporated. To gain more information in the future on the possible 
Incorporation of methylmalonate into monensin A, a double labelling 
experiment is advisable and then the Incorporation of intact xmits can be 
identified unambiguously. 
l^Cnmr/ [13C- [1-13C1-P- p c - [1-I3q- [3-i3q-
ppm methyiy AIBA methyiy methac- IBA 
P-AIBA methacr. rylate 
(a,c) (a,d) (b,c) (a,c) (a,c) 
a 181.26 - 0.94 - 1.14 -
C3 82.93 - 0.99 - 0.93 -
C5 68.32 - 1.04 - 1.02 -
C6 34.83 0.93* 0.87* 0.91* 0.88* 0.70* 
C9 106.94 0.71* 0.87* 1.20* 0.93* 0.54* 
C l l 33.16 - 1.08 - 1.26 -
C15 29.81 - 2.33 - 4.3 -
C16 85.79 - - - - 9.09 
C17 84.97 0.84* 1.03 0.9 0.88 0.38* 
C19 33.24 1.07* 1.03* 1.32* 1.11* 0.49* 
C21 74.46 - 0.96 - 1.16 -
C23 35.60 - 1.10 - 1.35 -
C27 16.69 6.55 - 1.4 - 2.31 
C29 11.07 7.11 - 1.74 - 2.67 
C30 10.50 7 - 1.24 - 2.41 
C31 27.44 5.58 - 1.57 - 2.66 
C33 8.23 1.58 - 4.36 - 9.86 
C34 14.57 7.08 - 1.43 - 2.78 
C35 16.82 6.14 - 1.21 - 2.45 
C36 16.07 6.85 - 1.19 - 2.71 
Fig. 10:13c enrichments 
a normalised relative to CIO = 
c 125MHz, dlOOMHz, 
of the carbons of monensin A, 
 1, b normalised relative to C28 = 1, 
* unenriched C as standard. 
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3. DISCUSSION OF RESULTS 
3.1 Sodium [S-^^Q.jsobutyrate, sodium P^C-mctfiyZl-methacrylate and 
sodiiun [l-i3C]-methacrylate feeding experiments 
The purpose of these experiments was to investigate the link between 
primary and secondary metabolism in Streptomyces, utilising the monensin 
A producing strain Streptomyces cinnamonensis (ATCC 15413). One of the 
best established metabolic routes linking primary and secondary metabolism 
























(R)<^(S) propionate units 
Scheme 11 
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The degradative pathway of valine metabolism has been studied extensively 
both in bacteria and i n mammals and where relevant the stereochemical 
coiuse has been defined. I t was shown originally in Pseudomonas putida, 
that isobutyryl-CoA (58) vmdergoes a,p-dehydrogenation with loss of H 
from the 2-pro-S-methyl group, followed by hydration by hydrogen addition 
to the re- face of the a-C of methacrylate (59) to produce (S)-p-
hydoxyisobutjrryl-CoA (60).^ The intermediacy of methacrylyl-CoA has only 
been implied because the feeding experiments are consistent wi th the 
existence of such an imsaturated intermediate.85 The stereochemical course 
of isobutjrrate dehydrogenation / hydration is the same in mammals^ as in 
baderia. 
L-Valine was soon recognised as a source of not only the propionate 
units in secondary metabolism but also the butyrate units.45/86 xhe existence 
of a reversible rearrangement, in whole ceUs of S. cinnamonensis, of 
isobutjrryl-CoA to butyryl-CoA was demonstrated i n 1988.66 This 
rearrangement is catalysed by a coenzyme-Bi2-dependent mutase and 
involves the intramolecular migration of the carboxyl carbon of isobutyrate 
to the 2-pro-S methyl, with a concomitant back migration of a H atom from 
the methyl group. The discovery of this rearrangement revealed an 
important l ink between straight chain and branched chain fatty add 
metabolism in these antibiotic producing organisms. The incorporation of 
sodixmi isobutyrate into monensin A was first demonstrated by Vanek and 
co-workers45 who showed that monensin A was effidently and similarly 
enriched by either [l-13C]-butyrate or [l-13C]-isobutyrate. This was a 
neccessary reference experiment, in our case, for comparison with the other 
feeding experiments. As expected, sodium [3-l3c]-isobut5rrate effidently 
enriched C16 and C33 of monensin A. 
As discussed, the intermediacy of methacrylyl-CoA in valine 
catabolism has only been implied. Therefore it was deemed appropriate to 
carry out the definitive experiment and feed, in the first instance, sodiimi 
P^C-methylJ-methacrylate to S. cinnamonensis. This proved to be a good 
substrate and resulted i n effident incorporation into monensin A at C33 
(carbon-4 of the butyrate tmit) by a magnitude of 4.3 fold. This can be 
rationalised by following valine catabolism as shown in scheme 11. The 
p3C-mefhyZl-methacrylate w i l l a f ford isobutyryl-CoA (58) after a 
stereospedfic reduction resulting in label exdusively on the pro-R 
methyl group (57). Stereospecific migration, mediated by isobutyryl-CoA 
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mutase, of the carboxyl group to the pro-S methyl group of isobutyryl-CoA 
would generate butyryl-CoA now labelled exclusively at the carbon-4 
position- If methacrylyl-CoA is a true intermediate between isobutyryl-CoA 
and (2S)-methylmalonyl-CoA, sodiiun [l3C-mct/iy/]-methacrylate shotild be 
incorporated into the seven sites derived from carbon-3 of propionate. As 
discussed these Incorporations were low (1.5 fold) but significant. 
To support the hypothesis for the intermediacy of methacrylyl-CoA 
in this pathway, the Incorporation of sodium [l-13C]-methacrylate into 
monensin A was studied. Incorporation of the substrate into C15, carbon-l 
of the butyrate derived imit of monensin A, was evident as a 4.3 fold 
enrichment by 13c n.m.r. Sigiuficantly this is exactly the same level of 
enrichment into the butyrate imit as was recorded in the sodium [13C-
methy/]-methacrylate feeding experiment. Similarly, the carbons derived 
f rom carbon-l of the propionate units are enriched slightly (1.2 fold). 
Therefore the [l-13C]-methacrylate and the [13C-OTetliy/]-methacrylate 
feeding experiments complement each other. 
These results give an insight into the relative flux of the conversion 
of methacrylyl-CoA to isobutyryl-CoA and methylmalonyl-CoA. It would 
appear that methacrylyl-CoA (and isobutyryl-CoA) furnishes the butyrate 
pathway to a greater extent than the propionate pathway (an approximate 
ratio of 3 : 1 respectively) .The potential reversibility of these steps i n 
Sfrcpfomyces could be further investigated by feeding experiments utilising 
isotopically labelled (S)-p-hydroxyisobutyrate. 
3^(DL)-[i3C-methyn-p-Aminoisobutyric add, (DL)-[l-l3a.p.aminoisobutyric 
add and (DL)-[3-2H2l-P-aminoisobut5rric add feeding experiments. 
A further objective was to investigate the potential of thjonine and i f s 
degradation product, p-aminoisobutyric add, to act as a soiurce of propionate 
units via (2S)-methylmalonyl-CoA and hence providing evidence of the 
reductive catabolism of th5amne occurring in Streptomyces, similar to that 
known to occur in mammals (scheme 3) 67,68,87 
The f i rs t experiment involved feeding (DL)-{l3C-meffey/}-p-
aminoisobutyric add to S. cinnamonensis. The results were very interesting 
as the sites derived from carbon-3 of the propionate units were enriched by a 
magnitude of 6 - 7 fold and the site derived from carbon-4 of the butyrate 
tmit was also enriched 1.5 fo ld . So p-aminoisobutyric acid is readily 
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This can be explained by the transamination of p-aminoisobutyric add (64) 
to methylmalonic acid semialdehyde (65) as an init ial event. The 
stereochemistry of the process has not been established in baderia, but in 
mammals (S)-p-aminoisobutyric add is converted to (S)-methylmalonic 
acid semialdehyde, mediated by S-p-aminoisobutyrate-a-ketoglutarate 
transaminase.88 Methylmalonic acid semialdehyde would then be 
converted to methylmalonyl-CoA (61), by an aldehyde dehydrogenase 
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activity, which would in turn furnish the propionate imits of the antibiotic. 
Scheme 12 highlights this l ink between valine catabolism and p-
aminoisobutyric add. It is of interest to note that i t is (S)-p-aminoisobutyric 
add which is an end product of valine metabolism in mammals,89/90 but 
(R)-P-aminoisobutyric add which is the end product of thymine catabolism. 
So further work is required to establish if it is the (R)- enantiomer of p-
aminoisobutyric add which is produced by the thymine degradation in 
Streptomyces, as i n mammals, and to establish if the enantiomers of p-
aminoisobutyric add are processed differently. 
The carbon signal corresponding to carbon-4 of the butyrate imit (C33) 
of monensin A, was also enhanced after feeding of [13C-mef/iy/]-p-
aminoisobutyric add, by a magnitude of 1.5 fold. This can be explained 
conventionally by going through the following intermediates in scheme 12:-
(65) ^ (61) • (60) (59) (58) • (62) ^ butyrate 
However this is a long reductive metabolic route, and perhaps there exists a 
short cut which bypasses the intermediacy of methylmalonyl-CoA (61). In 
particular we have been testing the hypothesis of a deaminase enzyme 
which could act on p-aminoisobutyric add (64) to afford, after activation, 
methacrylyl-CoA (59). Alternatively there covdd be an activity mediating the 







To assess further these alternatives, p-aminoisobutyric add was 
prepared w i t h the isotopic label i n a different position, i.e. [l-^^Q-p. 
aminoisobutyric add. The results of this experiment show an Incorporation 
into C15 (carbon-1 of the butyrate tmit of monensin A) by a magnitude of 2.3 
fo ld , but no observable Incorporation into the propionate units of 
monensin A. In the first experiment, [l^C-mefhyZJ-p-aminoisobutjnic acid 
was readily incorporated into monensin A and the l^c label was evident in 
those carbons derived f rom carbon-3 of the propionate units (scheme 13), 
whereas i n this [l-lSQ-p-aminoisobutjrric add experiment (scheme 14) the 












So the isotope f rom [l-13C]-p-aminoisobutyric add is not incorporated into 
the propionate units as i t is lost due to decarboxylation of (23)-
methylmalonyl-CoA during polyketide biosynthesis (scheme 14). I f this 
isotopically labelled methylmalonyl-CoA (labeUed at the carboxylate carbon, 
scheme 14), generated from feeding [l-l3C}-p-aminoisobutyric add, proceeds 
through the intermediates (S)-p-hydrox)dsobutyryl-CoA, methacrylyl-CoA 
and isobutyryl-CoA to furnish the butyrate vmit (outlined in scheme 12) 
then one may expert to see an enrichment of C16 (corresponding to carbon-2 
of the butyrate tmit) i n the 13c n.m.r. spectnmi of monensin A. On dose 
analysis there is no enrichment of C16, but there is an enrichment of C15 
(carbon-1 of the butyrate imit) by a magnitude of 2.3 fold. This Incorporation 
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into carbon-l of the butyrate unit of monensin A is consistent wi th the 
hypothesis of a deaminase enzyme mediating the conversion between p-
aminoisobutyric acid and methacrylyl-CoA (scheme 15), i.e. no 








In an attempt to investigate the existence of a deaminase enzyme 
further, a different approach was taken. Incorporation of deuterium from 
(DL)-[3-2H2}-P-aminoisobutyric add was analysed i n the lipids rather than 
monensin A. The carbon carrying these deuteriums becomes quaternary in 
monensin A and so all the deuteritmi are of course lost. However, the 
incorporation of deuteritim could be investigated by analysing the lipids 
produced by S. cinnamonensis. The mutase rearrangement of isobutyryl-
CoA to butyryl-CoA is an important l ink between straight chain and 
branched chain fatty add metabolism i n S. cinnamonensis and one of the 
major lipids produced by this strain is IS0-C16 fatty add which has an 
isobutyryl-CoA starter xmit. Therefore analysis of the lipids produced by S. 
cinnamonensis after administration of [3-2H2l-p-aminoisobutyric add 
would hopefully reveal incorporation of deuteriimi in the pro-S methyl 
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For this experiment a different S. cinnamonensis production media 
had to be employed as the media used to date contained Upids which 
interfered with the analysis procedure. A sample of cells was sent to Dr. K. 
Reynolds for l i p id analysis. This procedure involved base mediated 
hydrolysis of the cells to release the lipids, followed by methylation, and 
then gas chromatography / mass spectra (G.C. / M.S.) analysis. In the G.C. / 
M.S. spedrtrai, an Incorporation of [3-2H2}-p-aminoisobutyric add into the 
starter imit of the branched chain lipids would be evident by an increase of 
the M + 2 signal. However, an Incorporation of only about 2% was expeded 
(based upon incorporation values of previous p-aminoisobutjnic add 
feeding experiments) and in the event this proved to be below the threshold 
of detection by G.C. / MS. In the future, the experiment could be repeated 
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on a larger scale and the lipids analysed by deuterium n.m.r. to see if 
deuterium has been incorporated into the methyl group. 
3.3 p4C-mct/iyn-Thymine and {^H?H3-methyI\-thymine feeding 
experiments. 
After successfully demonstrating the Incorporation of p-aminoisobutjoic 
add into the polyketide metabolite, monensin A, the scene was set to 
investigate whether the catabolism of thymine occurs in Streptomyces and 
generates p-aminoisobutyric add, as in mammals. This p-aminoisobutyric 
add could access the methylmalonyl-CoA pool and become available for 
secondary metabolite biosynthesis. 
[14C-mef/iy/]-Thymine was administered to S. cinnamonensis and, in 
the event, a 2% Incorporation of radioactivity into the isolated monensins 
was evaluated. In order to establish the regiospecific incorporation of 
thymine into monensin A, a stable isotope experiment was designed. 
Accordingly [13C?H3-methyI]-thymine was synthesised and administered to 
the cultures of S. cinnamonensis and the resultant monensin A analysed by 
13C{lH, 2H} n.m.r. The results dearly show a 1 - 2 fold enrichment of the 
methyl groups derived f rom propionate units. Scheme 17 shows the 
postulated link between thymine and valine metabolism in Streptomyces. 
Incorporation of [l3C?H3-methy/]-thymine into the propionate units can be 
rationalised by degradation to p-aminoisobutyric add and then as detailed 
previously, through methylmalonic acid semialdehyde and (2S)-
methylmalonyl-CoA. This entry into the methylmalonyl-CoA pool would 
account for the exchange of deuterium on the methyl groups, discussed in 
section 2.3,2 B, i.e. an interconversion of (2R)-methylmalonyl-CoA and 











P^H3-mefhy/]-Thymine is also incorporated to a small extent (0.2 fold 
enrichment) into carbon-4 of the butyrate imit, C33. This observation 
illustrates the power of 13C-2H dual labelling followed by 13c{iH, ^H} n.m.r. 
analysis- Incorporation of [l3C-me^/iy/]-thymine into the butyrate unit 
would have been impossible to detect at this level by n.m.r. analysis. 
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however by utilising ['^K?Hs-methyl]-\hymine, the l^CDs incorporation into 
carbon-4 of the butyrate unit (C33) is detectable in the difference spectrum. 
Fig. 2(a). It is distinct and shifted to a lower frequency by a magnitude of 
0.84ppm from the natural abundance signal (i.e. three deuterium induced a-
shifts). The existence of only a l^CDs component for carbon-4 of the butyrate 
unit, lends further support for the existence of a deaminase enzyme 
mediating the transformation between p-aminoisobutyric acid and 
methacrylyl-CoA because there has been no significant deuterium exchange 
prior to incorporation into the butyrate imit, i.e. methylmalonyl-CoA is 
unlikely to have been an intermediate in the pathway. Thus thjonine does 
contribute to the methylmalonyl-CoA pool available for secondary 
metabolite biosynthesis. The incorporation of p-aminoisobutyric add into 
the propionate and butyrate units of monensin A, which mirrors the 
thymine incorporation into these imits, lends support for the reductive 
catabolism of thymine via p-aminoisobutyric acid, analogous to 
mammalian systems. 
There is, however, another pathway that can not be excluded from 
this discussion. This is the oxidative catabolism of thymine.^^ This pathway 
degrades thymine (66) to 5-methylbarbituric add (68) mediated by uracil 
dehydrogenase^l'^2 the fate of this intermediate is unknown. 
Analogously, uradl (67) is degraded by a similar mechanism to barbituric 
add (69) which is transformed, by the action of barbiturase, to urea (70) and 
malonic add(71) 91,93,94 (scheme 18). Some aerobically grown bacteria have 
been shown91'92,94-96 to grow in media containing uracil and thymine as a 
sole source of nitrogen and carbon and i n these bacteria an oxidative 
pathway has been fotmd.69 The results f rom our feeding experiments 
indicate a reductive catabolism of thymine occurring i n Streptomyces, 
however, feeding experiments with [l3C?H3-met/iyZl-dihydrothymine eind 
\^K?H3-meth}/l]-p-aminoisohutyTic acid to assess i f these incorporation 
patterns are similar to ['^K?Hy-methyl]-ihymme would vmambiguously 























3.4 L-[3-i*Cl-Serine feeding experiments 
A l l of these results which provide evidence of a reductive catabolism of 
thymine occurring i n Streptomyces, fuels an interesting discussion about 
the possible links between D N A synthesis / degradation and secondary 
metabolite production. Several studies have been performed to determine 
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the timing of growth and production of secondary metabolites in certain 
micro-organisms. Studies on Streptomyces griseus (production of 
candicidin)97 a n d Streptomyces coelicolor A3(2) (product ion of 
methylenomycin)^ have both demonstrated that the maximum 
concentration of the antibiotic in the culture medium is reached when 
DNA sjmthesis ceases. Therefore the products of DNA degradation could in 
principle be channelled into secondary metabolite production. Such a study 
has not been performed on S. cinnamonensis. 
We made an attempt to probe the link between DNA synthesis / 
degradation and monensin A production in S. cinnamonensis. Carbon-3 of 
L-serine enters the C i pool of the growing micro-organism and thymine is 
formed f rom uracil by utilising carbons f rom the C I pool, aided by 




C— N— C — CH2CH2COO-
H H 
(72) 
Therefore an experiment was designed whereby L-[3-l4(^]-serine (22.2nQ) 
and lOmg of cold serine as carrier were administered to cultures (6 x lOOcm )^ 
of S. cinnamonensis before innoculation such that the specific activity was 
0.233mCi/mmol. The monensins were isolated on day 7.5 and the 
Incorporation of radioactive serine into the monensins was shown to be 
2.5%. A parallel experiment was also performed, where L-[3-l^]-serine 
(23.3fia) and lOmg of a>ld serine were administered at day 3.5 to cultures (6 
X lOOcm^) of S. cinnamonensis. The specific activity of the L-[3-l^]-Serine 
added was 0.244mCi/mmol and the monensins which were isolated at day 
7.5 showed an Incorporation of radioactivity of 3.2%. Feeding L - [ 3 - ^ ^ -
serine at day 0 to the cultures of S. cinnamonensis was anticipated to 
generate in vivo [l^C-methyn-thymine (from tiradl and carbon-3 of serine) 
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which would then be utilised in DNA synthesis. The degradation products 
of DNA could then contribute towards secondary metabolite production, i.e. 
monensin A production, and hence this monensin A may be more 
radioactive than the monensin A isolated from a feeding experiment 
whereby L-[3-14(2]_serine was administered at day 3.5, a period when DNA 
and primary metabolism in general should have ceased or at least slowed 
down. 
However, this experiment was complicated by the fact that monensin 
A possesses a methoxyl carbon, which is known to derive also from the C I 
pool, so radioactivity incorporated in both experiments is quite probably due 
to this methoxyl carbon. Nevertheless, it was judged an interesting 
experiment to assess any large differences in the amount of radioactivity 
incorporated into monensin A during the trophophase and idiophase. 
4. CONCLUSION 
The links between primary and secondary metabolism in Streptomyces 
have been extensively probed wi th the aid of feeding experiments. It has 
been demonstrated that thymine can contribute to the methylmalonyl-CoA 
pool and be available for secondary metabolite biosynthesis. The evidence 
suggests that its entry is via a reductive pathway and p-aminoisobutyric add, 
however an oxidative pathway of thymine degradation via 5-
methylbarbiturate can not be ruled out. The relative importance of thymine 
as a source of methylmalonyl-CoA is unknown. Relatively large amounts of 
thymine was added to the cultures of S. cinnamonensis therefore the 
biological system has the capacity to utilise thymine i n the manner 
discussed, but the experiment gives no information about the true flux in 
batch fermentation. 
During this chapter, the existence of a novel deaminase enzyme, 
mediating the transformation of p-aminoisobutyric add to methacrylyl-CoA 
has been implied, and some supporting evidence has been highlighted. An 
enzyme has been identified i n Clostridium propionicum which catalyses 
the amination of acrylyl-CoA to p-alanyl-CoA, however the reversibility of 






The leptomycins are antiftmgal antibiotics found i n the course of a 
screening program for substances which cause abnormal morphology on the 
growth of various f imgi .^^ Elucidation of the chemical structures of these 
compounds have shown that they are long xmsaturated branched chain 
dicarboxylic acids in which one of the carboxyl groups has formed a 6-
lactone ring.101'102 Streptomyces sp. ATS1287 produces both leptomycin A 
(1) and B (2) in an approximate ratio of 1 : 6 respectively. 
(1) leptomycin A, R = CH3 
(2) leptomycin B, R = CH2CH3 
leptomydn A 
leptomydn B 
= acetate = propionate / = butyrate 
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Leptomydn A is biosjmthesised from 4 acetate and 8 propionate tmits 
and leptomycin B from 4 acetate, 7 propionate and 1 butyrate unit. 103 
Several antibiotics have been isolated from other strains of Streptomyces 
with very similar chemical structiu*es, e.g. kazusamycins A and and 
anguinomydns A and 
leptomydn A, = CH3, R2 = CH3, R3 = CH3 
leptomycin B, Rj = CH3, R2 = CH^CHy R3 = CH3 
kazusamydn A, Rj = c5i20H, R2 = CH2CH3, R3 = CH3 
kazusamydn B, Rj = CH2OH, R2 = CH3, R3 = CH3 
anguinomydn A, Rj = CH3, R2 = CH3, R3 = H 
anguinomydn B, Rj = CH3, R2 = CH2CH3, R3 = H 
Recently there has been reports of the isolation of two further antibiotics 
which have very similar structures to the leptomydns, with the exception 
that the terminal carboxyl group has been replaced with a hydroxymethyl 
group, i.e. reductoleptomydn A (3)1^6 isolated f rom Streptomyces sp. 
MJ132NF5 and leptolstatin (4)107 isolated from Streptomyces sp. SAM1595. 
(3) reductoleptomydn A 
The N.O.E. study of leptolstatin (4) demonstrated that the double bond 
between C8-C9 was the Z- geometric isomer.107 When the structure of the 
leptomydns was eluddated,!^^ the configuration of this C8 - C9 bond was 
ambiguous and left for further investigation. 
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(4) leptolstatin 
So after the N.O.E. study of leptolstatin, a similar study was performed on 
leptomycin B and this C8 - C9 double bond was also fotmd to have Z-
geometry.107 i t seems likely, therefore, that aU the members of this group 
possess a similar skeleton and hence a Z- double bond at this site. Therefore 
the leptomycins (5) and (6) should be redrawn wi th the correct double bond 
geometry. 
OH O 
(5) leptomydn A, R = CH3 
(6) leptomycin B, R = CH2CH3 
1.2 Steteochemical analysis of leptomycin B 
I t is established that propionyl-CoA is activated by carboxylation to (2S)-
methylmalonyl-CoA, a biosynthetic precursor to the propionate subvmits. 
The enzyme mediating this transformation, propionyl-CoA carboxylase, has 
been purified to near homogeneity f rom the erythromycin producing 
organism Saccharopolyspora erythraea?-^ This isomer of methylmalonyl-
CoA is then utilised i n polyketide biosynthesis by undergoing a 
decarboxylative condensation wi th inversion of configuration.108 This has 
been demonstrated w i t h the aid of feeding experiments to several 
Streptomyces metabolites, e.g. lasalodd A,109 monensin A,1'^ 0 erythromycin 
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A . ^ Sodium [2-13Q2H2]-propionate was administered to the fermentations 
and the isolated polyketide metabolites were analysed to establish if any 
deuterium had been retained at the methine centres of the polyketide 
backbone. Deuterixmi is only expected to be retained at sites where the 
functionality of the condensation unit is either a keto group or an alcohol. If 
the fimctionality has been reduced further to a double bond or a fu l ly 
saturated methylene group then all the deuteriimis are washed out. From 
these experiments it was established that deuteritmi was retained only at the 
D-methine sites, the L-methine sites were devoid of deuteriimi enrichment. 
This can be rationalised as outlined in scheme 1. [Z-^Hil-Propionyl-CoA (7) 
undergoes carboxylation giving specifically (2S)-methylmalonyl-CoA (8) 
w i t h one deuterium retained. Transesterification onto the polyketide 
synthase affords (9), which undergoes a decarboxylative condensation 
proceeding wi th inversion of configuration to give D-a-methyl-^-keto-
thioester (10) wi th retention of deuterium. However, deuterium is not 
retained at the L-methine site, i.e. L-a-methyl-p-keto-thioester (13), and 
therefore an epimerisation must be occurring causing loss of the deuterium. 
o o 9 o o 
>AsCoAf^X^SACPr_^ -AAsACP 
HO2C H V HO2C "H HoC H 
(11) (12) (13) 
Sdiemel 
This epimerisation could occur at one of two possible stages, i.e. the 
polyketide synthase utilises only (2S)-methylmalonyl-CoA and an enzyme 
mediates the epimerisation between D-a-methyl-p-keto-thioester (10) and L-
a-methyl-p-keto-thioester (13), or there a>uld be an epimerisation between 
(2S)-methyhnalonyl-CoA (8) and (2R)-methyhnalonyl-CoA (11) and the 
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polyketide synthase is capable of processing each diastereoisomer, the (S) 
affording D-alkylated centres and (R) the L-alkylated centres. Both options 
would afford L-methine sites devoid of deuterium. Attempts to delineate 
between these processes have been directed at accessing (2R)-
methylmalonyl-CoA specifically labelled in vivo. The experiments 
performed on erythromydn A^^ lasalodd Al09,64 utilised isotopically 
labelled succinyl-CoA (14) which would generate (2R)-methylmalonyl-CoA 
(15) (with the respective isotopic labels) by the action of methylmalonyl-CoA 
mutase.m However in these studies, there was extensive wash out of 
deuteritun probably due to the direct entry of succinate into the dtric add 
cyde and no condusions could be dravm. 
D D O O 
HO2C V SCoA V SCoA 
D D HO2C 'D 
(14) (15) 
The timing of epimerisation, which w i l l lead to both D and L alkylated 
centres during polyketide growth, has now been established by Leadlay and 
co-workers.29 Detailed work wi th the three DEBS multi-enzymes, which 
catalyse the formation of the macrolide core of erythromycin A, produced by 
Saccharopolyspora erythraea (discussed in detail in chapter 4B), has shown 
that all the units used in the construction of erythromydn A come from 
(2S)-methylmalonyl-CoA, i.e. there must be additional epimerisation steps 
catalysed by the synthase in order to generate the L-alkylated centres. 
Actinomycete metaboUtes are constructed in a similar maimer, i.e. a 
processive assembly from similar biosynthetic precursors, and so it seems 
likely that chain assembly in aU of these related polyketide S5mthases 
requires only this one stereoisomer of methylmalonyl-CoA.^^ 
So studies wi th Actinomycete metabolites, e.g. lasalodd A , ^ ^ 
monensin A^lO and erythromycin A , ^ have shown that the administration 
of sodiimi [2-l3Q2H2]-propionate to the antibiotic followed by analysis of 
deuterium incorporation is potentially a good biosynthetic tool for 
stereochemical assignment of polyketide metabolites. Deuterium 
incorporation at methine sites allows assignment of the D-configuration, 
whereas loss of deuterium provides evidence for the L-configuration. As 
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the stereochemistry of leptomydn B (and related metabolites) has not been 
reported, i t was of interest to attempt this strategy for the first time wi th 
leptomycin B to assign stereochemistry. 
There are only three sites in leptomycin B (16) where deuterium 
could realistically be retained by employing this strategy of feeding sodixmi 
[2-13Q2H2]-propionate to cultures of the producing strain, i.e. C4, C16, C18. 
If any of these three sites show deuteriimri enrichment upon isolation of the 
leptomycin B then this w i l l indicate a D-configuration and lack of 
deuteriimn may indicate an L-configuration (due to an epimerisation). 
The macrolide antibiotics are a major class of polyoxygenated 
metabolites produced by Streptomyces,^ e.g. erythromycin A. Celmer, in 
1965, proposed a single stereochemical model to represent the entire dass of 
macrolides.40 I t is of interest to highlight that a section of the Celmer model 
(17) is structurally analogous to a section of leptomycin B (18). Therefore it 
would be interesting to determine the stereochemistry of leptomydn B to 
assess or otherwise a stereochemical correlation to the Celmer model, and 
thus to macrolide antibiotics more generally. 
(17) Celmer model 
(18) fragment of leptomdn B 
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2. RESULTS A N D DISCUSSION 
2.1 Synthesis of sodium [2-l^2H2l-propionate 
The synthetic route47(b) to sodium [2-13C,2H2]-propionate is outlined in 
scheme 2. The synthesis started with a relatively large amoimt of sodiiun [1-
l3C]-acetate (6g) which was converted into (20), its p-phenylphenacyl 
derivative. [l-^^Cj^Hzi-Eihanol (21) was carefully generated by treating (20) 
wi th l i th i imi aluminium deuteride. The reaction was quenched by the 
addition of phenoxyethanol and the [l-^3Q2H2]-ethanol was carefully 
distilled from the high boiling solvent and collected in a liquid nifrogen 
cooled frap. The resultant [l-13Q2H2]-ethanol was then directly derivatised 
wi th p-toluenesulphonyl chloride. The crystals of [l-13Q2H2]-ethyl tosylate 
(22) were collected by filtration and stored at O^ C in a dessicator. This 
material was treated with KCN in MeOD : D2O and the reaction product [2-
13c2H2]-propionitrile (23) distilled into a dean flask. Utilisation of KOD in 
D2O for the base hydrolysis of (23) afforded [2-13Q2H2]-propionic add after 
addification and lyophilisation. The lyophilisate was neufralised wi th 
dilute NaOH and a further lyophilisation afforded soditmi [2-^^C,^H2^ 
propionate (24) in an overall yield of 16.5% from sodium [l-^^cj-acetate. 
The 13c n.m.r. spectrum of sodium [2-13Q2H2]-propionate is shown 
in Fig. 1(a). Fig. 1(b) shows an expansion of the 130)2 signal where a mixture 
of 13CD2 (pentet) and 13CDH (triplet) is obvious, in an approximate ratio of 
88% : 12% respectively, indicating a small amotmt of deuteritun exchange 
dining the synthesis. Fig. 1 (c) is an expansion of the ^^CDz signal from the 
first attempted synthesis of sodimn [2-13Q2H2]-propionate. A triplet dearly 
predominates over the pentet, indicative of a high proportion of 13Q)H. 
There is also a singlet present which corresponds to complete loss of 
deuteriimi. This extensive exchange of deuteritun in the first synthesis was 
presumably due to utilising KOH and D2O for the base hydrolysis. 
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Fig. 1(a), " C nmr (50MHz) of sodium (2-"C^H,]-propionate 
in a solution of D ,0 . 
:S0 :S9 






1 I I . I M 1 . . . . I . 1 1 1 I I 
•.23 ::o -a a a 
I I I I I I I I 
a 





' I ' ' ' ' I ' ' I I I { I I i I I i I I I 
34 32 








D D o 
(22) 
VI - vu 
D D 
(23) 
CN vm - IX 







Scheme 2. Reagents and conditions:- i) p-phenylphenacyl bromide, 
18-crown-6, C^H^: CH3CN (1:1), reflux 16h, ii) diglyme, -23°C, IiAlD4, 
r.t. 4h, iii) 0°C, phenoxyetiianol, iv) 50°C 8h distillation, 
v) p-toluenesulphonyl chloride, pyridine, -23°C 2h, vi) KCN, MeOD : 
(3 : 1), reflux 2h, vii) distillation, viii) KOD, D2O, reflux 3d, be) H^^qy 
lyophilise, pH 7 NaOH^aqj. 
22. Feeding experiments 
2 ^ 1 Feeding of sodium [l-i3C]-propionate to Sireptomyces sp. ATS1287 
In the first instance, soditam [l-l^CJ-propionate was fed to Streptomyces 
sp.ATS1287 to determine the level of incorporation before sodium [2-
13Q2H2]-propionate was synthesised and fed. The soditm:i [l-13C]-propionate 
was administered batchwise at day 3, 3.5 and 4 to Streptomyces sp. ATS1287. 
Leptomydn B was isolated on day 9 and converted to its methyl ester (about 
10mg/800cm3) and the resultant l^c n.m.r. spectrtmi is shown in Fig. 2. The 
sample is not very pure as there are related co-metabolites which could not 
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be separated, however the signals corresponding to leptomycin B methyl 
ester can be dearly identified (marked with a black spot in Fig. 2). The fuU 
13C n.m.r. assigrmient of leptomycin B methyl ester has been reported by 
Seto et <7Z.l02 and Table A2 (Appendix 1, pg. ii) lists the chemical shifts for 
each carbon of a standard sample of leptomycin B methyl ester, compared 
with the literature value. 
The Incorporation of sodium [l-l3C]-propionate into leptomycin B 
was evident by the enrichment in the 13c n.m.r. spectrum of the carbons 
corresponding to carbon-1 of the propionate units, i.e. C3, C9, C13, C15, C17, 
C19 and C21, by a magnitude of 3 - 4 fold. The enrichments are detailed in 
Fig. 3. These values were calculated by normalising the height of each signal 
relative to C29 (CH3), and then a further normalisation relative to a natural 
abundance spectrum. The figure corresponding to the enrichment at C21 is 
much higher than the others. The origin of this discrepancy is not dear but 
i t could be due to n.m.r. relaxation effects or perhaps another coinddent 
signal (corresponding to an impurity) at the same chemical shift and 
therefore effecting the calculation. 
13c/ppm sodium [1-13C3-
propionate 
C3 151.57 3.54 
C9 136.96 3.25 
C13 135.17 3.13 
C15 128.17 2.70 
CU 215.25 2.91 
C19 74.31 4.56 
C21 45.28 6.10 
C23* 116.95 0.99 
C5* 81.50 0.90 
Fig. 3, * unenriched C as standard 
2.2.2 Feeding sodium U-iSQ^HJ-propionate to Streptomyces sp. ATS1287 
The synthetic scheme and corresponding figures outlined i n section 2.1 
corresponds to the second preparation of sodium [2-l3Q2H2]-propionate. In 
the first attempt at the synthesis, precautions were not taken to prevent 
Fig. 2, nmr (lOOMHz) of leptomycin B methyl ester isolated 
from Streptomyces sp. ATS1287 fed with sodium [l-^^C^propionate 
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exchange of the deuterium and this lead to half of the material with only 
one deuterium, and a small amount carrying no deuterivuns. The feeding 
experiment was however attempted, with the anticipation that the primary 
kinetic isotope effect would help the situation, i.e. loss of H favoured over 
loss of D. 
Sodium [2-13Q,2H2]-propionate was fed as outlined in section 2.2.1 to 
Streptomyces sp.ATSl287 and leptomydn B methyl ester was isolated on 
day 9. The corresponding n.m.r. spectnmi is shown in Fig. 4. Again the 
sample is lacking in purity, but leptomydn B methyl ester is identifiable 
(marked with black spots). The Incorporation of sodium [2-13Q2H2]-
propionate into leptomycin B methyl ester is clearly evident by the 
enrichment in the ^^C n.m.r. spectrum of the carbons derived from carbon-2 
of the propionate units, i.e. C4, CIO, C14, C16, C18, C20 and C22 by a 
magnitude of 7 - 9 fold. The enrichments are detailed in Fig. 5, these values 
were calculated by normalising relative to C l l (CH2). 
13C/ppm Sodium [2-13C2H2]-
propionate 
C4 3Z43 9.05 
a o 31.14 7.98 
CIA 135.43 9.33 
C16 44.60 6.10 
CIS 45.58 7.95 
C20 32.37 9.47 
C22 157.49 837 
C23* 115.93 1.2 
C5* 80.45 1.10 
Fig. 5, * unenriched C as standard 
An Incorporation of a ^^C-D imit into leptomycin B methyl ester 
would appear as a triplet shifted to a lower frequency by a magnitude of 
about 0.3ppm from the natural abimdance signal in the n.m.r. spectrum. 
However there was no evidence of this in the 13c n.m.r. spectrtun and so 
the sample was analysed by l^cjlH, ^H] n.mr. This analysis is very clear and 
low level incorporations will be identifiable (e.g. chapter 2, a 0.2 fold 
enrichment of the butjrrate imit of monensin A when fed with p^C^Ha-
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methy/j-thymine). The resultant spectrum however showed no evidence of 
deuterium incorporation. This result could be explained in several ways :-
i) the methine sites at C4, C16 and C18 all possess L-configuration, i.e. the 
deuterium has been lost due to epimerisation. 
ii) there wasn't sufficient deuterium content in the sodium [2-13Q2H2]-
propionate. 
To have confidence in the results, it was necessary to prepare again sodimn 
[2-13Q2H2]-propionate, taking care to avoid deuteriimi loiss (section 2.1) such 
that the feeding experiment could be repeated. 
In the interim, leptomydn B production ceased. Many attempts were 
made to induce production and the Streptomyces strain did appear to 
produce leptomydn B again. After several sub-cultures the second sodium 
[2-13C2H2l-propionate feeding experiment was performed but in the event 
no leptomydn B cotild be isolated. 
3. CONCLUSION 
Little conclusive information can be gleaned from these experiments due to 
the diminishing leptomydn B production. Stereochemical information 
could be gained by other means. For example an X-ray crystal structure but 
this would require sufficient leptomycin B. In the future if the 
stereochemistry of the leptomydns or the structurally related metabolites 
(leptolstatin, kazusamycins e.Lc) can be assigned then it will be of interest to 
see if the configurations correlate with the Celmer macrolide model.40 
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THE BIOSYNTHESIS OF CUBENSIC A g P 
1. INTRODUCTION 
1.1 Cubensic add 
Cubensic acid (1) is a straight chain fimgal metabolite secreted by Xylaria 
cubensis (Mont) Fr. collected in the Peruvian Amazon rain forest. The 
genus Xylaria contains a large and xmdetermined number of species, most of 
them inhabiting tropical and sub-tropical regions. Their exact physiological 
role is unknown but most of them produce a white rot in wood. The 
isolation and structure elucidation of cubensic add (1) has recently been 
reported by Edwards et 
OO2R 
(1) R = H 
(2) R = Me 
The add is isolated from the static surface grown mycelium after eight 
weeks growth on 3% malt extract medium. Conversion to its methyl ester 
(2) by treatment with diazomethane aids purification of this metaboUte. 
Cytochalasin D is isolated from the supernatant of these cultures, and 
studies on the biosynthesis of cytochalasin D are discussed in chapter 5. 
12. Biosynthesis of cubensic add 
The long extended polyketide chain structure of cubensic add (1) with its 
eight pendant methyl groups looks at first glance reminiscent of many of 
the polyketide metabolites of Actinomycete bacteria. An example of such a 
metabolite is leptomycin B (3)^ 0^  isolated from Streptomyces sp. ATS 1287 
(discussed in chapter 3). It too has an extended polyketide chain with 
pendant methyl groups and is biosynthesised from the condensation of 
acetate C2- and propionate C3- \mits.l03 Hence by extending this analogy it 
was hypothesised, by Edwards et al.,'^^'^ that cubensic add (1) could also 
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derive from the condensation of acetate and propionate imits. There is a 
flaw in this hypothesis however, as leptomycin B is an Actinomycete 
metabolite whereas cubensic add is of fungal origin, and fimgal metabolites 
are not known to incorporate propionate, mid-chain, into their 
metabolites.19 There are however several fungal metaboUtes where 
propionate is utilised as a starter imit, e.g. aurovertins B and D, and 
asteltoxin which are metabolites of Emericella variecolor. 113/114 
OH O 
(3) leptomycin B 
A more attractive proposal for cubensic add is that it is constructed 
from acetate and the pendant methyls from L-methionine, cf. radidonic add 
(4)115 a fxmgal metabolite isolated from Penicillium sp. Radidonic add (4) 
and cubensic add are unusual metabolites as they are highly reduced long 
chain systems, whereas the majority of fungal metabolites are aromatic in 
character. The biosynthesis of radidonic add from 8 acetate and 7 L -
methionine tmits has been established-H^It appeared appropriate in view of 
the errant proposal in the literature and the extensive degree of 
methylation, to assess the biosynthetic make up of cubensic add. 
(4) radidonic add 
1^ ^ 
= acetate M = L-methionine 
77 
2. RESULTS AND DISCUSSION 
2.1 Feeding of L-P^C-mctfiyfl-methionine, sodium [l-^^C, 2-2H3]-acetate and 
sodium [^CJ-acetate to Xylaria cubensis 
L-[13C-met/iyZ]-Methionine was administered to the Xylaria cubensis 
cultures in one batch on day 4 (i.e. when the myceliimi appeared to have 
healthy growth) at a final concentration of 3.7mM. Cubensic add was 
isolated from the myceUum on week 8. Methylation with diazomethane 
yielded methyl cubensate which gives a distinctive blue colouration on a 
silica t.l.c. plate, after spraying with an anisaldehyde : gladal acetic add : 
sulphuric add solution. 
l^C Nudear magnetic resonance spectrum of crude methyl cubensate 
dearly identified that the L-[^^-methyl]-methiomne had been incorporated 
into the methyl groups of methyl cubensate, Le. C23, C24, C25, C26, C27, C28, 
C29 and C30 were enriched by a magnitude of 10 - 17 fold. The specific 
values given in Fig. 1, were calculated by normalising relative to the 
methoxyl carbon (OMe). The sample isolated was rather impure but 
purification with preparative Cis reverse phase chromatography afforded 
dean material and the resultant n.m.r. spectrum is shown in Fig. 2. 
There was littie sample after the purification and so only the enriched 
methyl signals are evident in the l^C n.m.r. spectrum. A full n.m.r. 
assignment of cubensic add has been reported by Edwards et aZ.l^ ^ and Table 
A3 (Appendix 1, pg. iii) contains all of the chemical shift values of methyl 
l3C/ppm [13C-wefhy/]-
methionine 
C23 14.89 15.53 
C24 11.11 15.71 
C25 17.22 13.91 
C26 17.44 17.63 
C27 18.04 17.01 
C28 12.08 10.50 
C29 66.82 17.31 
C30 19.12 17.50 
OMe* 51.46 -
C14* 40.70 1.09 
Fig. 1, * xmenriched C as standard 
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Fig. 1, '^C nmr (lOOMHz) of methyl cubensate isolated from 
Xylaria cubensis fed with (•^ C-mrf/iy/]-methionine. 
' ' I ' ' ' ' I ' ' ' ' I ' ' ' ' I ' ' ' ' I ' ' ' ' I ' ' ' ' I ' 
70 60 50 40 30 20 10 
Fig. 3, '•'C nmr (lOOMHz) of methyl cubensate isolated from 
Xylaria cubensis fed with sodium {l-^^C, 2-^ H3]-acetate. 
m 
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After successfully demonstrating that the eight methyl groups of 
cubensic add are heavily enriched by L-[l3C-mef/iy/]-methionine, the next 
experiment was designed to confirm that the backbone of cubensic add is 
constructed from acetate units. Accordingly sodiimi [l-13C,2-2H3]-acetate was 
administered to cultures of Xylaria cubensis at day 0 such that the final 
concentration was 16.15mM. The resultant cubensic add was isolated on 
week 8 and the 13C n.m.r. spectrum of the purified methyl cubensate is 
shown in Fig. 3. The Incorporation of sodium [l-l3C,2-2H3]-acetate into 
methyl cubensate is evident by the enhancement of the 13C signals 
corresponding to carbon-1 of the acetate units, ie. C I , C3, C5, C7, C9, C l l , 
C13, C15, C17, C19 and C21, in the 13C n.m.r. spectrum. The Incorporation is 
quite low at a magnitude of about 1.5 - 2 fold. The specific values are given 







a 176.67 1.50 C15 82.86 Z03 
C3 80.96 1.91 CU 130.96 1.63 
C5 133.14 1.46 C19 - -
C7 77.37 1.89 a i 30.97 1.52 
C9 - - OMe* 51.48 0.81 
a i 77.26 1.97 CIO* 43.74 0.95 
C13 136.41 1.68 
Fig.4, *imenriched C as standard 
The 13c signal corresponding to C9 is hidden by the C5D5N solvent 
signal and the signals corresponding to C18 and C19 coalesce, so calculation 
of these peak heights is difficult. The location of any residual deuterium 
isotope in cubensic add was investigated by assessing the presence of p-
shifted signals. Deuteritim can only be retained at the following sites in 
methyl cubensate (5), i.e. C2, C6, CIO, C14 and C22. This condusion is drawn 
as the fvmctionality along the backbone after the condensation has to be a 
ketone or reduced to an alcohol. If an elimination to a double bond has 





The n.m.r. spectrum was analysed for deuterium induced p-shifts 
(13C-C-D) of the signals corresponding to CI , C5, C9, C13, C21. This shift is 
normally to a lower frequency by a magnitude of between 0.01 - O.lppm per 
deuterium.31 Due to the low incorporation of acetate into methyl cubensate, 
the p-shifted signal will be of low intensity. There was no apparent p-shift of 
the resonances of the carbons C I , C5, C9 and C13, but expansion of the 
13C n.m.r. spectrum. Fig. 5, shows the signal corresponding to C21 and to a 
lower frequency there are three small sigiwls corresponding to a (a) i^C-C-D, 
(b) 13C-C-D2and (c) l^C-C-Ds component. The resonance corresponding to a 
p-shift induced by three deuterivim atoms is shifted by 0.26ppm from the l^C 
natural abtmdance signal of C21. There is a higher incorporation of sodiimi 
[l-13C2-2H3]-acetate into this C21 - C22 imit as it is the starter unit in the 
construction of the polyketide, i.e. malonyl-ACP (7) undergoes a 
decarboxylative condensation with acetyl-CoA (6) directly. Exchange of the 
deuteritmi is probably due to the conversion of acetyl-CoA to malonyl-CoA 
and tiien decarboxylation back to acetyl-CoA again. 
9 O 
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Fig. 5, expansion of Fig. 3 to show C21 
The lack of evidence for incorporation of deuterium at the other sites, 
Le. C I , C5, C9 and C13 may be due to the lack of sensitivity of the 13C run.!. 
technique or in some cases the p-shift can be to a higher frequency or zero, 
particularly when the enriched carbon is a carbonyl,^ e.g. C I , and therefore 
the presence of deuterium would not be observable in the 13C n.m.r. In 
order to confirm or otherwise the presence of deuterium at the methine 
sites the sample was submitted for n.m.r. Unfortunatdy this restilt was 
incondusive due to insuffident sample. 
To sustantiate further the derivation of the polyketide backbone of 
cubensic add from acetate tmits, sodium [l3C2]-acetate was also administered 
to the cultures of Xylaria cubensis at day 0 and at a final concentration of 
16.5mM. Cubensic add was isolated at week eight, however the cubensic 
add production was very low. The 13C rumj. spectrum of the resultant 
meUiyl cubensate is shown in Fig. 6 (a). An expansion of this spectrum is 
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shown in Fig. 6 (b) whidi shows more dearly the i^C-^^C coupling satellites 
flanking the nattiral abtmdance signals. Each acetate derived carbon, i.e. CI 
to C22, possess the ISC-^^C coupling satellites which indicate incorporation 
of intad acetate units along the backbone of cubensic add. The incorporation 
of sodium [13C2]-acetate is approximately 0.5 - 1 fold. 
These results demonstrate the incorporation of acetate into the 
backbone of cubensic add and show that the methyl groups are enriched by 
L-[13C-methyZ]-methionine, demonstrating unambiguously that cubensic 
add (8) is assembled in a dassical fungal mode from eleven acetate and eight 
L-methionine tmits. 
I I I I I I I I 
M M M M M M M M 
= acetate M = L-methionine 
(8) 
22 Feeding of N-acetylcysteamine-p3C2H3-met/iyfl-2-methyIbutyrate and L-
P^C^Ha-wiet/iyfl-methionine to Xylaria cubensis 
It is a challenge in polyketide biosynthetic studies to try and determine 
intermediates and possible advanced starter units in a biosynthetic pathway. 
There have been several reports of successful incorporations of isotopicaUy 
labelled advanced biosynthetic intermediates into such metabolites, e.g. 
nargenidn from Nocardia argentinensis^^ (discussed in chapter 5) and 
dehydrocurvularin from wild type Alternaria cinerariae ATCCC 1178^ 
(discussed in detail in chapter 1). These results reinforce the existence of a 
processive mode of assembly for polyketide metabolites. In fimgal systems, 
however, there still remains a certain amotmt of ambiguity over the timing 
of the methylations by S-adenosyl-L-methionine (disctissed in chapter 1). It 
seems likely that there are methyltransferase enzymes which are integral 
with the polyketide synthase and which mediate the methylations 
processively (scheme 1), i.e. as the polyketide chain is constructed, rather 
than a series of methylations occurring at the end of polyketide construction 
(scheme 2). There is no definitive experimental evidence to support either 
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Fig. 6 (a), nmr (125MHz) of methyl cubensate isolated from 
Xylaria cubensis fed with sodium [^ "'CjJ-acetate. 
i 
im 
Fig. 6 (b), expansion of part of Fig. 6 (a). 
42 40 38 35 34 32 30 
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methylation pathway as there has been no reported incorporations of 
partially assembled fragments which contain a methyl group derived from 
SAM into fungal polyketides. 
0 o 
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Cubensic add, with its eight pendant methyl groups, is an attractive 
metabolite to try to test this processive methylation hypothesis. Our 
approach was to feed N-acetylcysteamine-[^3c2H3-met/iyZ]-2-methylbutyrate 
(9), a partially assembled methylated precursor, to Xylaria cubensis. 
Assessment of the resiiltant cubensic add may determine if the substrate 
was utilised by the polyketide synthase and regiospedfically incorporated 
into the polyketide metabolite cubensic add (10) at the positions C19, C20, 
C21,C22and C30. [l3C2H3-methyO-2-Methylbutyrate was administered as its 
N-acetylcysteamine thioester (NAC) as this unit has been used as a 
coenzyme A mimic (discussed in chapter 1) and aids transfer of the labelled 









2.2.1 Synthesis of N-acetylcysteamine-r^C^Hs-wict/ty n-2-methylbutyrate 
The synthesis of N-acetylcysteamine-[l3C?H3-mefhy/]-2-methylbutyrate (15) 
is outlined in scheme 3. Diethyl ethyknalonate (11) was treated with sodium 
hydride to generate the soditim enolate, which was quenched with 13C2H3I. 
The resultant alkylated product (12) was hydrolysed to afford [13C?H3-. 
mefhy/]-ethylmethylmalonic add (13). Decarboxylation was mediated in a 
steel bomb to yield (14). CouplingH^ of (14) with N-propionylcysteaminell^ 
was performed in the presence of 1,3-dicydohexylcarbodiimide and 4-
dimethylaminopyridine to afford N-acetylcysteamine-[l3C?H3-mefhyi]-2-


















Scheme 3. Reagents and conditions: i) NaH, THF, 0°Q 
ii) "CD3I, reflux 2h, iii) 5M KOH, reflux 24h, HCi^^^y 
iv) H20,180°C 3h, aCL^aqy N-propionylcysteamine, 
DCC, DMAP, ether, r.t. 12h. 
2.2.2 Feeding experiment 
N-Acetylcysteamine-[13C?H3-methyn-2-methyIbutyrate was administered on 
day 3 to Xylaria cubensis such that the final concentration was 5mM. 
Cubensic add was isolated after week 8 and the 13C n.m.r. spectnmi of the 
purified sample is shown in Fig. 7. Particular attention was focused on 
assessing whether there was a regiospedfic Incorporation of 
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Fig.7, ^^ C nnu- (125MHz) of methyl cubensate isolated fromXyZflna cubensis 
fed with N-acetylq s^teamine-["c^ H3-mef/iy/]-2-methylbutyrate. 
wUw^tllUMli 'J 
I 




[13C?H3-mefhy/]-2-methylbutyrate into cubensic add (10) at C19, C20, C21, 
C22 and C30. No Incorporation was evident in the 13c{lH}-n.m.r. spectrum 
therefore the sample was sent to Edinburgh University for l3c{ lH, ^H}-
n.m.r. analysis. The resultant spectrum is shown in Fig. 8. Spectrum (b) is a 
13C{lH}-n.m.r. spectrum and in this spectrum the ISQDg appears as a septet 
but in spectrum (c), the 13C{lH, 2H}-n.m.r. spectrum, the septet collapses to a 
singlet and subtraction of the two spectra gives the difference spectrum, (a). 
Upon close examination of Fig. 8 (a), there is a signal which is shifted to a 
lower frequency by 1.7ppm from the C30 natural abundance signal. Typically 
deuteriimi induced a-shifts (l^C-D) can shift resonances between the range 
of 0.3 to 0.6ppm per deuteriimi.31 So theoretically the maximiun a-shift for 
three deuteriums could be l.Sppm. Therefore the peak in the difference 
spectrum. Fig. 8 (a), could be due to an incorporation of 13CD3 into the C30 
methyl group. In order to confirm this deduction it was judged necessary to 
establish the typical magnitude of em a-shift corresponding to three 
deuteriums in cubensic add at this carbon. So following from the L-[13C-
methyl]-methiomne experiment, it was appropriate to feed L-[13C?H3-
methy/]-methionine and assess the magnitude of the a-shift on the methyl 
carbons. 
The production of cubensic acid was low and when lA^K^-H^-
OTef^y/]-methionine was fed to seven Xylaria cubensis cultures, no cubensic 
add could be isolated. The feeding experiment was repeated on a larger 
scale, i.e. L-[^K?ii3-methyl]-methiomne was administered on day 4 at a 
concentration of 2.42mM and the cultures were worked up on week 8. A n 
impure sample was isolated and sent for 13C{lH, 2H}-n.m.r. analysis. The 
resultant difference spectnmi (^3C{lH}-n.m.r. subtracted by ISQ^H, 
n.m.r. spectrum) showed the presence of eight signals corresponding to the 
eight methyl groups of cubensic add whidi are derived from L-methionine, 
Fig. 9. Because of the impurities it was difficult to assign with confidence the 
natural abtmdance signals of methyl cubensate which therefore hampered 
the calculation of the a-shifts. So a sample of reference methyl cubensate 
was added to the n.m.r. tube to enhance the natural abxmdance signals. 
From this experiment it could be ascertained that the a-shift 
corresponding to three deuteriums (i.e. l^CDg) at C30 is about Ippm. 
Therefore the signal evident in Fig. 8 (a), 1.7 ppm to lower frequency from 
the C30 natural abimdance signal (in the [^KPH^-methyiyi-metixylhutyrate 
feeding experiment) is too large a shift to be due to three deuteriiuns, and 
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therefore it must correspond to an imptirity which is not associated with 
cubensic acid. This result forces the conclusion that [^K?ii3-methyl]-2-
methylbutyrate was not incorporated into cubensic add in an intact manner. 
C25 




Fig.9,13C{^H, 2H}-n.m.r. difference spectnmi of methyl cubensate isolated 
from Xylaria cubensis when fed with L-[13c2H3-me*/7y/]-methionine. 
Further information can be ascertained from the L-p^C^Hs-mcffey/}-
methionine feeding experiment, because the difference spectrum in Fig. 9 
shows the deuterium induced a-shifted signals of all the methyl carbons 
and that each methyl carbon possesses three deuteriums, except C29 which 
carries two deuteriums and an alcohol moiety. This proves that C29 is 
derived from L-methionine and the retention of the two deuteriums 
demonstrates that the hydroxylation is a post assembly modification, Le. C29 
hasn't been oxidised to an aldehyde moiety and then reduced to an alcohol 
duxix^ the construction of the polyketide backbone, scheme 4. 
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3. F A S T A T O M B O M B A R D M E N T (FAB) MASS S P E C T R A A N A L Y S I S O F 
M E T H Y L C U B E N S A T E 
Methyl cubensate is a long chain fatty acid ester with five - O H groups 
pertruding from the backbone, and potentially it may have ionophoric 
properties, i.e. the stereochemistry of methyl cubensate is tmknown but i f s 
backbone may curve aroimd and present the - O H groups in the right 
conformation to complex to metal cations, analogous to the polyether 
antibiotics and macrocydic crown ethers more generally. 
Fast atom bombardment (FAB) is a technique which is commonly 
used to obtain mass spectra from high molecular weight compounds (eg. 
peptides) and relatively unstable molecules. It can also be used for 
examining complex formation between metal cations and ionophoric 
ligands in solution-^^O A simple explanation of the technique is that there is 
a beam of fast moving neutral atoms (in this case xenon atoms) which is 
directed at the tip of a probe upon which is placed the sample (held in a 
glycerol matrix). The energy of the beam is dissipated in the surface layers. 
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causing molecules to be released which are either positive, negative or 
neutral in charge. It is possible to detect either the positive or negative ions 
that are emitted (in this case positive ions were detected) by reversing the 
potential difference of the metal target to the source slits. 
The eiim of this study was to determine if methyl cubensate would 
complex to any of the following mono- and di-valent cations K+ Na+, Li+, 
Mg2+, Ca2+ and Zn2+. The following aqueous salt solutions of equal 
concentrations were prepared, i.e. K C l , N a Q , LiBr, CaCl2, MgS04 and 
ZnS04. Methyl cubensate was dissolved in ethanol. The concentration of 
the salt solutions was higher than the methyl cubensate concentration in 
order to maximise the possibility of complexation. Six individual FAB mass 
spectra were recorded (run on a V G analytical 7070E mass spectrometer) by 
placing one drop of methyl cubensate solution on the tip of the probe and 
one drop of K C l solution and then a FAB mass spectra was recorded, the 
probe was wiped dean and the process was repeated with a different salt 
solution. 
The resulting mass spectra are shown in Fig. 10. Fig. 10 (a) is the FAB 
mass spectra of a standard sample of methyl cubensate, which dearly shows 
the M + 1 peak of 539. Spectrum (b) results from a solution of methyl 
cubensate and K C l with a peak at 577, evident, corresponding to M + 39. 
Spectrum (c) is the mass spectrum of methyl cubensate and N a Q with a 
peak at 561 (M + 23) and finally (d) is of methyl cubensate with LiBr, and a 
peak at 545 (M + 7) is evident. The same treatment with the salt solutions of 
divalent cations gave only the methyl cubensate signal, i.e. M + 1 = 539. 
This suggests that methyl cubensate can complex with the 
monovalent cations K+, Na"*" and Li+ but not with the divalent cations Mg2+, 
Ca2+ and Zn2+. These results are interesting and may suggest a mode of 
action for cubensic add in promoting transportation of monovalent cations 
across cell membranes, c.f. transport antibiotics. This type of antibiotic 
makes membranes permeable to ions in two different ways. One group of 
antibiotics known as channel formers (e.g. gramiddin A, an open chain 
poljrpeptide) form channels that traverse the membrane and ions can enter 
through this channel at one side and diffuse through to the other side. The 
second group of antibiotics (e.g. valinomydn, a cyclic molecule made up of 
amino add residues) are called carriers and they ftuiction by carrying ions 
through the hydrocarbon region of the membrane.121 
Fipl0.fABt 
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The biosynthetic origin of cubensic add from acetate and L-methionine 
imits has been firmly established. N-Acetylcysteamine-[l3c2H3-mgfhyri-2-
methylbutjorate showed no incorporation into cubensic add. This was 
shown by determining that the a-shift due to three deuteritmis was about 
Ippm, by feeding L-[i3(;2H3-methy/]-methionine. Therefore the signal in the 
difference spectrum. Fig. 8 (a), of the N-acetylcysteamine-[^3C^3-OT^^^y/]-2-
methylbutyrate feeding experiment, at 1.7ppm to lower frequency from C30, 
must be due to an impurity, i.e. it is not associated with C30 of cubensic add. 
Cubensic add is an interesting fungal metabolite because it possesses 
so many pendant methyl groups. It would dearly be interesting to know the 
absolute stereochemistry of cubensic add and to assess further its potential 
ionophoric capabilities. 
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P A R T B 
T H E B I O G E N E S I S O F CUBENSIC A C I D 
In recent years genetic studies have dominated polyketide chemistry. The 
lead has been taken with research into the biosynthesis of the bacterial 
aromatic actinorhodin (16).l22 A c t i n o r h o d i n is a d i m e r i c 
isochromanequinone antibiotic isolated from Streptomyces coelicolor and is 




The six act genes which have been identified in the assembly of 
actinorhodin are located adjacent to each other in a duster and they are 
believed to encode for the individual enzymes which are involved in 
polyketide assembly.1^ The individual genes are discrete and encode 
enzyme activities which are not covalentiy linked. This resembles the fatty 
add synthase (FAS) systems of most bacteria and is known as a Type II 
polyketide synthase (PKS), i.e. an acyl carrier protein chaperones the 
assembling polyketide aroimd a series of individual enzymes. PKS gene 
clusters associated with the generation of several other Streptomyces 
originating polyacetate aromatic compoxmds are emerging with a similar 
organisation.122 
The breakthrough in locating the actinorhodin PKS genes stimulated 
the search for PKS genes in other organisms and there is currently a large 
amoimt of information available on the strudxire of different polyketide 
synthases. For example, in contrast to the PKS for actinorhodin biosjnithesis, 
the PKS 6-methylsalicyclic a d d (17) has been isolated and purified from 
Penicillium patulum. It is composed of a set of covalentiy linked enzyme 
activities which together form a large multifunctional protein.l23 This is a 
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dassic Type I PKS (analogous to the Type I FAS of yeast and mammals, 
which consists of large multifunctional proteins with individual activities, 
induding an acyl carrier protein, located in catalytic domains of the 
protein) .124 
OO2H 
(17) 6-methylsalicyclic add 
The PKS genes of Saccharopolyspora erythraea which are responsible 
for the production of the erythromycin aglycone, 6-deoxyerythronoUde B 
(18), have been identified. 6-Deoxyerythronolide B is biosynthesised from a 
propionyl-CoA starter unit and six methybnalonyl-CoA condensations and 
it is the first enz5ane free intermediate to be secreted in the erythromycin 
biosynthetic pathway. 
(18) 6-deoxyerythronolide B 
Two research groups have cloned the entire PKS of S. erythraea and 
demonstrated that there are three open reading frames (ORF's) involved in 
the expression of 6-deoxyerythronolide B synthase.125,126 A topographical 




Module 1 Module 2 
ORF3 
Modules Module 4 
^ f \ 
Modules M ^ i l l i l 
I AT ACP KS AT KR ACP K5 AT KR ACP ) | KS AT ACP RS AT KR C»l ER A C T > | ( S A T K R A C P R S A T K R ACPTE > 
— 1 — ^ — I 7 1 / ' — r I y 
H O l i i 
AT = acyltransferase 
ACP = acylcarrier protein 
KS = p-keto-ACP synthase 
KR = ^keto-ACP reductase 
DH = dehydrogenase 
ER = enoyl reductase 
TE = thioesterase (cyclase?) 
(17) 6-deoxyerythronoIide B 
Scheme 5 
Each open reading frame encodes for a large multifunctional protein 
(i.e. DEBS 1, DEBS 2 and DEBS 3), each of which is thought to contain all the 
activities necessary for two of the six chain extension cydes, Le. there exists 
an individual activity for each step carried out by the erythromycin PKS. 
The activities are organised into six modules which may be linked further 
into pairs,127 and one pair of modules is expressed by one DEBS poljrpeptide. 
This type of PKS is dassified as a Type I PKS due to the multifunctional 
nature of the proteins. Progress in this field has been rapid and the three 
D E B S multifunctional enzymes have been isolated and purified from S. 
cry thr«efll28and the molecular basis of their actions is now tmder study. 
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Attention is currentiy focused on the genetic analysis of PKS genes 
from bacterial systems, particularly the commercially important 
Actinomycete antibiotic producers,l^i29 whereas the many fungal systems 
are relatively imexplored. The bacterial Type I PKS and the ftmgal Type I 
PKS may be very similar in structure and fimction. So applying a Type I PKS 
gene organisation to cubensic add, similar to that of erythromycin A, would 
lead to five discernible bios)aithetic regions, A - E , which could be further 
simimarised as three enzymatic modules, 1 - 3 , with modules 2 and 3 
repeating themselves (as outlined in scheme 6). 
OO2H 
Y V Y Y i 
A B C D E 
Module 1 Modvde2 Module 3 Module 3 Module 2 
Module 1 K S , M T , K R , D H , E R , K S , M T , K R , D H , E R 
Module 2 KS, MT, KR, DH, KS, MX, KR 
Module 3 KS, KR, DH, KS, MT, KR 
KS = ^ketoaq^l S3nnti^se, MT = methyl transferase 
KR = p-keto reductase, D H = dehydratase, ER = enoyl reductase 
Scheme 6 
This hypothesis assumes that there exists a methyltransferase activity which 
is integral with the polyketide synthase and hence the methylations occtir 
processively during polyketide construction. If this is the case then the 
cubensic add PKS may be even larger and of greater complexity than the 
erythromycin PKS. However this remains to be tested. Even so it must be 
noted that the structure of region A (Module 1 in scheme 6) is a common 
'starter unif foxmd in several fungal metabolites (the hydroxylation is a post 
assembly modification), e.g. obionin A (19) isolated from a marine fimgus 
Leptosphaeria obiones,^^ radidonic add (3) isolated from Penicillium sp.^^^ 




(19) obionin A 
CX)2H 
(3) radidonic add 
(20) funiculosin 
The Modules 2 and 3 are also identifiable in A C R L Toxin I (21) isolated from 
Alternaria citrf.l32 
Modtile 2 Module 3 
(21) A C R L toxin I 
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Similarly malaysionic add (22) and camaronic add (23) have been isolated 
from Xylaria sp.l33 
OH OH OH OH 
OD2H 
Module 1 Module 2 Module 3 Module 3 Module 3 
(22) malaysionic add 
OO2H 
- / V . 
Modtile 2 Module 3 Module 3 Modvde 3 
(23) camaronic add 
Both structxires are very similar to cubensic add, and by extending the 
module hypothesis, it can be interpreted that malaysionic add (22) has the 
same modular sequence as cubensic add but replaces the enzymatic Module 
2 of cubensic add at C4 with Module 3. The same is apparent for camaronic 
add (23), but the starter unit is smaller in this metabolite than in cubensic 
add. 
From this analysis it can be suggested that there exists a gene duster 
for Module 1 which has been replicated and selected through the 
evolutionary process such that region A is evident in several fimgal 
metabolites. It would also be of considerable interest to determine the 
absolute stereochemistry of cubensic add to establish, or otherwise, if the 
stereochemistry of the regions corresponding to Modules 2 and 3 (which are 
very similar and differ only by degree of methylation) is the same as that 
found in A C R L Toxin I from Alternaria citri, thereby giving evidence of 
modules evolving from common ancestral proteins.127 
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C H A P T E R S 
C Y T O C H A L A S I N D 
1. I N T R O D U C T I O N 
1.1 Cytochalasans 
The cytochalasans are a class of biologically active fimgal metabolites which 
were first isolated in 1966. They exert unique biological effects on 
mammalian ceUs in tissue culture, e.g. they inhibit cell movement and 
cytoplasmic cleavage. The isolation of these compounds resulted from the 
observation that cvdttire filtrates of certain micro-organisms had a cytostatic 
action on cell cultures in vitro.^'^ 
The isolation and characterisation of the first two substances of this 
new class of metabolites was achieved independently by Aldridge and 
Turnerl35 at I C I and by Tamm^^^ in Zurich. In the ICI laboratories, the 
metabolites named cytochalasin A (1) and B (2) were isolated from cultures 
of Helminthosporium dematioideum and in Zurich, Tamm isolated the 
metabolites named phomin (2) and dehydrophomin (1) from the micro-
organism Phoma, strain S298. A direct comparison of these two discoveries 
showed that phomin was identical with cytochalasin B and dehydrophomin 
with cytochalasin A. 
(1) R = 0 
(2) R = H , O H 
Since this initial discovery a great range of cytochalasans have been 
isolated and the class consists of five groups of compounds all with similar 
chemical structures, i.e. 
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[1] cytochalasins (Greek: cytos, a ceU; chalasis, relaxation) 
OH O 
(3) cytochalasin D 137,138 
[2] chaetoglobosins 
• ' " I I I 
(4) chaetoglobosin A 
[3] aspochalasins 








Al l are characterised by a highly substituted isoindolinone ring system to 
which is fused a macrocyclic ring. The latter is either carbocyclic, a lactone or 
a cyclic carbonate. The structviral differences occur at the 10 position where 
there exists a phenyl group in cytochalasins, indoyl group in 
chaetoglobosins and an isopropyl group in aspochalasins. Chaetoglobosin K 
(8) from Diplodia macrospora,^^^ is an unusual member of the 
cytochalasans. It consists of a methyl tryptophan residue and also possesses 
an ethyl group at C5 which may possibly originate from a propionate starter 
unit, c.f. aurovertins B and D and asteltoxin, metabolites produced by 
Emericella variecolorA'^^'^'^^ 
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" " • I I 
(8) chaetoglobosin K 
The dosely related structures of the cytochalasan metabolites is 
suggestive of a similar biogenesis. A mechanism can be speculated 
originating with a polyketide derived chain which is linked to a 
phenylalanine (leucine or tryptophan) residue through an amide linkage to 
give the intermediate (9). This could then xmdergo a cydoaddition reaction 
to (10) which has the ring system present in some of the cytochalasans, e.g. 
aspochalasin A (5). Epoxidation of the double bond wotdd yield another type 
of ring system which exists among the cytochalasans, e.g. chaetoglobosin A 
(4). The epoxides could then be transformed in vitro to a mixture of 
isomeric aUylic alcohols (11) and (12), another cytochalasan ring system. The 
lactone system that exists in cytochalasin B (2), for example, arises by a 
Baeyer-Villiger type oxidation of the carbocyclic system^44 ^^d likewise the 
cyclic carbonate system of cytochalasin E arises after a second oxidation.^ 45 
The mechanisml46 (scheme 1) for the formation of the cydohexane ring is 
speculative and there have been alternatives proposed.147 
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(9) (10) 
H N — ^ > f \ 
Scheme 1 :- A general hypothesis for the biosynthesis of cytochalasans 
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1.2 Cytochalasin D : - isolation 
Both q/^tochalasin C (13) and D (3) were first isolated and characterised from 
the cultures of Metarrhizium anisopliae by Aldridge and Turneries and 
independently Minato et al.^^^ described a new antibiotic isolated from the 
cultures of Zygosporium tnasonii. This metabolite was given the name 
zygosporin A. Aldridge and Tumerl^^ deduced that zygosporin A was in fact 
identical to cytochalasin D and this was established by an independent 
elucidation of the structure.^49 
••ml 
OH O 
(13) cytochalasin C 
More recently there has been the first report of the occurrence of a 
cytochalasan metabolite f rom a Xylaria species. Cytochalasin D (3) was 
isolated from the oilture meditim of Xylaria n ^^s expected 
that the Xylaria cubensis mycelium would also yield cytochalasin D because 
large quantities of cytochalasins constitute the mycelium of Hypoxylon 
terricola.^^^ This was however not the case and another unrelated 
metabolite, cubensic acid, predominated. 
1.3 Cytochalasin D : - synthesis 
The combination of the challenging structural complexity and the unusual 
cytological properties of the cytochalasans has created an interest in their 
syntheses. The total synthesis of cytochalasin D (3) has been achieved^^^ 
using a strategy that had been successful for other naturally occurring 
cytochalasans including cytochalasin H (14).152,153 j h ig approach involved 
the use of an intramolecular Diels-Alder reaction to form the reduced 
isoindolone, and large ring fragments, simultaneously. 
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••ml 
(14) cytochalasin H 
1.4 Cytochalasin D:- biosynthesis 
Extensive biosynthetic studiesl54-159 utilising both radioactive and stable 
isotopes have been performed on cytochalasin D f rom Zygosporium 
masonni and the origin of each carbon atom is now well established. 
Cytochalasin D is generated f rom nine acetate units, eight of which are 
coupled in a head to tail fashion to form the Ci6 polyketide moiety, three L-
methionine derived methyl groups and one L-phenylalanine unit. 
- M 
= acetate M = L-methionine 
A n interesting and controversial feature of the cytochalasans is the 
mechanism of formation of the six membered ring . A n attractive theory 
involves a biological intramolecular Diels-Alder reaction, a process which 
has chemical precedence, and would create the correct relative 
stereochemistry around the ring. The involvement of a biological Diels-
Alder reaction has been proposed in the biosynthesis of a variety of 
secondary metabolites, particularly decalin-based compounds such as 
betaenones,l60 and mevinolin^^l Qj^d i n dimeric indole alkaloids such as 
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the presecamines.162 a further example is ikarugamydn, an acyltetramic 
acid antibiotic isolated f rom Streptomyces phaeochromogenes var. 
ikaruganensis^^ and lachnanthocarpone, a major pigment found in the 
seed pods of Lachnanthes tinctoria .164 
It has however proved difficult to obtain conclusive experimental 
evidence for the participation of a biological intramolecular Diels-Alder. A l l 
other alternative mechanisms have to be eliminated and proof that the 
reaction actually takes place in a living organism is not straightforward. 
There has however been some very promising results obtained from work 
on several metabolites in which a Diels-Alder reaction can be implicated. 
One example is solanapyrone A (15), a phytoxin isolated f rom Alternaria 
solani. 
CHO CHO CHO 





solanapyrone D (17) 
Extensive feeding experiments have been performed^^S and show 
that solanapyrone A (15) is derived f rom eight acetate imits and two L-
methionine derived methyl groups. After feeding sodium 
acetate, the sites of retained deuterium are consistent w i t h an 
intramolecular Diels-Alder reaction. Additional evidencel66 came from the 
isolation of an optically active diastereoisomer, solanapyrone D (16). This 
co-exists with solanapyrone A as a minor component i n the culttires of 
Alternaria solani, and coxild clearly arise from anendo cycloaddition of the 
postulated triene intermediate (17) in a biological Diels-Alder reaction. I n 
more than 30 decalin polyketides, solanapyrones represent the only example 
of a putative triene intermediate which would not possess any chiral centres 
and this may be the reason for the biological production of two 
diastereoisomers, the en do and exo cycloaddition products. Most recently 
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the solanapjnrone stoiy has gone one step futher and the deuterium labelled 
precursors (18) and (19) have been regiospedfically incorporated^^^ jj^to 
solanapyrone A providing strong experimental support for the operation of 
a biosynthetic Diels-Alder reaction. The pathway of incorporation into the 
solanapyrones is outlined in scheme 2.^ 67 
O C D 3 
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(16) solanapyrone D (15) solanapyrone A 
Scheme 2 
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Further evidence of an intramolecular biological Diels-Alder reaction 
comes f r o m nargenicin (20), an antibiotic isolated f r o m Nocardia 
argentinensis. 
(20) nargenicin 
Cane et fll.26 have been successful in incorporating the following and 










These incorporations provide evidence for a processive model of polyketide 
assembly and chain elongation in which the stereochemistry and oxidation 
level are adjusted prior to each successive condensation. Also the 
incorporation of the tetraketide precursor (21d) is consistent w i th an 
intermediate which undergoes an intramolecular Diels-Alder reaction to 







Biosynthetic studies on chaetoglobosin A (4)168,169 isolated f rom 
Chaetomium suhaffine have revealed indirect evidence of a biological 
Diels-Alder reaction to form the cyclohexane ring. This was obtained by 
isolating a non-oxidised derivative called prochaetoglobosin I (23) by adding 
a cytochrome P-450 inhibitor to the cultures of Chaetomium suhaffine. 
' " I l l 
(23) prochaetoglobosin I 
It is beheved that this compoimd is one of the first intermediates in post-
cyclisation and that a variety of modifications produce a number of 
analogues.170,171 xj^e occurrence of non-oxidised derivatives, eg. 
proxiphomin, have also been reported from cytochalasins.172 
In order to provide imambiguous evidence for the existence of an 
intramolecular Diels-Alder reaction, studies involving a retro-Diels-Alder 
reaction on prochaetoglobosin I were performed in order to obtain the 
putative hexaene (24)^ 9^ (scheme 4). In the event the reaction produced not 
the hexaene intermediate (24), as expected, but a new compound (25) which 
was shown to be the diastereoisomer of prochaetoglobosin I . With this 
result it was suggested that the endo and exo transition states do not possess 
a sufficient energy difference and therefore both adducts (23) and (25) result. 
I n a biological system however, the enzyme responsible for the 
cydoadditions may stabilise the endo transition state and therefore only 
prochaetoglobosin I (23) is generated. 




2. RESULTS A N D DISCUSSION 
2.1 A i m 
If an intramolecular Diels-Alder reaction is asstmied in the biosynthesis of 
cytochalasin D then a possible intermediate could be (26). 
(26) 
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Cydisation and then post assembly modifications such as oxidation would 
then generate cytochalasin D. I t is envisaged that incorporation of the early 
putative intermediate (27) into cytochalasin D would support an 
intramolecular Diels-Alder cycloaddition during the biosynthesis of 
cytochalasans. It would also provide evidence of a processive mechanism of 
methylation as the polyketide chain is constructed, i.e. the existence of a 
methyltransferase enzyme integral with the polyketide synthase, mediating 
the methylations at some point before the next condensation. 
Therefore i t was judged appropriate to prepare the N -
acetylcysteamine thioester (NAC) of (27) with a iSc.iSc label, to incubate to 
cultures of Xylaria cubensis i n order to assess Incorporation into 
cytochalasin D. Substrates are generally fed24,117 as their NAC thioesters as 
this imit mimics coenzyme-A (discussed in chapter 1) and aids transfer of 
the labelled acyl residue onto the appropriate thiol binding site on the 
polyketide S3mthase. The use of a double 13c-13c label was employed to 
provide greater sensitivity in the detection of low levels of enrichment, and 
to help identify the presence of an intact tmit, observable by the 13(2-l3c 
coupling satellites aroimd the natiiral abundance signal in the n.m.r. 
spectrum. 
2.2 Synthesis of N-acetylcysteamine-(E,E)-[l>l3c2]-4-methyl-2,4-
hexadienoate 
The approach to the synthesis of N-acetylcysteamine-(E,E)-[l,2-l3C2]-4-
methyl-2,4-hexadienoate is outlined in scheme 5. [13C2]-Bromoacetic acid 
(Ig) was methylated to afford (29) which was carried on directly to the next 
reaction by treatment wi th triphenylphosphine in acetonitrile. Collection by 
filtration of the precipitated (30) and treatment wi th aqueous soditim 
hydroxide solution afforded (31). A Wittig reaction with tiglic aldehyde 
generated methyl (E,E)-[l,2-13C2]-4-methyl-2,4-hexadienoate which was 
hydrolysed to the corresponding carboxylic acid (33). The final reaction 
involved the coupUngl^S of (33) with N-acetylcysteamine^l^ in the presence 
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of 1,3-dicydohexylcarbodiimide (DCC) and 4-dimethylanunopyridine 
( D M A P ) to afford N-acetylcysteamine-(E,E)-[l,2-l3C2l-4-methyl-2,4-
hexadienoate (34) in an overall yield from [l^CzJ-bromoacetic add of 8.7%. A 
small amount, about 4%, of (Z,E)-material was evident i n the l^C n.m.r. 
spec t rum. N-Acetylcysteamine-(E,E)-[ l,2-l3C2]-4-methyl-2,4-hexadienoate 




(33) (32) (31) 
VI 
(34) 
Scheme 5 :- Reagents and conditions: i) CH2N2, ii) Ph3P, acetonitrile, 
r t 3d, iii) aq. NaOH, iv) f rflns-2-methyl-2-butenal, ethanol, reflux 24h, 
v) I M NaOH, metiianol rt 16h, vi) DCC, DMAP, 
N-propionylcysteamine, ether, rt 12h. 
23 Feeding of N-acetylcysteainme-(E,E)-[l,2-^C2l-4-methyl-2,4-hexadienoate 
to Xylaria cubensis 
N-Acetylcysteainine-(E,E)-[l,2-l3C2]-4-methyl-2,4-hexadienoate was fed in 
one batch to growing cultures of Xylaria cubensis on day 4 (i.e. when the 
mycelium showed a degree of healthy growth) at a final concentration of 
1.3mM. Cytochalasin D was isolated after three weeks and the resultant 
114 
(a) 
Fig. 1, '-'C nmr spectrum {C5D5N, lOOMHz], (a) cytochalasin D fed 
withN-acetylcysteamine-(E,E)-Il,2-"C2]-4-methyl-2,4-hexadienoate, 
(b) C8 of cytochalasin D, (c) C13 of cytochalasin D 
!40 120 
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13c n.m.r. spectrvun is shown in Fig. 1. The ^Kl n.m.r. spectrtun of 
cytochalasin D has previously been fuUy assignedl^^ (Table A4, Appendix 1, 
pg. iv). The two carbons of particular interest in assessing a regiochemical 
incorporation of the labelled substrate (34) into cytochalasin D are C8 and 





13C-13C Coupling satellites, in the l^ c n.m.r. spectrum, at each of the signals 
corresponding to C8 and C13 would be indicative of an intad incorporation 
of substrate (34) into cytochalasin D. Inspection of the l^ c n.m.r. spectnmi 
Fig. 1 (a), reveals that each of the signals corresponding to the acetate 
derived carbon atoms possess l^C-^^C coupling satellites. Expansion of the 
spectrum to reveal C8 Fig. 1(b), and C13 Fig. 1(c), demonstrates that the C8-
C13 coupling satellites are of equal intensity to the satellites of the other 
acetate derived carbons. This observation indicates that (34) has been 
degraded by p-oxidationl73 to [l3C2]-acetate and that i t is this that has been 
utilised by the polyketide synthase enzymes and incorporated into 






So we have obtained a n.m.r. spectrum of cytochalasin D which has a 
similar enrichment pattern to that of cytochalasin D isolated from cultures 
fed with sodixmi [l3C2]-acetate, Fig. 2. 
Fig. 2, "C nmr spectrum of cytochalasin D fed wit i i sodium [^^Cjl-acetate 
[C5D5N, lOOMHz] 
zoo ISO •JCO 120 100 to 60 
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2.4 Feedii^ of N-acetylcysteamine-(E,E)-[l^-^C2l-4-methyl-2,4-hexadienoate 
wi th a p-oxidation inhibitor to Xylaria cubensis 
Experiments aimed at the intad incorporation of functionalised di- and tr i-
ketides into metabolites are generally plagued by rapid degradation of 
prectirsors by p-oxidation.l73,56 Vederas et flZ.25 examined the effect of 
several p-oxidation inhibitors to supress the breakdown of the 13c labelled 
precursors into dehydrocurvularin by v^dld-tjrpe Alternaria cinerariae ATCC 
11784. When 3-(tetradecylthio)propanoic add (35) was used as a ^ -oxidation 
inhibitor little breakdown, if any, of the tetraketide substrate by p-oxidation 
was observed. In an effort to omit p-oxidation in our system this inhibitor 
was employed. Thus 3-(tetradecylthio)propanoic add (35)174 ^ as synthesised 
in a straightforward manner by coupling 3-mercaptopropanoic add and 1-
bromotetradecane in a methanol solution of potassium hydroxide. 
(35) 
The feeding experiment vdth Xylaria cubensis was repeated as before 
with the addition of 2 batches (day 0 and day 4) of 3-(tetradecy thio)propanoic 
add (it had to be dissolved i n ethanol with heating and then administered 
to the cultures rapidly before i t cooled and predpitated out) to a final 
concentration of 3.7mM. N-acetylcysteamine-(E,E)-[l,2-13C2]-4-methyl-2,4-
hexadienoate was also administered on day 4 at a final concentration of 
1.3mM. Cytochalasin D was isolated after three weeks and the 13C n.m.r. 
spectrum is shown i n Fig. 3. A small amount of residual 3-
(tetradecylthio)propanoic add is evident f rom the 13C n.m.r. analysis. It can 
dearly be seen, however, that the degradation of the substrate has been 
substantially suppressed wi th only a very small amotint of [l3C2]-aoetate 
incoiporated into C5^ochalasin D. Expansion of the spectrum to see C8, Fig. 3 
(b), and C13, Fig. 3 (c), signals more dearly reveals small 13C-13C satellites 
indicative of acetate incorporation (also evident at the same level in all of 
the acetate derived carbon atoms). There is no increased intensity of the 
satellites at C8 and C13 which would indicate regiospedfic incorporation of 
substrate (34) into cytochalasin D. 
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Fig. 3, ^^C nnir spectnnn (CjDjN, lOOMHz], (a) cytochalasin D fed 
withN-acetylcysteairuneKE,E)-{l,2-"C2H-methyl-i4-hexadienoate 






The feeding experiments to investigate the mode of ring formation in 
cytochalasin D, isolated f rom Xylaria cubensis, have proved inconclusive. In 
the first experiment, the [13C2]-substrate (34) was degraded to [^ 3C2]-acetate 
and this incorporation was evident i n the n.m.r. spectrum of 
cytochalasin D. In the second experiment, a p-oxidation inhibitor was 
employed which was successftil in suppressing p-oxidation, however there 
was no evidence for regiospedfic incorporation of (34) into cytochalasin D. 
The lack of regiospedfic incorporation of (34) into cytochalasin D does 
not rule out the possibility that the acyl moiety is an intermediate on the 
polyketide synthase. There could be several factors governing the 
incorporation of such a substrate.56 poj- example, it may be imable to access 
the polyketide biosynthesis enzymes due to its inability to cross the cell 
membrane, possibly as a restdt of the natural mechanism for excreting 
metabolites f rom the cell. Alternatively compartmentalisation within the 
cell may present a problem. Another possibility is that the substrate is not 
suitably primed for transesterification onto the polyketide synthase. Of 
course the structure of the substrate may be wrong, e.g. the true 
intermediate may be the alternative geometric isomers. 
Finally the l ^C-^^ double labelling technique may not be sensitive 
enough to detect a very low level of incorporation. Labelling of (34) with 
deuterium and analysis by n.m.r.34 may provide both increased 
sensitivity (due to the low natural abundance of deuterium) and economy. 
Such an approach has been successfxil in the recent work of Statmton et 
flZ.175 investigating the incoporation of partially assembled intermediates in 






Nuclear magnetic resonance spectra were recorded on a Gemini (200MHz) 
spectrometer operating at 199.97MHz. l^C Nudear magnetic resonance spectra 
were recorded on a Varian VXR 400S (400MHz) spectrometer operating at 
100.57 MHz. Chemical shifts are quoted in ppm relative to TMS [(CH3)4Si] in 
CDQ3. Coupling constants are quoted in Hz. Mass spectra were recorded on a 
VG analytical 7070E mass spectrometer. Infrared spectra were recorded on a 
Perkin-Elmer F.T. 1600 spectrometer. Melting points were performed on a 
Gallenkamp melting point apparatus. Rash chromatography was undertaken 
with the use of Huka silica gel-60 (35 - 70nm) or Sorbsil-C60-H (40 - 60\an). All 
sterilisations were carried out in an autoclave at 121°C/ 20 min. Organic 
extracts were dried with MgS04 and the solvent removed imder reduced 
pressure unless stated otherwise. Solvents were always dried and distilled 





A suspension of S-bromouradl (7.64g, 40mmol) in phosphorus oxychloride (50 
an3) was heated under reflux (IIS^C) for 6 days. Excess phosphorus 
oxychloride was removed by distillation (25^C, l.SmmHg) and the residue 
subsequently cooled with an ice bath. Ice was very cautiously added to the 
flask resulting in the evolution of HQ gas. The resrdtant dark brown oUy tar 
was extracted into ether. The ether extract was dried and tiien concentrated to 
yield a yeUow cloudy oil (4.49g, 49.2%); Vmax (neat)/an-l 3080 and 3030,1530 
and 1515,760,680,530; 6H (CDOs) 8.73 (IH, s, CH); 6c (CDQa) 161.4 ( Q , 158.8 
(C), 118.9 (CH); m/z (EI) 230 (M+, 44.5%), 228 (100%), 226 (61.0%), 195 (13.1%), 
193 (52.75%), 191 (41.45%). 
2.4-Dimethoxv-5-bromopvriinidine (28) 
A solution of sodium (0.73g, 31.61mmol) in dried and distilled methanol 
(20cm3) was added to a solution of 2,4-dichloro-5-bromopyrimidine (2g, 
8.77mmol) in methanol (5cm3) imder N2. After stirring for 30 min., the fawn 
coloured precipitate was removed by filtration and discarded. Concentration of 
the filtrate followed by the addition of H2O (15cm3) resulted in a white 
precipitate of 2,4-dimethoxy-5-bromopyrimidine (1.62g, 84.4%) which was 
collected by filtiration; m.p. 63.9 - 64.9oC (UL [176] m.p. 63 - 64oC); (Found: C, 
32.73; H, 3.17; N, 12.71%. C6H7N2Q2Br requires C, 32.90; H, 322; N, 12.79%); 
Vmax (KBr)/cm-l 3080 - 2900,1580,1470,1400; 6H (CDQs) 8.30 (IH, s, CH), 4.03 
(3H, s, CH3), 3.98 (3H, s, CH3); 6c (CDCb) 168 (C), 16727 (C), 159.64 (C), 98.63 
(CH), 55.76 (CH3), 55.43 (CH3); m/z (EI) 220 (97.5%), 218 (100%). 
Thymine 
A solution of n-butyllithium (3.2cm3,1.6M, 5.1mmol) in hexane was carefully 
added to a solution of 2,4-dimethoxy-5-bromopyrimidine (0.82g, 3.73mmol) in 
THE (10cm3) whilst imder an atmosphere of nitrogen and cooled with a dry ice 
/ acetone bath. A solution of CH3I (023cm3,3.73mmol) in THE (5cm3) was then 
added. After stirring for 90mins at -65oC, the reaction was quenched by the 
cautious addition of solid CO2. Upon stirring for Ih at room temperature, the 
solution was added to water and the organic layer extracted into ether. 
Concentration afforded an orange residue. 6M HQ (3,7cm3 cone HQ in 20cm3 
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H2O) was added to this residue and heated under reflux for 2h. The subsequent 
solution was concentrated to dryness and the residue suspended in ether, 
filtered and the solid sublimed in vacuo to afford thymine (170oC/0.06mmHg) 
(0.12g, 26.4%); v^ax (KBr)/cm-l 3540 - 3300, 3220, 3070, 2940, 1735,1680,1390; 
6H (DMSO-d6) 11.03 (IH, broad s, NH), 10.60 (IH, broad s, NH), 7.24 (IH, s, 
CH), 1.73 (3H, s, CH3); 6c (DMSO-de) 165.30 (CO), 151.78 (CO), 138.03 (CH), 
108.05 (C), 12.04 (CH3); m/z (El) 127 (M+1,100%). 
r^^C-mgtftv/l-Thvmine (29) 
A solution of n-butyllithivim (1.47cm3,1.6M, 2.35mmol) in hexane was carefully 
added to a solution of 2,4-dimethoxy-5-bromopyrimidine (0.57g, 2.61mmol) in 
THF (15cm3) under and cooled with a dry ice / acetone bath. After stirring 
for 15 min. at -78oC, the resultant orange solution was further cooled to -198oC. 
Under vacuimi, the solution was charged firstly with ^^CHsI (ImQ), and then 
the flask was purged with nitrogen and CH3I (0.13cm3, 2.09mmol) was added 
via a syringe. The reaction mixture was allowed to warm to -78°C at which 
temperature it stirred for Ih followed by a further 30 min. between -50 and 
-60°C. The reaction was quenched by the addition of CO2 [generated in situ by 
the careful addition of BaCOs (1.03g, 5.22mmol) to concentrated H2SO4 (2cm3) ] 
at -1980C and imder vacuum. The flask was allowed to gradually warm from 
-1980C to -780C and then to -50oC and finally to room temperature. The 
organics were extracted into ether and washed with saturated sodium 
bicarbonate solution followed by drying and concentration to afford an oil. The 
residue was hydrolysed by heating imder reflux for 24h in 6M HQ (47.4cm3) 
followed by concentration and purification over Dowex (50X2-400). Loaded 
onto the coltmin in NH4OH (2cm3) and elution with water afforded a mixture 
of [^MZ-methyiythymine and uradl (9:1, [l4C-;ne%/]-thymine : uradl). [^ ^C-
w^%/]-Thymine (926.5fiCi, 289mg) was isolated in a radiochemical yield 92.6% 
and the radiochemical purity by t.l.c. ("BuOH : H2O [86 : 14 v/v] on silica) 
91.2%; 6H (DMSO-d6) 7.23 (IH, s, CH), 1.71 (3H, s, CH3); 6c (DMSO-de) 165.49 
(CO), 152.04 (CO), 138.28 (CH), 108.23 (C), 12.36 (CH3). 
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ri3c2H^-wictftvn-Thvmme (30) 
A solution of n-butyllithium (3J25cm3,1.6M, 521mmol) in hexane was carefuUy 
added to a solution of 2,4-dimethoxy-5-bromopyrimidine (12g, 5.48mmol) in 
THE (30cm3) xmder an atmosphere of nitrogen and cooled with a dry ice / 
acetone bath. The solution was stirred for 15 min. at -78oC and then ^^CZHSI 
(0.31cm3, 4.93mmol) was added. The solution was stirred for Ih at -78oC and 
then for a further 30min at a temperature between -50 to -60oC The reaction 
was quenched with CO2 gas at -78°C and the temperature was gradually 
allowed to rise to -50°C The reaction was then allowed to reach room 
temperature and work up followed by acid hydrolysis proceeded as above to 
yield a yellow solid. Purification was accomplished by sublimation (157oC/ 
0.023mmHg) affording [13c2H3-TOe%/]-aiymine (029g, 44.9%) as a white solid; 
(Eound M+, 130.0663. C4l3CH3E)302N2 requires M+, 130.0651); Vmax (KBr)/cm-l 
3560 - 3300, 3159.8, 3044.8, 2814.4, 1734.1,1672.9, 1448.3; 6H (DMSOds) 7.21 
(IH, d, J 3.6, CH); 6c (DMSO-de) 165.11 (CO), 151.60 (CO), 137.88 (CH), - (C), 
11.08 (septet, IJcD 19.41,13CD3); m/z (EI) 130 (M+, 99.28%). 
Dihvdrothvmine 
Rh (~5%) on alumina (lOOmg) was added to a solution of th)anine (O.lOg, 
0.83mmol) in O.OOIM H Q (40cm3) and stirred under H2 at room temperature 
for 16h. Eiltration of the reaction mixture through a celite pad and then 
concentration afforded dihydrothjonine (O.lOg, 96.4%) as a white solid; m.p. 
261.3-2630C (Ut [177] m.p. 262.5 - 263oC); Vmax (KBr)/cm-l 3240 and 3090,2980, 
2940, 2900 and 2840, 1740 and 1715, 1680,1390; 6H (P2P) 3.35 (IH, dd, J 12.7 
and 6.3, 6CHs), 3.05 (IH, dd, J 12.6 and 10.0, 6CHR), Z67 (IH, m, 5-CH), 1.06 
(3H, d, J 7.0, CH3); 6c (D2O) 180.23 (CO), 177.0 (CO), 44.79 ( C H ) , 36.97 (CH2), 
14.79 (CH3); m/z (EI) 128 (M+, 100%). 
r^^-mgtftvfl-Dihvdrothvmine 
Rh (~5%) on alumina (19.67mg) was added to a solution of [^K.-metiij/l\-
thymine (37.77^0, 11.78mg, 0.093mmol) in O.OOIM HQ (5cm3). Under the 
same hydrogenation conditions and work up as above, ['^MZ-meihyl\-
dihydrothymine (30.4fiQ, 16.34mg) was isolated with a radiochemical yield 




A solution of diethyl malonate (2.25g, 14.09mmol) in THF (5cm 3) was added to 
a suspension of sodium hydride (0.55g, 13.67mmol) in THF (40cm3) imder N2 
and at O^ C. After effervescence had ceased, a solution of CH3I (2g, 14.09mmol) 
in THF (5cm 3) was added and the reaction mixture was heated imder reflux for 
2h. Upon cooling a drop of ethanol, then water, was added and the organics 
extracted into ether. After drying, concentration of the ether extract yielded 
diethyl methylmalonate (1.95g, 79.4%) as a yellow oil; (Found: M+1,175.0939. 
C8H14O4 requires M+1,175.0970); Vmax (neat)/cm-l 2970, 2927,1734,1458; 6H 
(0X33) 4.19 (4H, q, J 7.1, CH2), 3.42 (IH, q, J 8, CH), 1.40 (3H, d, J 6.84, CH3), 
1.27 (6H, t, J 7.16, CH3); 6c (CDa3) 170.19 (CO), 61.37 (CH2), 46.29 (CH), 14.19 
(CH3), 13.64 (CH3); m/z (EI) 175 (M+1,100%), 129 (10.73%). 
Diethyl r^C-wtctfevn-methvlmalonate (32) 
A solution of diethyl malonate (5.64g, 3523mmol) in THF (15cm3) was added 
to a suspension of sodium hydride (1.37g, 34.18mmol) in THF (100cm3) under 
N2 and at O^C. After the effervescence had ceased, 13CH3I (5g, 34.97mmol) in 
THF (10cm3) was added and the reaction proceeded as above to afford diethyl 
[13C-w2ethyIl-methyhnalonate (5.76g, 93.5%); Vmax (neat)/cm-l 2980,2910,1730, 
1455; 6H (CDa3) 4.10 (4H, q, J 7.2, CH2), 3.32 (IH, dq, J 72 and 2jcH 4.6, CH), 
1.31 (3H, dd, IJcH 130.6 and 7.3,13CH3), 1.18 (6H, t, J 6.6, CH3); 6c (CDa3) 
170.50 (CO), 61.64 (CH2), 46.52 (d, J 34.3, CH), 1439 (CH3), 13.87 (iSCHs); m/z 
(EI) 176 (M+1,7.99%), 130 (37.11%). 
Diethyl methyl(N-metiiylphtiialimide)malonate 
A solution of diethyl methylmalonate (1.94g, 11.15mmol) in THF (5cm3) was 
added to a suspension of sodium hydride (0.46g, 11.71nunol) in THF (100cm 3) 
under N2 and at OoC. N-(bromomethyl)phthalimide (2.68g, 11.15mmol) was 
subsequently added and the mixture stirred for Ih at O^ C and then for a further 
30 mins. at room temperature. A drop of ethanol, then water, was added and 
the product extracted into ether. Drying and concentration yielded diethyl 
methyl(N-methylphthalimide)malonate (2.79g, 75.2%) as a yellow solid; m.p. 
93.2 - 95.80C (Ut. [79] m.p. 96oC); (Found: M+1, 334.1251. C17H19O6N requires 
M+1, 334.1291); Vmax (KBr)/cm-l 2%0 and 2920,1775,1720,1610,1440,1420, 
1390,715; 6H (DMSOde) 7.90 (4H, m, Ph), 4.18 (4H, q, J 7.1, CH2), 4.08 (2H, s, 
CH2), 1.28 (3H, s, CH3), 1 ^ (6H, t, J 7.1, CH3); 6c (DMSO-ds) 170.23 (CO), 
168.08 (CO), 134.98 (CH), 131.54 (C), 123.56 (CH), 61.74 (CH2), 5326 (C), 41.06 
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(CH2), 18.43 (CH3), 13.99 (CH3); m/z (EI) 334 (M+1,26.97%), 288 (33.52%), 160 
(100%). 
Diethyl \^C-methvn-metinyl(N-m^hY^phiha\iTmde)maionite (33) 
A solution of diethyl [13C-me%q-methylmalonate (5.76g, 32.92mmol) in THE 
(10em3) was added to a suspension of sodium hydride (1.38g, 34.57mmol) in 
THE (200cm3) under N2 and at 0<<:. N-(Bromomethyl)phtiialimide (7.90g, 
32.92mmol) was subsequentiy added and the reaction proceeded as above to 
afford diethyl [13C-me%Z]-methyl(N-methylphthalimide)malonate (9.59g, 
87.24%); m.p. 93.5 - 94.8oC (lit. [79] m.p. 96^0; (Eound: M+1, 335.1324. 
Cie^^CHj^ OeN requires M+1,335.1324); Vnax (KBr)/cm-l 2980,2930 and 2860, 
1780,1725,1620,1470 and 1440,1395; 6H (DMSOde) 7.90 (4H, m, Ph), 4.18 (4H, 
q, J 7.0, CH2), 4.09 (2H, d, 3JCH 3.8, CH2), 1.29 (3H, d, IJcH 130.9,13CH3), 1.22 
(6H, t, J 7.2, CH3); 6c (DMSO-de) 170.25 (CO), 168.11 (CO), 135 (CH), 131.55 (C), 
123.58 (CH), 61.75 (CH2), 53.1 (d, IJcc 302, C), 41.89 (CH2), 18.43 (I3CH3), 14.00 
(CH3); m/z (Q) 352 (M+NH4+, 1.25%), 335 (M+1,8.35), 206 (4.96%). 
Diethyl (aminometfayDmetfaylmalonate 
Anhydrous hydrazine (2.5cm3, 822mmol) was added to a solution of diethyl 
methyl(N-methylphthalimide)malonate (2.74g, 8.22mmol) in dry methanol 
(70cm3) under N2 and at room temperature. The reaction mixture was stirred 
for 12h. The resulting white precipitate was removed by filtration and 
discarded. The filtrate was added to water and extracted into dichloromethane. 
Drying and then concentration of the extract afforded diethyl 
(aminomethyl)methyhnalonate (1.04g, 622%) as a yellow oil; Vmax (neat)/cm-l 
3500 - 3300,2930 and 2860,1735,1465,1380; 6H (CDas) 4.1 (4H, q, J 72, CH2), 
2.93 (2H, s, CH2), 2.1 (broad s, NH2), 1.31 (3H, s, CH3), 1.16 (6H, t, J 7.0, CH3); 
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6c (CDa3) 171.70 ( C O ) , 61.24 (CH2), 56.17 (C), 47.85 (CH2), 18.55 (CH3), 14.10 
(CH3); m/z (EI) 204 (M+1,19.79%), 174 (71.78%), 128 (33.70%). 
Diethyl f ^ C-»ic<fevn-(aminometfavl)methylmalonate (34) 
Anhydrous hydrazine (9cm3, 287.1mmol) was added to a solution of diethyl 
[13C-7ne%/]-methyl(N-methylphthalimide)malonate (9.59g, 28.71mmol) in dry 
methanol (100cm3) under N2 and the reaction proceeded as above to afford 
diethyl [13C-mef/iy/]-(aminomethyl)methylmalonate (2.95g, 50.4%); vmax 
(neat)/cm-l 3500 - 3300,2930 and 2850,1730,1470,1380; 6H ( C D Q S ) 4.20 (4H, q, 
J 7.1, CH2), 3.05 (2H, d, 3jcH 3.5, CH2), 1.42 (3H, d, IJCH 130.4,13CH3), 126 (6H, 
t, J 7.1, CH3); 6c (CDa3) 172.10 ( C O ) , 61.61 (CH2), 56.17 (d, Ijcc 26.6, C), 48.28 
(CH2), 18.97 (13CH3), 14.44 (CH3); m/z (EI) 205 (M+1,44.42%), 191 (6.17%), 176 
(7.04%), 175 (7.22%). 
(DD-d-Aminoisobutyric add 
A solution of diethyl (aminomettiyl)methyhnalonate (1.04g, 5.12mmol) in HQ 
(5cm3) and H2O (5cm3) was heated under reflux for 12h. Residual organics 
were extracted into ether and the remaining aqueous layer was concentrated to 
dryness to yield a pale yellow coloured solid of p-aminoisobutyric add 
hydrochloride (0.55g, 76.6%) which was used directly for feeding experiments; 
vmax (KBr)/cm-l 3420,3050,1720,1590,1460; 6H (D2O) 3.02 (2H, m, CH2), 2.73 
( I H , m, C H ) , 1.07 (3H, d, J 72, CH3); 6c P2O) 180.16 ( C O ) , 44.03 (CH2), 39.68 
( C H ) , 17.04 (CH3); m/z (EI) 104 ( M - H a 100%), 86 (14.64%). 
A small amount was purified over Dowex (50X2-400), elution with 
NH4.OH solution. After concentration to dr5aiess of the active fractions, the 
residue was recrystallised with ethanol to afford white crystals of p-
aminoisobutyric add; m.p. 174.8 - 175.80C (lit. [178] m.p. 176.5 - 177.50C); 
(Found: M+1,104.0669. C4H9O2N requires M+1,104.0712); vmax (KBr)/cm-l 
3354.5, 3043.0,1676.2,1628.9,1560.1; 6H (D2O) 2.91 (2H, m, CH2), 2.46 ( I H , m, 
C H ) , 1.04 (3H, d, J 7.2, CH3); 6c (D2O) 184.39 ( C O ) , 45.15 (CH2), 42.04 ( C H ) , 
17.98 (CH3); m/z (EI) 104 (M+1,100%), 86 (52.08%). 
(DL)-r^C-mgtftvn-B-Aminoisobutyric add hydrochloride (35) 
A solution of diethyl [l3C-methyri-(aminomethyl)methylmalonate (2.95g, 
14.46mmol) in HQ (15cm3) and H2O (15cm3) was heated under reflux for 12h. 
Extraction as above yielded a pale yellow solid of [ISC-mrfhyZJ-P-
aminoisobutyric add hydrochloride (1.80g, 88.60%); 6H (D2O) 3.03 (2H, m. 
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CH2), 2.77 (IH, m, CH), 1.14 (3H, dd, IJcH 129.1 and J 6.6, 13CH3); 6c (D2O) 
180.32 (CO), 44.04 (CH2), 39.76 (d, iJcc 32.7, CH), 17.00 (I3CH3). 
g-Cyanopropionic add 
Sodium carbonate (1.04g, 9.81mmol) was carefully added to a solution of a-
bromopropionic add (3g, 19.61mmol) in acetonitrile (20cm3). After stirring at 
room temperature for 2h, sodium a-bromopropionate was collected by 
filtration and dried tmder reduced pressure. A solution of this sodiimi salt 
(2.94g, 16.82mmol), NaOH (0.05g, 1.26nunol) and NaCN (0.82g, 16.82mmol) in 
H2O (10cm3) was heated between 65 - 8O0C for 2.5h. After coohng, addification 
with dilute HQ followed by extraction of the organics into ether, drying and 
concentration afforded a-cyanopropionic add (1.39g, 83.5%) as a colourless oil; 
vmax (neat)/cm-l 3471.9,2257.5,1736.6; 6H (CDQ3) 3.64 (IH, q, J 7.4, CH), 1.60 
(3H, d, J 7.4, CH3); 6c (CDa3) 170.73 (CO), 117.81 (CN), 32.09 (CH), 15.61 
(CH3); m/z (EI) 100 (M+1,32.60%). 
fl-^CT-a-cyanopropionic add (37) 
Sodium carbonate (0.34g, 3.25mmol) was carefully added to a solution of [1-
13C]-a-bromopropionic add (Ig, 6.49mmol) in acetonitrile (7cm3). Reaction 
proceeded as above to afford [l-13C]-a-cyanopropionic add which was carried 
on to the next step without charaderisation. 
(DL)-6-Aminoisobutyric add 
Pt02 (lOOmg) was added to a solution of a-cyanopropionic add (0.24g, 
2.37mmol) in dried and distilled ethanol : chloroform (10 : 1, 27.5cm3) and 
shook xmder 2.5atm H2 at room temperature for 18h. Eiltration of the reaction 
mixture through a celite pad followed by concentration of the filtrate afforded 
an oil which was purified with Dowex (H+ form). Elution with NH4.OH 
afforded p-aminoisobutyric add (0.018g, 7.4%) which was recrystallised with 
ethanol; Charaderisation the same as before. 
(DL)-[l-i3Cl-B-Aminoisobutyiicadd (39) 
[l-13C]-a-Cyanopropionic add was hydrogenated utilising the same conditions 
as above to afford, after Dowex (H"*" form) chromatography, [l-l3c]-p-
aminoisobutyric add (0.054g, 8%); 6H (D2O) 2.96 (2H, m, CH2), 2.54 (IH, m, 
CH), 1.06 (3H, dd, 3jcH 4.6 and J 72,013); 6c (D2O) 183.41 (13CO), 44.90 (CH2), 
41.48 (d, IJcc 51.74, CH), 17.05 {CH3). 
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(DL)-r3-^9]-B-Aminoisobutyric add (40) 
a-Cyanopropionic add was deuterated utilising the conditions of Pt02 
(200mg), MeOD : 0003 (10 : 1 , 33cm3), 2.5atm D2, i w m temperature for 18h. 
Dowex chromatography afforded [3-^H2}-p-aminoisobutyric add (0.07g, 10%); 
6H (D2O) 2.52 (IH, q, CH), 1.05 (3H, d, J 7.2, CH3); 6c (D2O) 183.62 (CO), 
- (CD2), 41.49 (CH), 17.82 (CH3); 6D (H2O) 3.21 (s, CD), 3.11 (s, CD). 
Diethyl dimethylmalonate 
A solution of diethyl methylmalonate (3.61g, 20.71mmol) in THF (5cm3) was 
carefully added to a stirred suspension of sodium hydride (0.845g, 21.14mmol) 
in THF (50cm3) at O^ C and under N2. A solution of CH3I (3g, 21.14mmol) in 
THF (5cm3) was added and the mixture was heated under reflux for 2h. Water 
was added to the reaction mixture and the whole was extracted with ether. The 
organic extracts were dried and concentrated to afford diethyl 
dimethyhnalonate (4.01g, 102.9%) as a yellow oil; (Found: M+, 188.1050. 
C9H16O4 requires M, 188.1049); Vmax (neat)/cm-l 2984.2,2938.6,1732.1,1469.9, 
1447.6,1386.1,1366.2; 6H (CEXls) 4.05 (4H, q, J 6.4, CH2), 1.29 (6H, s, CH3), 1.13 
(6H, t, J 6.36, CH3); 6c (CDa3) 172.34 (CO), 60.88 (CH2), 49.59 (C), 22.54 (CH3), 
13.89 (CH3); m/z (EI) 189 (M+1,100%), 143 (29.67%). 
Diethyl fiaC-meffevn-dimPthYlmalnnate (42) 
A solution of diethyl methylmalonate (3.61g, 20.71mmol) in THF (5cm3) was 
carefully added to a stirred suspaision of sodium hydride (0.845g, 21.14mmol) 
in THF (50cm3) at O^ C and under N2. A solution of 13CH3I (3g, 21.14mmol) in 
THF (5cm3) was added and the reaction proceeded as above to yield diethyl 
[l3C-me%q-dimethylmalonate (4.17g, 104.2%); (Found: M+1, 190.1076. 
C8l3cHi604 requires M+1, 190.1160); Vmax (neat)/cm-l 2983.9, 2935.9,1734.0, 
1470.8,1448.5,1383.8,1365.9; 6H (0X^3) 4.08 (4H, q, J 7.08, CH2), 1.32 (3H, d, 
IJCH 130.14, 13CH3), 1-32 (3H, d, 3JCH 4.6, CH3), 1.15 (6H, t, J 7.12, CH3); 6c 
(0X13) 172.96 (CO), 61.33 (CH2), 49.97 (d, Ijcc 34.92, C), 22.91 (I3CH3), 1423 
(CH3); m/z (EI) 190 (M+1,100%), 144 (44.67%). 
Dimetfaylmalonic add 
Diethyl dimethylmalonate (4.01g, 21.32mmol) was added to a solution of 5M 
KOH (42g KOH in 15cm3 H2O) and heated under reflux for 24h. Addification 
with dilute HQ and extraction of the whole into eflier afforded a white solid of 
dimefhylmalonic add (2.18g, 79.7%) after drying and concentration; m.p. 194.0 -
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195.70C; (Eound: M+1 133.0405. C5H8O4 requires M+1, 133.0501); vmax 
(KBr)/cm-l 3005.1,2923.5,1700.3,1466.0,1403.7; 6H (D2O) 1.13 (6H, s, CH3); 6c 
(D2O) 179.77 (CO), 52.60 (C), 24.84 (CH3); m/z (EI) 133 (M+1, 100%), 115 
(4624%). 
r^C-mgtftvn-Dimethylmalonic add (43) 
Diethyl [l3C-metfiyI]-dimethylmalonate (4.17g, 22.04mmol) was added to a 
solution of 5M KOH. The reaction and work up as outlined above afforded 
[l3C-nKthy/]-dimethyhnalomc add (2.65g, 90.3%); m.p. 192.0 - 193.0OC; (Found: 
M+1 134.0476. C4^ 3CH804 requires M+1, 134.0534); Vnux (KBr)/cm-l 30883, 
2922.8,1703.0,1460.3,1403.5; 6H (D2Q) 1.24 (3H, d, IJcH 130.42,13CH3), 124 
(3H, d, 3jcH 4.62, CH3); 6c (D2O) 180.03 (CO), 52.75 (d, IJcc 35.22, C), 24.92 
(13CH3); m/z (EI) 134 (M+1,100%), 116 (69.69%). 
Sodium isobutyrate 
A solution of dimethyhnalonic add (2g, 15,14mmol) in H2O (10cm3) was heated 
to 180<>C for 3h. Careful addification with cone HQ and then extraction of the 
whole into ether afforded isobutyric add after drying and concentration. 
Neutralisation to pH 7 with dilute NaOH solution, followed by washing with 
ether to remove xmwanted organics, and removal of the water yielded sodium 
isobutyrate (1.13g, 67.9%) as a white solid; m.p. 249.8 - 251.40C; Vmax 
(KBr)/cm-l 29682, 2932.7,1547.1,1477.2,1420.8; 6H (D2O) 2.27 (IH, septet, J 
7.04, CH), 0.94 (6H, d, J 7.00, CH3); 6c (D2O) 190.75 (CO), 39.82 (Ol), 2227 
(Qia). 
Sodium [^C-metfivZl-isobutyrate (44) 
O 
A solution of [l3C-met/iyZl-dimethylmalonic add (2.65g, 19.92nrunol) in H2O 
(10cm3) was heated to I8O0C for 3h. After careful addification with cone HQ 
the work up was as outlined above to afford sodiimi [ISC-methyH-isobutyrate 
(1.60g, 68.65%); m.p. 244.4 - 245.70C; Vmax (KBr)/cm-l 2967.1, 2931.5,1548.1, 
1477.3,1420.7; 6H (D2O) 2.26 (IH, ds, J 6.96 and 2JCH 4.05, CH), 0.93 (3H, dd, 
I J C H 126.6 and J 6.9,13CH3), 0.93 (3H, dd, J 6.92 and 3JCH 5.48, CH3); 6c (D2O) 
190.73 (CO), 39.80 (d, i jcc 33.80, CH), 2228 (}KHS). 
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Diethyl (hydroxymetfayl)inethylmalonate 
A solution of diethyl methybnalonate (2.69g, 15.42mmol), formaldehyde (37% 
in H2O, 1.25g, 15.42mmol) and potassium bicarbonate (0.2g, 2mmol) was 
heated to 70°C for 2h and stirred for a following 12h at room temperature. The 
reaction mixture was washed with saturated ammonium sulphate solution and 
the organics were extracted into ether. Drying and concentration yielded an oil 
which was purified by silica gel column chromatography. The active fractions 
were eluted with a solvent system starting with 100% dichloromethane but 
gradually increasing the ethyl acetate concentration until 100%, afforded 
diethyl (hydroxymettiyl)methylmalonate (Z36g, 74.8%) as a colourless oil; Vmax 
(neat)/cm-l 3530,2980,2935,1730; 6H (CDQs) 421 (4H, q, J 7.1, CH2), 3.86 (2H, 
d, J 6.64, CH2), 3.36 (IH, t, J 6.64, OH), 1.45 (3H, s, CH3), 1.27 (6H, t, J 7.1, CH3); 
be (CDa3) 171.70 (CO), 66.55 (CH2), 61.71 (CH2), 56.13 (C), 17.83 (CH3), 14.20 
(CH3); m/z (EI) 205 (M+1,47.63%), 175 (67%), 129 (7921%). 
Diethyl f ^ C-wigtfivn-(hydTOxymetfayl)methylmalonate (47) 
O 
OH O 
A solution of diethyl [13C-mc%r|-methyhnalonate (3.72g, 21.23mmol), 
formaldehyde (37% in H2O, 1.72g, 21.23mmol) and potassium bicarbonate 
(0.3g, 3mmol) was heated to 70oC for 2h and stirred for a following 12h at room 
temperature. Work up and purification was as outlined above to yield diethyl 
(l3C-methyn-(hydroxymethyl)methyhnalonate (0.93g, 64.8%); (Found: M+1, 
206.1081. C8l3CHi604 requires M+1, 206.1110); Vmax (neat)/cm-l 3400, 2983, 
2930,1730,1465; 6H (CDa3) 4.21 (4H, q, J 7.14, CH2), 3.86 (2H, dd, J 6.77 and 
3jcH 3.16, CH2), 327 (IH, t, J 6.86, OH), 1.44 (3H, d, IJcH 130.76,13CH3), 127 
(6H, t, J 7.1, CH3); 6c (CDa3) 171.21 (CO), 66.09 (CH2), 61.17 (CH2), 55.51 (d, 
IJcc 34.69, C), 17.22 {^KHS), 13.64 (CH3); m/z (EI) 206 (M+1, 36.28%), 176 
(8325%), 130 (96.92%). 
Sodium metfaacrylate 
A solution of diethyl (hydroxymethyl)methylmalonate (l.lOg, 5.39mmol) and 
dilute hydrochloric add (1.5cm3 cone HQ and 20cm3 H2Q) was gently heated 
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under reflux for 3 days. The organics were extracted into ether. Drying and 
concentration afforded a yellow oil which was pvirified by silica gel colxmm 
chromatography. The active fractions were eluted with a solvent system 
starting with 100% dichloromethane and gradually increasing the ethyl acetate 
concentration until 100%. Addition of water to the concentrated active fractions 
and neutralisation to pH7 with dilute NaOH solution afforded, after 
concentration to dryness, sodiimi methacrylate (0.34g, 58.37%) as a white solid; 
m.p. >360oC; 6H (D2O) 5.51 (IH, m, CH), 5.21 (IH, m, CH), 1.72 (3H, m, CH3); 
6c (D2O) 180.28 (CO), 145.13 (C), 123.55 (CH2), 21.90 (CH3). 
Sodium [^^c-mef/tvfl-methacrvlate (48) 
O 
A solution of diethyl [13C-met/iy/]-(hydroxymethyl)methylmalonate (0.93g, 
4.53mmol) and dilute hydrochloric add (1.5cm3 cone HQ and 20cm3H2O) was 
gently heated under reflux for 3 days. The isolation and purification was as 
outlined above to afford [13C-mefhy/]-methaciylic add as a colourless oil; Vmax 
(neat)/cm-l 3000, 2926.4, 1696.8, 1635.8; 6H (CDQ3) 6.25 (IH, dm, 3JCH 10.1, 
CH), 5.70 (IH, dm, 3JCH 5.90, CH), 1.96 (3H, dm, iJcH 1282, ^^CHs); m/z (Q) 
87 (M+ 1.8%). 
[13C-methy/]-Methacrylic add was neutralised to pH7 with dilute NaOH 
solution to afford sodium [13C-we%/]-methacrylate (0.16g, 32.38%); Vmax 
(KBr)/cm-l 3100,2958,2924,1555,1458,1419; 6H (D2O) 5.51 (IH, dm, 3JCH 9.56, 
CH), 5.20 (IH, dm, 3JCH 6.14, CH), 1.72 (3H, dm, I J C H 127.14,13CH3); 6c (D2O) 
179.60 (d, 2jcc 3.32, CO), 144.43 (d, iJcc 43.25, C), 122.58 (CH2), 21.10 (ISCHs). 
Sodium methacrylate 
A solution of 2-bromopropene (2.05cm3, 23.03nmiol) in dry ether (6cm3) was 
carefully added to a stirred suspension of activated Mg turnings (6.16g, 
253.35mmol) in dry ether (6cm3) over Ih. The reaction mixture was cautiously 
heated under reflux for a further Ih using a water bath at 45oC. After cannular 
transfer, the Grignard reagent was quenched with CO2 [generated in situ by the 
careful addition of BaCOs (5g, 25.34mmol) onto sulphuric add (15cm3)]. After 
quenching, the reaction mixture was concentrated to dryness. Water was added 
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and the solution was altered to pH3 with dilute sulphuric add. The organics 
were extracted into ether, dried and concentrated to yield a yellow oil which 
was chromatographed over silica. The activity was eluted with a solvent system 
starting with 100% dichloromethane and gradually increasing to 100% ethyl 
acetate. Concentration of active fractions yielded methacrylic add as a 
colourless oil. Neutralisation to pH7 with dilute NaOH solution afforded, after 
concentration, sodium mefhacrylate (0.50g, 18.10%) as a white soHd; 6H (D2O) 
5.51 (IH, m, CH), 5.20 (IH, m, CH), 1.72 (3H, m, CH3); 6c (D2O) 180.50 (CO), 
14521 (C), 123.35 (CH2), 21.86 (CH3). 
Sodium ri-l3C]-methacrylate (51) 
A solution of 2-bromopropene (2.05cm3, 23.03mmol) in dry ether (7cm3) was 
carefully added to a stirred suspension of activated Mg turnings (6.16g, 
253.35mmol) in dry ether (7cm3) over Ih. The reaction was as outlined above 
with the exception that the Grignard reagent was quenched with ^KX)2 
[generated in situ by the addition of Bal3<n02 (5g^  25.21mmol) onto sulphuric 
add (20cm3)]. Work up and purification afforded [l-13C]-methacrylic add 
which was neutralised to pH7 with dilute NaOH solution. Concentration of this 
aqueous extract afforded sodium [l-13c]-methacrylate (0.62g, 22.51%); 6H 
(D2O) 5.53 (IH, dm, 3jcri 4.16, CH), 521 (IH, dm, 3JCH 11.72, CH), 1.72 (3H, 
dm, 3jcH 2.72, CH3); 6c (P2O) 18021 (13CO), 145.06 (d, IJcc 61.60, C), 123.67 (d, 
2jcc 2.16, CH2), 21.97 (d, 2jcc 3.22, CH3). 
p3C-mgffevn-Methylmalomc add (52) 
Diethyl [13C-7ne%Z]-(hydroxymethyl)methylmalonate (0.71g, 3.47mmol) was 
added to a solution of lOM KOH (4.2g KOH in 7.5cm3 H2O) and heated under 
reflux for 24h. Addification with dilute HQ and extraction of the whole into 
ether afforded a white solid of [i3C-me%/]-methyhnalonic add (0.22g, 53.2%) 
after drying and concentration. This material was stored as the dicaiboxylic 
add and converted to the sodium salt before the feeding experiment; m.p. 128.7 
- 130.1OC; (Found: C, 40.51; H, 5.09; N, 0%. Cs^KHeOi requires C, 40.68; H, 
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5.11: N, 0%); v^ax (KBr)/cm-l 3838.6,2726.2,1542.1; 6H (D2O) 3.37 (IH, dq, J 72 
and 2jcH 4.8, CH), 1.16 (3H, dd, IJcH 131 and J 7.3, 13CH3); 6c (D2O) 177.19 
(CO), 48.79 (d, iJcc 33.72, CH), 15.80 {^KMS); m/z {O) 137 (M+NH4+, 100%). 
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Growth of Streptomvces cinnamonensis ATCC15413 
Streptomyces cinmmonensis was grown on yeast - malt agar plates (yeast extrad 
2g, malt extirad 5g, glucose 2g, agar 7.5g, distilled water 500cm3, pH adjusted 
to 7.2 with dilute KOH solution) for 14 days at 30oC 
The spores from the producing strain were used to innoculate two Erlenmeyer 
flasks (250cm3), each containing 70 cm3 of seed meditmi (glucose 3.36g, 
soybean flour 2.1g, CaCOs 0.42g, FeS04.7H20 0.77g, MgCl 0.004g, distilled 
H2O 140cm3). These flasks were incubated on a orbital shaker (32oC, 150rpm) 
for 10 days. 
9 Erlenmeyer flasks (500cm3) each containing 100cm3 of production mediirai 
(glucose 45g, soybean flour 13.5g, CaC03 2.7g, FeS04.7H20 4.94g, MgQ 0.027g, 
distilled H2O 900cm3) were innoculated with 3cm3 of seed culture. The 
fermentation was carried out at 32oC and 200rpm for 7.5 days. 
Isolation and purification of monensin A 
Methanol (400cm3) was added to tiie meditun and the brotii was homogenised 
and filtered. The pellet was resuspended in methanol (50cm3), homogenised 
and re-filtered. The supernatant was extraded into dichloromethane, dried and 
concentrated to dryness to yield a brown coloured oil. This residue was 
chromatographed over silica. Activity was eluted with a solvent system starting 
with 100% dichloromethane and gradually increasing the ethyl acetate 
concentration xmtil 100%. Activity was deteded by the appearance of orange 
colouration on thin layer chromatography {CHiCiz : EtOAc [50 : 50 v/v]) 
sprayed with anisaldehyde: gladal acetic add: sulphxiric add (0.5cm3:50cm3: 
lcm3 v/v) reagent and heated. Combination and concentration of active 
fractions yielded an off-white coloured solid which could be further piirified 
withCis reverse phase preparative chromatography, elution with MeOH: H2O 
(9 :1), to afford a mixture of the monensins A and B [8 : 2 v /v] (lOmg). A fuU 
13c n.m.r. assignment is given in Table A l (Appendix 1, pg. i). 
Feeding of sodium metfaacrylate to Streptomvces cinnamonensis 
Sodium methacrylate (0.25g, 2.31mmol) was dissolved in water (18cm3) and 
pulse fed at 3, 3.5 and 4 days to 6 x 100cm3 cultures of Streptomyces 
cinnamonensis using a micropore filter, such tiiat the final concentration of 
sodium methacrylate was 3.86mM. Monensin A was subsequentiy isolated on 
day 7.5 as outlined above. 
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Feeding of sodium f ^ C-mgffei/n-metiiacrvlate to Streptomvces cinnamonensis 
Sodium [l3c-met/iy/]-methacrylate (0.35g, 3.16mmol) was dissolved in water 
(15cm3) and pulse fed at 3,3.5 and 4 days to 6 x 100cm3 cultures of Streptomyces 
cinnamonensis using a micropore filter, such that the final concentration of 
sodium [13C-mefhy/]-methacrylate was 5.27mM Monensin A was subsequentiy 
isolated on day 7.5 as outlined above. 
Feeding of (DL)-[^C-fflgffivn-6-aminoisobutyric add to Streptomvces 
cinnamonensis 
(DL)-[l3C-me%/]-p-Aminoisobutyric add hydrochloride salt (0.5g, 3.56mmol) 
was dissolved in water (18cm3) and neutralised to pH7 with dilute NaOH. It 
was pulse fed at 3, 3.5 and 4 days to 6 x 100cm3 cultures of Streptomyces 
cinnamonensis using a micropore filter, such that the final concentration of [13C-
mcf/iy/]-p-aminoisobutyric add was 5.93mM. Monensin A was subsequentiy 
isolated on day 7.5 as outlined above. 
Feeding of [^ ^C-mgffevri-thvmine to Streptomvces cinnamonensis 
[14C-me%Z]-Thymine (32.46|JO) and thymine (14mg) were added to 6 x 100cm3 
flasks of production medium before sterilisation. After innoculation, monensin 
A (0.66 [iCi, 2% incorporation) was subsequentiy isolated on day 7.5 as outlined 
above. 
Feeding of r^C^^ -^metftvn-thymine to Streptomvces cinnamonensis 
[13c2H3-me%n-Thymine (0.27g, 2.10mmol) was dissolved in water (18cm3) 
and sterilised. It was administered to the cultures (5 x 100cm3) of Streptomyces 
cinnamonensis via a sterilised pipette on day 3, such that \he final concentration 
of [^3c2H3-7ne%n-thymine was 4.21mM. Monensin A was subsequentiy 
isolated on day 7.5 as outlined above. 
Feeding of sodium fS-^CI-isobutyrate to Strevtomvces cinnamonensis 
Sodium [3-l3C]-isobutyrate (0.40g, 3.60mmol) was dissolved in water (18cm3) 
and pulse fed at 3, 3.5 and 4 days to 6 x 100cm3 cultures of Streptomyces 
cinnamonensis using a micropore filter, such that the final concentration of 
sodium [3-l3C]-isobutyrate was 5.59mM. Monensin A was subsequentiy 
isolated on day 7.5 as outlined above. 
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Feedine of sodium f3-^C1-isobutvrate and sodium methacrylate to 
Streptomvces cinnamonensis 
Sodium [3-13C]-isobutyrate (0.40g, 3.60imnol) and sodivun methacrylate (0.39g, 
3.60mmol) were dissolved together in water (IScrn )^ and piilse fed at 3,3.5 and 
4 days to 6 x lOOcm^ cultures of Streptomyces cinmmonensis using a micropore 
filter, such that the final concentration of sodium [3-l3C]-isobutyrate was 
5.59mM and sodixmi methacrylate was 6mM. Monensin A was subsequently 
isolated on day 7.5 as outlined above. 
Feeding of sodium fl-^CI-metiiacrylate to Streptomvces cinnamonensis 
Sodium [l-l3C]-methacrylate (0.34g, 3.11mmol) was dissolved in water (18cm3) 
and pulse fed at 3, 3.5 and 4 days to 6 x 100cm3 cultures of Streptomyces 
cinnamonensis using a micropore filter, such that the final concentration of 
sodium [l-13C]-methacrylate was 5.18mM. Monensin A was subsequently 
isolated on day 7.5 as outlined above. 
Feeding of L-f3-^^l-serine to Streptomvces cinnamonensis at day 0 
I^[3-14C]-Serine (22.18na) and L-serine (lOmg) were dissolved in H2O (6cm3) 
and fed before innoculation to 6 x lOOcm^ sterilised flasks of production 
medium via a micropore filter such that the specific activity was 
0.24mCi/mmol. After innoculation, monensin A (0.33nQ, specific activity 
0.00584mQ/mmol, 2.51% incorporation) was isolated on day 7.5 as outlined 
above. 
Feeding of L-f3-^Kll-serine to Streptomvces cinnamonensis at day 33 
L-[3-14C]-Serine (23.25^0) and L-serine (lOmg) were dissolved in H2O (6cm3) 
and administered at day 3.5 to 6 x lOOcm^ cultures of Streptomyces 
cinnamonensis via a micropore filter such that the specific activity was 
0.24ma/mmol. Monensin A (0.35|Aa, specific activity 0.007884ma/mmol, 
3.3% incorporation) was isolated on day 7.5 as outlined above. 
Feeding of (DLHl-^CT-&-aminoisobutvric add to Streptomvces 
cinnamonensis 
(DL)-[l-13Cl-p-Aminoisobutyric add (0.054g, 0.52mmol) was dissolved in water 
(6cm3) and pulse fed at 3,3.5 and 4 days to 2 x lOOcm^ cultures of Streptomyces 
cinnamonensis using a micropore filter, such that the final concentration of [1-
^3C]-p-aminoisobutyric add was 2.6mM. Monensin A was subsequently 
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isolated on day 7.5 as oudined above. 
Feeding of sodium f ^ C-mgtfavn-metitvlmalonate to Streptomuces 
cinnantonensis 
[13C-mefhyr|-Methylmalonic add (0.22g, l.SSmmol) was dissolved in water 
(12cm3) and neutralised to pH7 with dilute NaOH solution. The resulting 
sodium salt was pulse fed at 3, 3.5 and 4 days to 4 x lOOcm^ cultures of 
Streptomyces cinnamonensis via a micropore filter, such that the final 
concentration of [l^C-mef/iyZJ-inethylmalonic add was 4.6mM. Monensin A was 
subsequently isolated on day 7.5 as outlined above. 
Feeding of (DLM3-^?]-B-aminoisobutviic add to Streptomvces 
cinnamonensis 
Streptomyces cinnamonensis was grown on a different medium (yeast extract 
0.3g, peptone 0.5g, malt extract 0.3g, glucose Ig, distilled H2O lOOcm ,^ pH 
adjusted to 7.3). [3-2H2>p-Aminoisobutyric add (0.07g, 0.67mmol) was 
dissolved in water (3cm3) and admiiustered at day 0 to 1 x lOOcm^ culture of 
Streptomyces cinnamonensis using a micropore filter, such that the final 
concentration of [3-2H2]-p-aminoisobutyric add was 6.67mM. Samples were 
taken at day 1,2 and 3 and filtered to separate the cells, whidi were sent to Dr. 




A solution of sodium acetate (3g, 36.56mmol), p-phenylphenacyl bromide 
(9.33g, 36.56mmol) and 18-crown-6 (732mg) in a mixture of benzene : 
acetonitrile (1 : 1, lOOcm )^ was heated under reflux for 16h. The solvent was 
concentrated to afford a pale brown solid. After the addition of 
dichloromethane, filtration removed xmdissolved impure solid and tiie filtrate 
was concentrated to dryness. The solid residue was applied to the top of a silica 
gel column and eluted with dichloromethane. The active fractions were 
combined and concentrated to yield a white crystalline solid of p-
phenylphenacyl acetate (5.25g, 56.5%); Vnax (KBr)/cm-l 3600 - 3300,3100 - 3020, 
2940,1720,1703,1608,1585; 6H (CDQa) 8.1- 7.4 (9H, m, Ph), 5.36 (2H, s, CH2), 
2.24(3H,s,CH3). 
p-Phenvlphenacyl fl-^l-acetate (20) 
A solution of sodium [l-13C]-acetate (6g, 72.26mmol), p-phenylphenacyl 
bromide (19.88g, 7Z26mmol) and 18-crown-6 (1.44g) in benzene: acetonitrile (1 
: 1, 140cm3) was heated under reflvix for 16h- The solvent was evaporated to 
yield a cream coloured solid. Addition of dichloromethane followed by 
filtration and concentration of the filtrate afforded p-phenylphenacyl [l-l^C]-
acetate (21.43g, 116%), which was used without further purification; mp. 106.7 
- 1090c (lit. [179] m.p- l l loC; Vmax (KBr)/cm-l:- same as above; 6H (CIXI3) 8.1-
7.4 (9H, m, Ph), 5.37 (2H, d, 3JCH 4.4, CH2), 2.25 (3H, d, 2JCH 6.9, CH3); 6c 
(CDQa) 170.95 (13CO), 169.24 (CO), 147.2 (C), 140.03 (C), 133.32 (C), 129.50 
(CH), 128.85 (CH), 127.93 (CH), 127.75 (CH), 69.92 (CH2), 21.15 (d, Ijcc 55.30, 
CH3); m/z (EI) 256 (M+1,24.25%), 181 (100%). 
Ethanol 
A solution of p-phenylphenacyl acetate (5.25g, 20.67mmol) in anhydrous 
diglyme (50cm3) under nitrogen was cooled with a dry ice / Ca4bath. lithiimi 
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aluminium hydride (1.14g, 30.07mmol) was carefully added over a period of 20 
min and the contents of the flask were stirred for 4h under a constant flow of 
nitrogen at room temperature. The flask was cooled with an ice bath, the 
nitrogen flow removed, and phenoxyethanol (25cm3) was added dropwise to 
quench the reaction. The flask was heated to 50oC, and over a period of 8h, the 
ethanol passed over a glass bridge into a trap. The ethanol was carried onto the 
next step without characterisation. 
ri-^Cl-2H,l-Ethanol (21) 
Lithium alxmiinium deuteride (5.13g, 122.25mmol) was added to a solution of 
p-phenylphenacyl [l-13C]-acetate (21.43g, 84.05mmol) in anhydrous digljone 
(90cm3) as described above, resulting in the formation of [l-13c,l-2H2]-ethanoL 
Ethvl tosvlate 
A solution of ethanol in dry pj^dine (5cm3) was cooled with a dry ice / CQ4 
bath (-230C) whilst under N2. p-Toluenesulphonyl chloride (3.11g, 16.34mmol) 
was carefully added and the solution stirred for 2h. After warming to 0°C with 
an ice bath, the reaction was quenched with ice cold concentrated HQ (15cm 3). 
Ethyl tosylate predpitated upon standing at 0°C. The solid was collected by 
filtration, dried tmder vacuum and then finally dried in a dessicator at 0°C to 
give white crystals of ethyl tosylate (0.6g, 14.6%); 6H (CDQS) 7.8 (2H, d, J 7.92, 
CH), 7.35 (2H, d, J 8.08, CH), 4.12 (2H, q, J 7.16, CH2), 2.45 (3H, s, CH3), 1.3 (3H, 
t^J7.06,CH3). 
n-iaci-^H^l-Ethyl tosylate (22) 
D O 
CH3 
p-Toluenesulphonyl chloride (12.67g, 64.44mmol) was carefully added to a 
solution of [l-13c,l-2H2]-ethanol in dry pyridine (16cm3) whilst under N2 and 
at -23°C. Following the procedure described above, crystals of [l-^Kl,l-^H2\-
ethyl tosylate (3.99g, 27.3%) were isolated; m.p. 29.4r 30.6oC (lit [47(b)] m.p. 32-
340C); (Found: M+ 203.0536. C8I3C2H2H10O3S requires M+, 203.0664); Vnax 
(KBr)/cm-l 3120 - 3020,3000 - 2930,1600,1500,1360,1190; 6H (CDQa) 7.79 (2H, 
d, J 8, CH), 7.34 (2H, d, J 8, CH), 2.45 (3H, s, tos-CHs), 1-28 (3H, dp, 2JCH 4.4 and 
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3JDH 0.9, CH3); 6c (CDa3) 145.18,133.76,130.33 and 128.33 (Ph), 66.74 (p, IJCD 
22.9,13CD2), 22.14 (CH3), 14.97 (d, iJcc 38.1, CH3); m/z (EI) 203 (M+ 2121%), 
172 (13.37%), 155 (38.73%), 108 (14.9%), 107 (13.34%), 91 (100%). 
Propionitrile 
Potassium cyanide (0.19g, 2.97mmol) was added to a solution of ethyl tosylate 
(0.6g, 3.02nunol) in methanol: water (2:1,9cm3). After heating imder reflux for 
2h, L1.C. (petroleum ether: dichloromethane [70 : 30 v/v]) indicated that all the 
ethyl tosylate had been consiuned. The reaction mixture was distilled and used 
directly for the next reaction. 
[2-l3C2-2H?l-Propiomtrile (23) 
Potassium cyanide (1.26g, 19.37mmol) was added to a solution of [1-13C,1-2H2]-
ethyl tosylate (3.99g, 19.68mmol) in MeOD : D2O (3 : 1, 16cm3) under an 
atmosphere of nitrogen. Reaction and isolation conditions as above afforded [2-
l3C,2-2H2l-propionitrile. 
Sodium propionate 
A solution of KOH (2g, 35.65mmol) in H2O (2cm3) was added to the 
propionitrile distillate prepared above and the resulting mixture was heated 
under reflxix for 3 days. The lyophilisate collected after addification was 
neutralised with dilute NaOH. Fiiwl lyophilisation afforded sodium propionate 
(0.27g, 93.3%) as a white amorphous solid; Vmax (KBr)/cm-l 3620 - 3380,2900 -
2700,1570,1470; 6H (D2O) 2.04 (2H, q, J 7.6, CH2), 0.9 (3H, t, J 7.6, CH3); m/z 
(CD96(M+ 15%),72(15%). 
Sodium r2-^C2-2H9l-ptopionate (24) 
O 
D D 
A solution of KOD (3g, 52.53mmol) in D2O (3cm3) was added to the [2-l3C,2-
2H2]-propionitrile distillate prepared above and the resulting mixture was 
heated under reflux for 3 days imder an atmosphere of nitrogen. The 
lyophilisate collected after addification was neutralised wifli dilute NaOR A 
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final lyophilisation yielded sodiimi [2-l3c,2-2H2]-propionate (1.18g, 60.6%); 
m.p. 281.2 - 2830C (Ut [180] 285 - 286oC); Vmax (KBr)/cm-l 3600 - 3200, 2980 -
2840,1630,1560,1420; 6H (DzO) 0.93 (3H, dp, 2JCH 4.4 and 3JDH 1.1, CH3); 6c 
(D2O/TMS salt) 188.03 (d, Ijcc 51.3, CO), 33.35 (t, IJCD 19.5, 13CD), 33.05 (p, 
IJCD 19.4,13CD2), 12.% (d, iJcc 34.3, CH3). 
Diazomethane 
A solution of N-methyl-N-nitrosotoluene-p-sulphonamide (Dizald) (2.14g, 
lOmmol) in ether (60cm3) was placed in an Erlenmeyer flask (250cm3). A 
second Erlemneyer flask was charged with a solution of the sample to be 
methylated in ether (70cm3). A smooth glass bridge connected the two flasks 
which were cooled to 0°C and a solution of potassium hydroxide (0.8g, 
14.26mmol) in ethanol (20cm3) was added to the Dizald flask. After 5 min the 
solution of Dizald was heated and an ethereal solution of diazomethane 
(explosive, carcinogenic) distilled across into the reaction flask. Reaction was 
complete when the yellow colour persisted in this reaction flask. Excess 
diazomethane was removed by purging witii nitrogen. The ethereal solution 
was concentrated to dryness to afford the methylated sample. 
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Growth of Streptomvces sv. ATS 1287 
Streptomyces sp. ATS 1287 was grown on yeast - malt agar plates (yeast extract 
2g, malt extract 5g, glucose 2g, agar 7.5g, distilled water 500cm3, pH adjusted to 
7.2 with dilute KOH solution) for 16 days at 26.5oC 
The spores from the producing strain were used to iraioculate six Erlenmeyer 
flasks (250cm3), each containing 70 cm^ of seed medium (glucose 2.1g, malt 
extract 2.1g, yeast extract 0.84g, KQ 1.68g, distilled water 420cm3, pH adjusted 
to 7.3 with dilute KOH solution). These flasks were incubated on a orbital 
shaker (26.5oC, 200rpm) for 4 days. 
10 Erlenmeyer flasks (500an3) each containing lOOcm^ of production medium 
(soybean flour 50g, soybean oil 30g, dried yeast 3g, KG 3g, K2HPO4 0.2g, 
CaC03 3g, distilled water 1000cm3, pH adjusted to 7.2 with dilute KOH 
solution) were innoculated with 3cm3 of seed culture. The fermentation was 
carried out at 26.50c and 200rpm for 9 days. 
Isolation and purification of leptomvdn B 
The cells were harvested by centrifugation (14000rpm, A°C, 45min) and the 
myceUitun exhaustively extraded into acetone using a Soxhlet apparatus. The 
acetone extrad was dried and concentrated to drjTiess to yield a green/brown 
residue. This was washed with ethyl acetate (200cm3) and filtered to remove 
tmwanted solid. After concentration, the oil was extraded into methanol (2 x 
20cm3) to remove lipids. Concentration of the methanol layer afforded a 
residue containing leptomydn B. The supernatant, from the centrifugation, was 
extraded into ethyl acetate. The extrad was dried and concentrated to afford an 
011 which was combined with the oil obtained from the myceUiimi. Methylation 
with an etheral solution of diazomethane afforded an orange residue which 
was chromatographed over silica, activity eluted with chloroform and ethyl 
acetate (70 : 30 v/v) . Using a reference sample, the active fractions were 
combined and concentrated to dryness and then rechromatographed over 
silica, activity eluted with chloroform and ethyl acetate (85 : 15 v/v). This 
yielded a residue containing leptomydn A/B methyl ester (lOmg). A full 
n.m.r. assignment is given in Table A2 (Appendix 1, pg. ii). 
Feeding of sodium fl-^Cl-propionate to Strevtomvces sa. ATS 1287 
Sodivun [l-l3C]-propionate (1.29g, 13.30mmol) was dissolved in water (30cm3) 
and pulse fed at 3, 3.5 and 4 days to 10 x lOOcm^ cultures of Streptomyces sp. 
ATS 1287 using a micropore filter, such that the final concentration of sodixmi 
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[l-13C]-propionate was 13.3mM. Leptomydn A/B was subsequentiy isolated 
on day 9 as outlined above. 
Feeding of sodium r2-"C.2-2H9l-propionate to Streptomvces sv. ATS 1287 
Sodium [2-l3C,2-2H2]-propionate (1.09g, ll.Olmmol) was dissolved in water 
(30cm3). It was pulse fed at 3, 3.5 and 4 days to 8 x 100cm3 cultures of 
Streptomyces sp. ATS 1287 using a micropore filter, such that the final 
concentration of sodium [2-13c,2-2H2]-propionate was 13.76mM- Leptomydn 





Diethyl ethylmalonate (3.76g, 20mmol) was added carefully under N2 to a 
suspension of NaH (0.8g, 20mmol) in THF (20cm3) cooled to O C^. After initial 
effervescence, CH3I (2.84g, 20mmol) was added and the reaction mixture 
heated under reflux for 2h. A drop of ethanol was added to ensure that all the 
sodium hydride had been consmned. After the addition of water (10cm3), the 
produd was extraded into dichloromethane, dried and concentrated to afford 
diethyl ethylmethyhnalonate (2.75g, 68%) as a colourless oil; Vmax (neat)/cm-l 
2980,2930,1735,1470,1390 -1370; 6H (CDQs) 4.05 (4H, q, J 7, CH2), 1.78 (2H, q, 
J 7.5, CH2), 1.25 (3H, s, CH3), 1.13 (6H, t, J 7.1, CH3), 0.75 (3H, t, J 7.5, CH3); 6c 
(CDQs) 172.02 (CO), 60.87 (CH2), 53.98 (C), 28.58 (CH2), 19.23 (CH3), 14.04 
(CH3), 8.61 (CH3); m/z (EI) 203 (M+1,100%), 157 (45.83%), 129 (13.74%), 73 
(15%). 
Diethyl r^C^H^wirtfevn-ctfaylmethylmalonate (12) 
Diethyl ethylmalonate (2.58g, 13.7mmol) was added to a suspension of NaH 
(0.55g, 13.7mmol) in TOF (20cm3) cooled to O^C and under N2. 13C2H3I (2g, 
13.7mmol) was added and the reaction proceeded as above to afford diethyl 
[13c2H3-mc%/]-ethylmethylmalonate (1.98g, 70.2%); Vmax (neat)/cm-l 2980, 
2940,2230,1740,1465,1390,1370; 6H (CDQs) 4.17 (4I i q, J 7.0, CH2), 1.89 (2H, 
m, CH2), 125 (6H, t, J 7.1, CH3), 0.87 (3H, t, J 7.5, CH3); 6c (CDQs) 17Z23 (CO), 
60.99 (CH2), 53.91 (d, IJcc 34.5, C), 28.58 (CH2), 18.55 (septet, IJCD 19.7,13CD3), 
14.13 (CH3), 8.73 (CH3); m/z (EI) 207 (M+1,100%), 161 (75.24%), 133 (28.06%), 
73 (34.02%). 
Ethylmethvlmalonic add 
A solution of diethyl ethylmethyhnalonate (2.75g, 13.61mmol) in 5M KOH (4.2g 
KOH in 15cm3 H2O) was heated imder reflux for 12h. Upon cooling, the 
reaction mixture was addified with dilute HQ and the oiganics extraded into 
ether. The ether extrad was dried and concentrated to afford a white solid of 
ethyhnethyhnalonic add (1.56g, 78.5%); Vnox (KBr)/cm-i 3600 - 2500, 1705, 
1460; 6H (D2O) 1.57 (2H, q, J 7.6, CH2), 1.08 (3H, s, CH3), 0.58 (3H, t, J 7.5, CH3); 
6c (D2Q) 179.28 (CO), 56.98 (C), 31.13 (CH2), 21.61 (CH3), 10.83 (CH3). 
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ri3c2H<-ffleffevn-Ethvlmethvlmalonic add (13) 
A solution of diethyl [i3c2H3-me%/]-ethylmethylmalonate (1.98g, 9.61mmol) 
in 5M KOH was heated imder reflux for 12h. The reaction was worked up as 
above to afford [l3c2H3-?ne%r|-ethyhnetiiyhnalonic add (1.39g, 96.5%); Vmax 
(KBr)/cm-l 3560 - 3300, 3100 - 2900, 2220,1700,1400; 6H (D2O) 1.71 (2H, dq, J 
7.5 and 3JCH 3.2, CH2), 0.72 (3H, t, J 7.5, CH3); 6c (D2O) 179.83 (CO), 57.00 (d, 
IJCC 34.6, C) , 3129 (CH2), 21.09 (septet, IJcD 19.5,13CD3), 10.97 (CH3); m/z (Q) 
168 (M+ NH4+, 2.35%), 106,89. 
2-MethvIbutvric add 
A solution of ethylmetiiylmalonic add (1.56g, 10.68mmol) in H2O (15cm3) was 
carefully sealed imder vacuum in a Carius tube, and heated to ISO^C for 3h. 
After cooling, the tube was opened and the contents were extraded into ether. 
The ether extracts were dried and concentrated to give 2-methylbutyric add 
(0.4g, 36.4%); Vnax (neat)/cm-l 3500 - 3100, 2980, 2940, 2880,1710,1460,1410 
and 1390; 6H (CDQS) 12.05 (IH, broad s, OH), 2.4 (IH, sextet, J 7.5, CH), 1.61 
(2H, dq, J 7.4, CHt), 123 (3H, d, J 7.3, CH3), 0.95 (3H, t, J 7.5, CH3); 6c (CDa3) 
183.97 (CO), 40.94 (CH), 26.85 (CH2), 16.59 (CH3), 11.83 (CH3); m/z (EI) 104 
(M+1,89.63%), 86 (100%), 75 (54.78%), 58 (66.81%). 
p3C2H»-incffevn-2-Methvlbutvric add (14) 
OH 
13 CDa 
A solution of [13c2H3-me%Zl-€thybnethyhnalomc add (1.39g, 9.27mmol) in 
H2O (10cm3) was carefully sealed under vacuum in a steel bomb, and heated to 
I8O0C for 3h. Upon cooling, the contents of the steel bomb were worked up as 
previous to afford [l3c2H3-mefhyri-2-methylbutyric add (0.56g, 57%); Vmax 
(neat)/cm-l 3600 - 2800, 2960 - 2930, 2220,1710, 1420; 6H (CDQS) 12.05 (IH, 
broad s, OH), Z37 (IH, m, CH), 1.61 (2H, ddq, CH2), 0.95 (3H, t, J 72, CH3); 6c 
(CDQs) 184.09 (CO), 41.12 (d, IJcc 33.95, CH), 26.82 (CH2), 15.82 (septet, IJcD 
19.5,13CD3), 11.85 (CH3); m/z (EI) 107 (M+1,31.08%), 78 (100%), 61 (72.04%). 
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N.N-Dipropionyl cvstamine 
Propionyl chloride (20g, 216mmol) was very carefully added dropwise to an ice 
cooled solution of cystamine dihydrochloride (22.5g, lOOmmol) in H2O (20cm3). 
The pH of the reaction mixture was kept above pH 8.2 throughout the addition 
of the propionyl chloride by the addition of 12.5M KOH solution (35g of KOH 
and 50cm3 H2O). The resulting white predpitate was colleded by filtration and 
washed thoroughly with cold water. Upon drying, the white solid of N,N'-
dipropionyl cystamine (6.7g, 25.4%) was stored in a dessicator; m.p. 92-94.20C; 
Vmax (Nujol)/cm-i 3260, 3060,1625,1545; 6H (CDCI3) 6.59 (2H, broad s, NH), 
3.57 (4H, dt, J 6.3 and 5.8, CH2), 2.84 (4H, t, J 6.5, CH2), 2,27 (4H, q, J 7.6, CH2), 
1.16 (6H, t, J 7.4, CH3); 6c (CDa3) 175.09 (CO), 38.90 (CH2), 38.32 (CH2), 30.03 
(CH2), 10.31 (CH3); m/z (Q) 265 (M+1,4.18%), 209 (15.94%), 134 (40.88%). 
3% Sodium amalgam 
Distilled mercury (430g, 2.14mol) was carefully dropped onto small pie<^ of 
soditim (13g, 0.56mol) tmder an atmosphere of N2. The reaction was kept hot 
with the aid of a bimsen burner to maintain continuous reactiori. The hot liquid 
was subsequentiy poured into a glass dish and cut up into small pieces before 
the sodium amalgam cooled and solidified as a solid blodc 
N-Propionvl cysteamine 
3% Sodium amalgam (26g) was added to a solution of N,N'-dipropionyl 
cystamine (2.64g, lOmmol) in dry methanol (50an3) imder N2 and tiie reaction 
mixture stirred for 90 min. at room temperature. The ranaiiung mercury was 
removed by filtration, and the resulting doudy liquid was added to dilute HQ 
and extracted into dichloromethane. Drying and concentration of the 
dichloromethane extrad afforded N-propionyl cysteamine (l,88g, 70.7%) as a 
colourless oil; Vnax (neat)/cm-l 3300,3080,2980 - 2940,2580 - 2480,1650,1545, 
1465,1380; 6H (CDa3) 7.73 (IH, broad s, NH), 3.43 (2H, dt, J 7.9 and 6.2, CH2), 
2.68 (2H, dt, J 8.1 and 5.5, CH2), 2.29 (2H, q, J 7.6, CH2), 1.64 (IH, t, J 9.4, SH), 
1.17 (3H, t, J 7.5, CH3); 6c (CDQs) 175.12 (CO), 42.97 (CH2), 29.58 (CH2), 24.42 
(CH2), 10.30 (CH3); m/z (EI) 134 (M+1,100%), 74 (40.59%), 57 (38.47%). 
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N-Acetvlcvsteamine-2-methvlbutvrate 
1,3-Dicydohexylcarbodiimide (l.Olg, 3.8mmol), 4-dimethylaminopyridine 
(0.46g, 3.8mmol) and N-propionyl cysteamine (1.24g, 9.32nraiol) were added to 
a solution of 2-metiiylbutyric add (0.4g, 3.8mmol) in dry ether (25cm3) under 
N2. The reaction mixture was stirred for 12h at room temperature. A white 
predpitate formed which was removed by filtration and discarded. The filtrate 
was concentrated and then purified over silica gel (chloroform : ethyl acetate 
[70 : 30 v/v]). The active fractions were combined and concentrated to afford 
N-acetylcysteamine-2-methylbutyrate (0.59g, 71%) as a colourless oil, which 
was stored at 40C; Vmax (neat)/cm-l 3300, 3080, 2980, 2940, 2880,1690, 1655, 
1550,1460,1380; 6H (CDa3) 7.08 (IH, broad s, NH), 3.43 (2H, dt, J 8.0 and 6.0, 
CH2), 3.04 (2H, t, J 6.8, CH2), 2.61 (IH, sextet, J 6.0, CH), 222 (2H, q, J 7.0, CH2), 
1.60 (2H, dq, J 7.2, CH2), 1.15 (3H, d, CH3), 1.15 (3H, t, CH3), 0.91 (3H, t, J 7.6, 
CH3); 6c (CCOs) 204.16 (CO), 174.76 (CO), 50.04 (CH), 39.78 (CH2), 29.75 
(CH2), 28.38 (CH2), 27.35 (CH2), 17.36 (CH3), 11.83 (CH3), 1022 (CH3); m/z (EI) 
218 (M+1,6.81%), 134 (9.70%), 85 (14.04%), 57 (25.50%). 
N-Acetvlcvsteamine-fl3c2H^-mgf^hi/n-2-methvlbutvrate (15) 
1,3-Dicydohexylcarbodiimide (1.41g, 5.28mmol), 4-dimethylaminopyridine 
(0.65g, 5.28mmol) and N-propionyl cysteamine (0.9g, 6.77mmol) were added to 
a solution of [13c2H3-mefhyr|-2-methylbutyric add (0.56g, 5.28mmol) in dry 
ether (25cm3) under N2. The reaction and work up proceeded as above to 
afford N-acetylcysteamine-[l3c2H3-me%/]-2-methylbutyrate (1.16g, 96%); 
(Found: M+1, 222.1407. C9I3C2H3H16O2SN requires M+1, 222.1437); Vmax 
(neat)/cm-l 3342.1, 2972.0, 2928.6,1688.9,1657.2,1555.5; 6H (CDCI3) 7.42 (IH, 
broad s, NH), 3.38 (2H, dt, J 6.1 and 5.9, CH2), 3.03 (2H, t, J 8.0, CH2), 2.55 (IH, 
m, CH), 2.23 (2H, q, J 7.7, CH2), 1.59 (2H, m, CH2), 1.14 (3H, t, J 7.4, CH3), 0.90 
(3H, t, J 7.4, CH3); 6c (CDa3) 203.65 (CO), 174.72 (CO), 50.09 (d, IJcc 33.95, 
CH), 39.59 (CH2), 29.58 (CH2), 28.29 (CH2), 2725 (CH2), 16.49 (septet, IJCD 19.4, 
13CD3), 11.76 {CH3\ 10.16 (CH3); m/z (EI) 222 (M+1,100%), 133 (81.86%), 89 
(38.12%), 61 (86.87%). 
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Growth of Xvlaria cubensis 
Ten Erlenmeyer flasks (500cm3) containing 90cm3 of medium (malt extrad 
broth 27g, distilled water 900cm3) were innoculated from the producing strain. 
The culture was incubated in the dark at 23°C for 8 weeks. 
Isolation and purification of cubensic add 
The thick brittie mycelliimi was removed, cut up and air dried overnight The 
mycellium was exhaustively extraded (Soxhlet, 2 x lOh) into chloroform and 
the chloroform extrad dried and concentrated to yield an orange/red gum. 
This residue was treated with etheral diazomethane and concentrated to afford 
an off-white predpitate, which was purified over silica gel (100% ethyl acetate). 
Active fractions gave a blue colouration by Ll.c. (100% ethyl acetate) sprayed 
with anisaldehyde : gladal acetic add : sulphuric add (0.5ml: 50ml: 1ml v/v) 
and then heated. Combination and concentration of these active fractions 
followed by further purification with Cis reverse phase preparative 
chromatography, elution with MeOH : H2O (9 :1), afforded metiiyl cubensate 
(lOmg). A full 13c n.m.r. assignment is detailed in Table A3 (Appendix 1, pg. 
iii). 
Feeding of h-l'^-methvl 1-methionine toXvlaria cubensis 
L-[13C-me%fl-Methionine (0.50g, 3.33mmol) was dissolved in water (20cm3). It 
was fed on day 4 to cultiu-es (10 x 90cm3) of Xykria cubensis via a micropore 
filter, such that the final concentration of L-[l3C-me%Z]-methionine was 
3.7mM. After eight weeks, cubensic add was isolated as above. 
Feeding of h-\'^C^7.-methul 1-metfaionine to Xvlaria cubensis 
L-[^3c2H3-me%n-Methionine (0.50g, 3.26mmol) was dissolved in water 
(15cm3) and administered via a micropore filter to 15 x 90cm3 cultures of Xylaria 
cubensis on day 4 such that the final concentration of h-]}Kl'^3-methyl\-
methionine in each flask was 2.42mM. After eight weeks, cubensic add was 
isolated as previously described. 
Feeding of sodiimi fl-^C^-^H^tl-acetate toXvlaria cubensis 
Sodium [l-l302H3]-acetate (Ig, 11.63nmiol) was added to the culhire 
meditun before sterilisation. Thus the final cont^ntration of sodium 
2H3l-acetate was 16.15mM. Cubensic add was isolated from the cultures (8 x 
90cm3) dght weeks after innoculation as described above. 
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Feeding of sodium f ^ ^Vacetate toXularia cubensis 
Sodiimi [l3C2]-acetate (Ig, 11.91mmol) was added to the culture medium 
before sterilisation. Thus the final concentration of sodium [13C2]-acetate was 
16.5mM. Cubensic add was isolated from the cultures (8 x 90cm3) dght weeks 
after innoculation as described above. 
Feeding of N-acetvlcvsteamine-f2-^ C2Hi-mgtfevfl-2-methYlbutvrate to 
Xvlaria cubensis 
N-acetylcysteamine-[2-l3c2H3-mefhyZ]-2-methylbutyrate (Ig, 4.52mmol) was 
dissolved in ethanol (2.7cm3) and administered tHo a micropore filter on day 3 
to 10 X 90cm3 cultures of Xylaria cubensis such that the final concentration of N -
acetylq^steamine-[2-13c2H3-mef/iy/]-2-methylbutyrate was 5mM. After eight 




An ethereal solution of diazomethane was added to a solution of bromoacetic 
add (Ig, 7.20mmol) in ether (70cm3). Excess diazomethane was quenched 
cautiously with acetic add. After washing with saturated sodiiun bicarbonate 
solution (30cm3), the ether was removed by distillation at atmospheric 
pressure. The resultant methyl bromoacetate was not charaderised. 
Methyl r^^Vbromoacetate (29) 
An ethereal solution of diazomethane was added to a solution of [13C2]-
bromoacetic add (Ig, 7.09mmoles) in ether (70cm3). The isolation of methyl 
[l3C2]-bromoacetate was as outlined above. 
Carbomethoxymetiiyltriphenylphosphonium bromide 
Triphenylphosphine (1.98g, 7.56mmol) was added to a solution of methyl 
bromoacetate in acetonitrile (10cm3). The solution was stirred at room 
temperature for 3 days. A predpitate was colleded by filtration and washed 
w i t h hexane (5cm3). Dry ing under vacuum afforded 
carbomethoxymethyltriphenylphosphonium bromide (1.34g, 44.9%) as a white 
soUd; m.p. 148.8 - 150.7OC (Ut. [181] m.p. 163°C); (Found: C, 60.65; H, 4.81; N , 
0%. C2iH2oQ2BrP requires C, 60.74; H, 4.85; N , 0%); Vmax (KBr)/cm-l 3053.4, 
3006.1,2800.4,27313,1723,1586.6,1485.0,1439.5; 6H (CDQS) 7.96 to 7.65 (15H, 
m, Ph), 5.61 (2H, d, 2jpH 13.4, CH2), 3.60 (3H, s, CH3); 6c (CEOs) 165.22 (d, 2jpc 
3.12, CO), 13520 (d, 4jpc 3.1, p-CH), 134.01 (d, 3jpc 10.7, m-CH), 130.32 (d, 2jpc 
13.4, o<H), 117.93 (d, Ijpc 89.3, C), 53.47 (CH3), 33.04 (d, Ijrc 58.0, CH2); m/z 
(EI) 277 (41.98%), 262 (10.58%). 
n. 2 -^C^l-Carbomeflioxymethyltriphenylphosphoniimi bromide (30) 
O 
J -
¥ ^ OMe 
Triphenylphosphine (1.98g, 7.56mmol) was added to a solution of methyl 
[l3C2]-bromoacetate in aoetonitrile (8cm3). Reaction and isolation conditions as 
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outlined above afforded [l,2-l3C2]-carbomethox5miethyltriphenylphosphonium 
bromide (1.99g, 672%); m.p. 151.7 - 153.20C; (Found: C, 60.95; H, 4.64; N, 0%. 
Ci9l3C2H2o02BrP requires C, 60.93; H, 4.83; N , 0%); Vmax (KBr)/cm-l 3053.5, 
3008.1,2791.8,2728.8,1681.8,1586.7,1485.0,1439.6; 6H (CDa3) 7.92 - 7.65 (15H, 
m, Ph), 5.54 (2H, ddd, IJCH 134.4 and 2jpH 13.6 and 2JCH 7.7,13CH2), 3.59 (3H, 
d, 3jcH 4.06, CH3); 6c (CDa3) 165.51 (dd, i j c c 62.9 and 2jpc 3.3,13CO), 135.71 
(d, 4jpc 3.0, p-CH), 134.38 ( d, 3jpc 10.8, m-CH), 130.79 (d, 2jpc 13.3, o-CH), 
118.40 (d, i j p c 85.5, C), 54.0 (CHsl 33.37 (dd, IJcc 59.6 and I j pc 58.5,13CH2); 
m/z (EI) 303 (31.93%), 277 (100%), 262 (60.84%). 
Carbomethoxvmethvlenetriphenvlphosphine 
A solution of caibomethoxymethyltriphenylphosphonium bromide (1.31g, 
3.15mmol) in H2O (15cm3) was warmed imtil all the solid dissolved. Once 
cooled, dilute NaOH solution was added until the solution was just alkaline. 
The reaction was stirred for 30 min. at room temperature. H2O was added and 
the product extraded into chloroform. Drying the organic extract and 
concentration yielded an oil which immediately predpitated a white solid upon 
the addition of ether. This solid was colleded by filtration and dried to afford 
carbomethoxymethylenetriphenylphosphine (0.94g, 89.2%); m.p. 161.9 -
163.50C (lit. [181] m.p. 162 - 163oC); (Found: C, 75.66; H, 5.81; N, 0%. 
C21H19Q2P requires C, 75.44; H, 5.72: N , 0%); v^ax (KBr)/cm-l 3057.7,2958.8, 
2842.0,1618.3,1482.0,1434.5,1347.9; 6H (CDQS) 7.75 - 7.4 (16Ii m, Ph and CH), 
3.52 ( 3H, s, CH3); 6c (CDa3) 171.75 (d, 2jpc 4.0, CO), 133.04 (d, 3jpc 10.0, m-
CH), 131.9 (d, 4jpc 2.3, p-CH), 128.73 (d, 2jpc 12.4, o<H), 128.10 (d, Ijpc 91.9, 





A solution of [l,2-13C2]-carbomethoxymethyltriphenylphosphonium bromide 
(1.99g, 4.77mmol) in H2O (20cm3) was warmed until all the solid had dissolved. 
Reaction and isolation proceeded as above to yield the first crop of [1,2-13C2]-
carbomethoxymethylenetriphenylphosphine (1.26g, 3.74mmol). The ether 
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f i l t ra te was concentrated to y ie ld a second crop of [1,2-13C2]-
carbomethoxymethylenetriphenylphosphine (0.33g, 0.99minol). These two 
crops were combined (1.59g, 99.3%); Vnax (KBr)/cm-l 3053.9, 3006.1, 2790.6, 
1681.8,1579.9,148Z7, 1439.5; 6H (CDQS ) 7.9 - 7.4 (15H, m, Ph and C H ) , 3.56 
(3H, d, 3jcH 3.9, CHs); 6c (CDOs) 171.90 (dd, i j c c 87.2 and 2jpc 12.1, l3CO), 
133.51 ( dd, 4Jcc 26.8 and 3jpc 10.1, m-CH), 132.5 (d, 4jpc 5.2, p-CH), 129.12 ( 
dd, 3jcc 33.5 and 2jpc 12.8, o-CH), - (d, J -, C), 50.3 (CH3), 30.41 (dd, I jcc 124.6 
and ijpc 87.3,13CH); m/z (Q) 337 ( 0.32%), 305 (1.90%), 279 (2.59%). 
Methyl (E,E)-4-methvl-2,4-hecadienoate 
Trflns-2-methyl-2-butenal (0.29cin3, 2.97mmol) was added to a solution of 
carbomethoxymethylenetriphenylphosphine (0.90g, 2.70mmol) in dried and 
distilled etiianol (20cm3) under an atmosphere of N2. The solution was heated 
under reflux for 24h. The ethanol was evaporated under reduced pressure and 
purification over silica gel (100% dichloromethane) afforded methyl (E,E)-4-
methyl-2,4-hexadienoate (0.24g, 64.1%) as a colourless oi l ; Vmax (neat)/cm-l 
2949.8,1718.1,1620.1,1432.9; 6H ( C D Q S ) 7.32 ( IH , d, J 15.7, CH), 5.97 ( IH, q, J 
6.0, CH), 5.78 ( IH , d, J 15.1, CH), 3.74 (3H, s, CH3), 1.81 (3H, d, J 7.6, CH3), 1.77 
(3H, s, CH3); 6c (CDa3) 168.05 (CO), 149.73 (CH), 136.50 (CH), 133.78 (C), 
114.85 (CH), 51.40 (OMe), 14.56 (CH3), 11.76 (CH3); m/z (EI) 141 (M+1,100%), 
125 (56.45%), 109 (61.32%). 
Metfavl (E.E)-ri2-i3c,1.4-methvl-2.4-hexadienoate (32) 
OMe 
Trans-2-methyl-2-butenal (0.50cm3, 5.20mmol) was added to a solution of [1,2-
ISCzJ-carbomethoxjonethylenetriphenylphosphine (1.59g, 4.73mmol) in dried 
and distilled ethanol (30cm3) under an atmosphere of N2. Reaction and 
purif icat ion as above afforded methyl (E,E)-[l,2-13C2]-4-methyl-2,4-
hexadienoate (0.53g, 80.4%); v^ax (neat)/cm-l 2949.1, 1672.4, 1631.2, 1594.0, 
1433.2; 6H (CDQs) 7.32 ( IH, ddd, 3JHH 15.7 and 2JCH 6.6 and 3JCH 26, CH), 5.98 
( I H , q, J 7.0, CH), 5.77 ( IH , ddd, IJcH 161.97 and 3JHH 15.7 and 2JCH 3.2, CH), 
3.74 (3H, d, 3jcH 3.8, CH3), 1.81 (3H, d, J 7.6, CH3), 1.77 (3H, s, CH3); 6c (CDQs) 
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1 6 8 ^ (d, iJcc 76.3,13CO), 149.75 ( d, iJcc 75.4, CH), 136.72 (d, 3jcc 7.9, CH), 
134.2 (d , 2jcc 10.5, C), 115.14 (d, IJcc 76.4,13CH), 51.8 (OMe), 14.79 (CH3), 12.2 
(CH3). 
(E,E)-4-MetfavI-2,4-hexadienoic add 
A solution of methyl (E,E)-4-methyl-2,4-hexadienoate (0.24g, 1.72inmol) in 
methanol (12cm3) and I M NaOH (8cm3) was stirred for 16h at room 
temperature. The methanol was removed under reduced pressure. After 
addition of water, the aqueous extract was acidified with dilute H Q at O^C The 
organics were extracted into ether, dried and concentrated to yield (E,E)-4-
methyl-2,4-hexadienoic add (0.19g, 85.1%) as a white solid; m.p. 91.0 - 92.7oC 
(Ut. [182] 94 - 950C); vmax (KBr)/cm-l 2995.4, 2702.2, 2593.4, 1705.9,1674.5, 
1616.1,1417.8; 6H ( C E O S ) 11.98 ( IH, s, OH), 7.41 ( IH, d, J 15.7, CH), 6.06 (IH, q, 
J 10.0, CH), 5.79 ( IH, d, J 15.6, CH), 1.83 (3H, d, J 7.4, CH3), 1.79 (3H, s, CH3); 6c 
(CDa3) 173.47 (CO), 151.90 (CH), 137.91 (CH), 133.85 (C), 114.49 (CH), 14.68 
(CH3), 11.76 (CH3); m/z (EI) 126 (M+ 64.52%), 111 (100%), 81 (63.39%). 
(E.E)-ri.2-13c>>l-4-MctfavI-2.4-hexadienoic add (33) 
A solution of methyl (E,E)-[l,2-13C2l-4-methyl-2,4-hexadienoate (0.53g, 
3.75mmol) i n methanol (18cm3) and I M NaOH (12cm3) was stirred for 16h at 
room temperature. Isolation as outlined above yielded (E,E)-[1,2-13C2H-
methyl-2,4-hexadienoic add (0.18g, 38.4%); 6H (CDQS ) 12.15 ( IH , s, OH), 7.40 
( IH , ddd, 3JHH 15.7 and 2JCH 6.5 and 3JCH 22, CH), 6.04 ( IH , q, J 6.8, CH), 5.78 
( IH , ddd, IJcH 162.5 and 3JHH 15.6 and ^^CH 2.8, CH), 1.83 (3H, d, J 7.7, CH3), 
1.79 (3H, s, CH3); 6c (CDCla) 173.89 (d, iJcc 69.7,13cO), 152.5 ( d, iJcc 70.4, 
CH), 138.6 (d, 3jcc 20.1, CH), 134.3 ( d, C), 114.91 (d, iJcc 73.8,13CH), 15.07 
(CH3), 11.01 (CH3); m/z (EI) 128 (M+, 69.23%), 113 (100%), 82 (71.34%). 
N-AcetvIcvsteamine-(E,E)-4-inethvI-2.4-hexadienoate 
13-Dicydohexylcarbodiimide (029g, 1.40mmol) and 4-dimethylaminopyridine 
(0.17g, 1.40mmol) and N-propionyl cysteamine (0.19g, 1.40mmol) was added to 
a solution of (E,E)-4-methyl-2,4-hexadienoic add (0.18g, 1.40mmol) in dried and 
distilled ether (20cm3) imder an atmosphere of N2. The reaction mixture was 
stirred at room temperature for 12h. The white predpitate was removed by 
filtration and discarded. The filtrate was concentrated and purified over silica 
gel (ethyl acetate : acetone [85 : 15 v / v ] ) . The active fractions combined 
afforded N-a<Ktylcysteamine-(E,E)-4-methyl-2,4-hexadienoate (0.22g, 66%) as a 
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white soUd; m.p. 86.1-87.9°C; v^ax (KBr)/cm-l 3301.7, 3080.6, 2980.6, 2931.0, 
1673.0,1641.4,1599.8,1550.6; 6H (CDQs) 7.26 ( IH, d, J 15.5, CH), 6.44 ( IH, m, 
CH), 6.09 ( IH , d, J 15.5, CH), 3.48 (2H, dt, J 6, CHz), 3.13 (2H, t, J 8.5, CH2), 221 ( 
2H, q, J 7.7, CH2), 1.84 (3H, d, J 7.0, CH3), 1.78 (3H, s, CH3), 1.14 (3H, t, J 7.4, 
CH3); 6C (CDQs) 190.43 (CO), 174.20 ( CO), 146.20 (CH), 138.99 (CH), 133.62 
(C), 122.10 (CH), 39.73 (CH2), 29.59 (CH2), 28.36 (CH2), 14.88 (CH3), 11.74 
(CH3), 9.84 (CH3); m/z (O) 242 (M+1,100%), 109 (38.49%). 
N-AcetvIcvsteaiiiine-(E.E)-ri^-^3C'>l-4-metfavl-2.4-hexadienoate(34) 
13-Dicydohexylcaibodiimide (0.30g, 1.44mmol) and 4-dimethylaminopyridine 
(0.18g, 1.44mol) and N-propionyl cysteamine (0.26g, 1.95mmol) were added to 
a solution of (E,E)-[l,2-13C2]-4-methyl-2,4-hexadienoic add (0.18g, 1.44mmol) in 
dried and distilled ether (25cm3) imder an atmosphere of N2. Reaction and 
isolation conditions as outlined above yielded N-acetylcysteamine-(E,E)-[l,2-
13C2]-4-methyl-2,4-hexadienoate (0.15g, 43.5%) which had to be stored at 40C; 
(Found: M+1, 244.1291. C10I3C2H19Q2NS requires M+1,244.1282); 6H (CDQs) 
7.26 ( IH , ddd, 3JHH 15.5 and 2JCH 7.2 and 3JCH 1.5, CH), 6.44 ( IH, q, J 7.0, CH), 
6.09 ( IH , ddd, IJcH 160.9 and 3JHH 15.3 and 2JCH 5.4, CH), 3.47 (2H, dt, J 6.4, 
CH2), 3.13 (2H, t, J 5, CH2), 221 (2H, q, J 7.6, CH2), 1.84 (3H, d, J 7.0, CH3), 1-77 
(3H, s, CH3), 1.14 (3H, t, J 7.7, CH3); 6c (CDa3) 190.85 (d, iJcc 63.4, 13C0), 
174.65 (CO), 146.8 ( d, I j cc 55.3, CH), 139.5 (d, 3jcc 10.1, CH), 134.02 ( d, C), 
122.51 (d, IJcc 63.5, 1 3 C H ) , 40.15 (CH2), 30.02 (CH2), 28.79 (CH2), 15.03 (CH3), 
12.03 (CH3), 10.27 (CH3). 
3-Tetradecvlfluopropiomc add 
3-Mercaptopr<^ionic add (0.41cm3,4.71mmol) was carefully added to a stirred 
solution of KOH (0.64g, 11.35mmol) in dried and distilled methanol (10cm3) 
imder N 2 and at room temperature. 1-Bromotetradecane (0.55cm3,1.84mmol) 
was then added dropwise and the reaction mixture stirred for 12h at room 
temperature. H 2 O (20cm3) was added and the mixture heated until a turbid 
solution was obtained. Addification with cone H Q afforded a white 
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predpitate which was collected by filtration. Recrystallisation with acetone : 
water (9 : 1, lOcm^) yielded 3-tetradecylthiopropionic add (023g, 41.4%) as a 
white crystalline soUd; m.p. 70.0 - 70.9oC; (Found: M+, 302.2277. C17H34Q2S 
requires M+, 302.2280); Vmax (KBr)/cm-l 2917.7, 2846.9,1686.0,1462.5,1407.5; 
6H (CDQs) 2.78 (2H, broad t, J 6.8, CH2), 2.67 (2H, t, J 6.8, CH2), 2.54 ( 2 I i broad 
t, J 7.20, CH2), 1.58 (2H, p, J 8.0, CH2), 137 (2H, p, J 7.20, CH2), 1.26 (20H, broad 
s, CH2), 0.88 (3H, t, J 6.4, CH3); 6c (CDCI3) 177.96 (CO), 34.64 (CH2), 32.19 
(CH2), 31.92 (CH2), 29.65 (6 x CH2), 2952 (CH2), 2936 (CH2), 29.22 (CH2), 28.86 
(CH2), 26.56 (CH2), 22.69 (CH2), 14.12 (CH3); m/z (EI) 302 (M+, 22.58%), 229 
(100%). 
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Isolation and purification of cvtochalasin D 
The supernatant from the Xylaria cubensis cultures (10 x 90cm3) was extraded 
into ethyl acetate (400cm 3) and this organic extrad was dried and concentrated. 
Purification by silica gel coltimn chromatography (100% ethyl acetate) afforded 
cytochalasin D (lOOmg) as a white solid. A ful l I3c njn.r. assignment is detailed 
in Table A4 (Appendix 1, pg. iv); m.p. 238.5 - 240.7^0 
Feeding of N-acetvlcvsteamine-(E.E)-fl.2-^'>1-4-methvl-2A-hexadienoate 
toXvlaria cubensis 
N-Acetylcysteamine-(E,E)-[l,2-13C2]-4-methyl-2,4-hexadienoate (55.8mg, 
0.23nunol) was dissolved in ethanol (4cm3) and administered to 2 x 90cm3 
cultures of Xylaria cubensis via a micropore filter on day 4, such that the final 
concentration of N-acetylcysteamine-(E,E)-[l,2-13C2]-4-methyl-2,4-hexadienoate 
was 1.3mM. Cytochalasin D was isolated after three weeks as outlined above. 
Feeding of N-acetvlcvsteamine-(E.E)-fl.2-^C7l-4-methvl-2,4-hexadienoate 
and 3-tetradecvlthiopropionic add toXvlaria cubensis 
3-Tetradecylthiopropionic add (50mg, 0.17mmol) was dissolved in ethanol 
(0.75cm3) with heating and was administered qtdckly before cooling (in order 
to prevent i t crashing out of solution) xm a micropore filter to 1 x 90cm3 flask of 
Xylaria cubensis before innoculation. On day 4, 3-tetradecyltiiiopropionic add 
(50mg) was administered in a similar manner, followed by the addition of N -
acetylcysteamine-(E,E)-[l,2-l3(22]-4-methyl-2,4-hexadienoate (30mg, 0.12mmol) 
which was dissolved in ethanol (lcm3) and administered via a micropore filter 
such that the final concentration of N-acetylcysteamine-(E,E)-[l,2-l3C2H-
methyl-2,4-hexadienoate was 1.37mM. Cytochalasin D was isolated after three 
weeks as outlined above. 
APPENDIX 1 
TABLES 
10" 15 34 
HO^^A^/^ \i2 / \^ 1 
^/ ' / . l l 5^ ° 1 5^^ r>9 35 





a 181.26 181.20 a 9 3324 33.33 
C2 44.98 45.07 C20 76.40 76.45 
C3 82.93 83.11 C21 74.46 74.51 
C4 37.44 37.50 C22 31.83 31.87 
C5 68.32 68.33 C23 35.60 35.75 
C6 34.83 34.87 C24 36.50 36.56 
C7 70.41 70.51 C25 9826 98.31 
C8 33.51 33.56 C26 64.85 64.92 
C9 106.94 107.03 C27 16.69 16.72 
CIO 39.21 39.28 C28 57.92 57.84 
C l l 33.16 3325 C29 11.07 10.97 
C12 85.19 8526 C30 10.50 10.48 
C13 82.49 82.52 C31 27.44 27.47 
a 4 27.26 2726 C32 30.65 30.60 
a 5 29.81 29.91 C33 823 8.14 
€16 85.79 85.90 C34 14.57 14.56 
C17 84.97 84.94 C35 16.82 16.80 
a s 34.30 34.39 C36 16.07 16.03 
Table A l : 13c n.m.r. chemical shifts of monensin A recorded as a solution in 
CDa3at lOOMHz compared with literature values.47 
u 
OH o 7^ 
M o n 2^ 21 1 I I 15 13 11 9 
N j K S ^ ^ ' ^ N Z ^ X ^ ^ S l ^ ^ ^ ^ S l ^ 26 





a 164.3 1642 C18 46.5 47.0 
C2 120.1 120.0 C19 743 742 
C3 151.5 151.7 C20 33.4 33.6 
C4 33.6 33.6 C21 452 45.7 
C5 81.5 81.5 C22 158.5 158.4 
C6 122.7 122.8 C23 117.0 117.1 
C7 130.2 130.2 C24 167.0 167.0 
C8 135.5 135.5 C25 1Z4 12.4 
C9 137.0 137.0 C26 26.6 26.6 
a o 322 322 C27 13.6 13.6 
C l l 40.8 40.8 C28 13.1 13.1 
C12 1282 1282 C29 18.4 18.4 
C13 1352 1353 C30 12.5 12.4 
a 4 136.5 136.4 C31 20.9 20.8 
a s 128.1 128.0 C32 13.7 13.7 
C16 453 45.7 C33 16.1 16.1 
C17 2153 2152 OMe 50.9 50.8 
Table A2:13c n.m.r. chemical shifts of leptomydn B methyl ester recorded 
as a solution in CDQsat lOOMHz compared with literature values.102 
m 
OH OH OH OH 0 





a 176.59 176.61 C17 131.17 131.81 
C2 44.22 43.97 C18 39.03 38.91 
C3 80.98 8127 a 9 39.03 38.79 
C4 135.67 135.62 C20 32.37 32.41 
C5 133.19 133.58 a i 30.89 30.91 
C6 38.80 38.55 C22 11.74 11.72 
C7 77.48 78.01 C23 14.73 14.71 
C8 13321 133.66 C24 10.88 10.73 
C9 135.92 136.64 C25 17.39 17.48 
CIO 43.68 43.74 C26 17.47 17.84 
C l l 77.35 77.81 C27 17.96 18.02 
C12 132.92 133.12 C28 11.66 11.53 
C13 136.60 137.32 C29 66.82 66.93 
C14 40.69 40.78 C30 19.04 19.05 
C15 82.93 833 OMe 51.43 51.50 
C16 138.40 138.33 
Table A3:13C n.m.r. chemical shifts of methyl cubensate recorded as a 
solution in C5D5N at lOOMHz compared with literature values.112 
IV 
12 
4 N ^ 2 - HN—1 | \ ^ ^ 1 8 





a 17527 174.9 C16 42.60 42.45 
C3 54.16 54.00 C17 211.03 210.7 
C4 50.22 50.00 a 8 78.56 78.32 
C5 33.30 33.12 C19 128.00 127.7 
C6 151.77 151.4 C20 133.97 133.7 
C7 71.44 7120 C21 78.14 77.92 
C8 48.02 47.8 c r 138.59 1383 
C9 54.52 54.37 C2',C6' 130.06 129.9 
a o 45.64 45.49 C3',C5' 128.96 128.7 
a i 13.76 13.65 C4' 126.97 126.8 
a 2 112.34 1122 C22 19.52 19.44 
a 3 132.35 132.10 C=0(Ac) 170.64 1703 
C14 132.92 132.7 CH3(Ac) 20.69 20.61 
a 5 38.71 38.58 C23 24.77 24.64 
Table A4:13C n.m.r. chemical shifts of cytochalasin D recorded as a solution 
in C5D5N at lOOMHz compared with literature valuesl56 
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